Amalgamated Financial (AMAL) 10-K 9 Mar 23 2022 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 09, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-40136
Entity Registrant Name	Amalgamated Financial Corp.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-2757101
Entity Address, Address Line One	275 Seventh Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	212
Local Phone Number	255-6200
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	AMAL
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Smaller Reporting Company	false
Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 277,069,932
Entity Common Stock, Shares Outstanding		30,736,141
Documents Incorporated by Reference	The information required by Part III of this Annual Report on Form 10-K is incorporated by reference from the registrant’s definitive proxy statement relating to the 2023 Annual Meeting of Stockholders, which will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Annual Report on Form 10-K relates.
Entity Central Index Key	0001823608
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Audit Information [Abstract]
Auditor Name	Crowe LLP
Auditor Location	New York, New York
Auditor Firm ID	173

Consolidated Statements of Fina

Consolidated Statements of Financial Condition - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 5,110	$ 8,622
Interest-bearing deposits in banks	58,430	321,863
Total cash and cash equivalents	63,540	330,485
Securities:
Available for sale, at fair value (amortized cost of $1,944,343 and $2,103,049, respectively)	1,812,476	2,113,410
Held-to-maturity (fair value of $1,414,871 and $849,704, respectively)	1,541,301	843,569
Loans held for sale	7,943	3,279
Loans receivable, net of deferred loan origination costs	4,106,002	3,312,224
Allowance for loan losses	(45,031)	(35,866)
Loans receivable, net	4,060,971	3,276,358
Resell agreements	25,754	229,018
Federal Home Loan Bank of New York ("FHLBNY") stock, at cost	29,607	3,720
Accrued interest and dividends receivable	41,441	28,820
Premises and equipment, net	9,856	11,735
Bank-owned life insurance	105,624	107,266
Right-of-use lease asset	28,236	33,115
Deferred tax asset, net	62,507	26,719
Goodwill	12,936	12,936
Intangible assets, net	3,105	4,151
Equity investments	8,305	6,856
Other assets	29,522	46,439
Total assets	7,843,124	7,077,876
Liabilities
Deposits	6,595,037	6,356,255
FHLBNY advances	580,000	0
Subordinated debt, net	77,708	83,831
Operating leases	40,779	48,160
Other liabilities	40,645	25,755
Total liabilities	7,334,169	6,514,001
Stockholders’ equity
Common stock, par value $0.01 per share (70,000,000 shares authorized; 30,700,198 and 31,130,143 shares issued and outstanding, respectively)	307	311
Additional paid-in capital	286,947	297,975
Retained earnings	330,275	260,047
Accumulated other comprehensive income (loss), net of income taxes	(108,707)	5,409
Total Amalgamated Financial Corp. stockholders' equity	508,822	563,742
Noncontrolling interests	133	133
Total stockholders' equity	508,955	563,875
Total liabilities and stockholders’ equity	$ 7,843,124	$ 7,077,876

Consolidated Statements of Fi_2

Consolidated Statements of Financial Condition (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Available for sale, amortized cost	$ 1,944,343	$ 2,103,049
Fair Value	$ 1,414,871	$ 849,704
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	70,000,000	70,000,000
Common stock, shares issued (in shares)	30,700,198	31,130,143
Common stock, shares outstanding (in shares)	30,700,198	31,130,143

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
INTEREST AND DIVIDEND INCOME
Loans	$ 145,649	$ 123,318	$ 141,983
Securities	110,654	56,557	47,815
Interest-bearing deposits in banks	2,186	651	697
Total interest and dividend income	258,489	180,526	190,495
INTEREST EXPENSE
Deposits	11,056	5,823	10,452
Borrowed funds	7,593	399	27
Total interest expense	18,649	6,222	10,479
NET INTEREST INCOME	239,840	174,304	180,016
Provision for (recovery of) loan losses	15,002	(287)	24,791
Net interest income after provision for loan losses	224,838	174,591	155,225
NON-INTEREST INCOME
Trust Department fees	14,449	13,352	15,222
Service charges on deposit accounts	10,999	9,355	9,201
Bank-owned life insurance	3,868	2,388	3,085
Gain (loss) on sale of securities	(3,637)	649	1,605
Gain (loss) on sale of loans, net	(610)	1,887	2,520
Loss on other real estate owned, net	(168)	(407)	(482)
Equity method investments income (loss)	(2,773)	150	7,411
Other	1,769	1,015	2,042
Total non-interest income	23,897	28,389	40,604
NON-INTEREST EXPENSE
Compensation and employee benefits	74,712	69,844	69,421
Occupancy and depreciation	13,723	14,023	23,040
Professional fees	10,417	12,961	11,205
Data processing	17,732	16,042	11,330
Office maintenance and depreciation	3,012	3,057	3,314
Amortization of intangible assets	1,046	1,207	1,370
Advertising and promotion	3,741	3,230	3,514
Federal deposit insurance premiums	3,228	2,531	3,150
Other	12,960	9,360	7,542
Total non-interest expense	140,571	132,255	133,886
Total reclassifications	108,164	70,725	61,943
Income before income taxes	108,164	70,725	61,943
Income tax expense (benefit)	26,687	17,788	15,755
Net income	$ 81,477	$ 52,937	$ 46,188
Earnings per common share - basic (in dollars per share)	$ 2.64	$ 1.70	$ 1.48
Earnings per common share - diluted (in dollars per share)	$ 2.61	$ 1.68	$ 1.48

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 81,477	$ 52,937	$ 46,188
Other comprehensive income (loss), net of taxes:
Change in total obligation for postretirement benefits and for prior service credit and for other benefits	635	(63)	362
Net unrealized gains (losses) on securities:
Unrealized holding gains (losses) on securities available for sale	(163,001)	(15,438)	20,374
Reclassification adjustment for losses (gains) realized in income	3,621	(654)	(1,604)
Accretion of net unrealized loss on securities transferred to held-to-maturity	1,255	0	0
Change in unrealized gains (losses) on available for sale securities	(158,125)	(16,092)	18,770
Change in unrealized gains (losses) on available for sale securities	(157,490)	(16,155)	19,132
Income tax benefit (expense)	(43,374)	(4,388)	5,181
Other comprehensive loss, net of taxes	(114,116)	(11,767)	13,951
Total comprehensive income (loss), net of taxes	$ (32,639)	$ 41,170	$ 60,139

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Total Stockholders' Equity	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2019			31,523,442
Beginning balance at Dec. 31, 2019	$ 490,544	$ 490,410	$ 315	$ 305,738	$ 181,132	$ 3,225	$ 134
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	46,188	46,188			46,188
Dividend declared on AREMCO Sr. Preferred class B shares and Jr. Preferred shares	(22)	(22)			(22)
Dividends on common stock	(10,081)	(10,081)			(10,081)
Redemption of AREMCO class B shares	(5)	(4)			(4)		(1)
Repurchase of common stock (in shares)			(525,015)
Repurchase of common stock	(7,001)	(7,001)	$ (5)	(6,996)
Exercise of stock options, net of repurchases (in shares)			1,872
Stock-based compensation expense	(23)	(23)		(23)
Restricted stock unit vesting, net of repurchases (in shares)			49,226
Restricted stock unit vesting, net of repurchases	(116)	(116)		(116)
Stock-based compensation expense	2,386	2,386		2,386
Other comprehensive loss, net of taxes	13,951	13,951				13,951
Ending balance (in shares) at Dec. 31, 2020			31,049,525
Ending balance at Dec. 31, 2020	535,821	535,688	$ 310	300,989	217,213	17,176	133
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	52,937	52,937			52,937
Dividend declared on AREMCO Sr. Preferred class B shares and Jr. Preferred shares	(22)	(22)			(22)
Dividends on common stock	(10,081)	(10,081)			(10,081)
Repurchase of common stock (in shares)			(178,937)
Repurchase of common stock	(2,920)	(2,920)	$ (1)	(2,919)
Exercise of stock options, net of repurchases (in shares)			173,532
Stock-based compensation expense	(1,799)	(1,799)	$ 2	(1,801)
Restricted stock unit vesting, net of repurchases (in shares)			86,023
Restricted stock unit vesting, net of repurchases	(90)	(90)		(90)
Stock-based compensation expense	1,796	1,796		1,796
Other comprehensive loss, net of taxes	$ (11,767)	(11,767)				(11,767)
Ending balance (in shares) at Dec. 31, 2021	31,130,143		31,130,143
Ending balance at Dec. 31, 2021	$ 563,875	563,742	$ 311	297,975	260,047	5,409	133
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	81,477	81,477			81,477
Dividend declared on AREMCO Sr. Preferred class B shares and Jr. Preferred shares	(22)	(22)			(22)
Dividends on common stock	(11,227)	(11,227)			(11,227)
Repurchase of common stock (in shares)			(669,176)
Repurchase of common stock	$ (12,478)	(12,478)	$ (7)	(12,471)
Exercise of stock options, net of repurchases (in shares)	402,420		92,244
Stock-based compensation expense	$ (897)	(897)	$ 1	(898)
Restricted stock unit vesting, net of repurchases (in shares)			115,222
Restricted stock unit vesting, net of repurchases	(1,004)	(1,004)	$ 2	(1,006)
Common stock issued under Employee Stock Purchase Plan (in shares)			31,765
Common stock issued under Employee Stock Purchase Plan	665	665		665
Stock-based compensation expense	2,682	2,682		2,682
Other comprehensive loss, net of taxes	$ (114,116)	(114,116)				(114,116)
Ending balance (in shares) at Dec. 31, 2022	30,700,198		30,700,198
Ending balance at Dec. 31, 2022	$ 508,955	$ 508,822	$ 307	$ 286,947	$ 330,275	$ (108,707)	$ 133

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 81,477	$ 52,937	$ 46,188
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,547	3,638	6,194
Amortization of intangible assets	1,046	1,207	1,370
Deferred income tax expense (benefit)	14,375	7,050	(407)
Provision for (recovery of) loan losses	15,002	(287)	24,791
Stock-based compensation expense	2,682	1,796	2,386
Net amortization (accretion) on loan fees, costs, premiums, and discounts	1,361	2,743	3,199
Net amortization on securities	4,396	3,869	1,837
OTTI loss (gain) recognized in earnings	(16)	(5)	1
Net loss (income) from equity method investments	2,773	(150)	(7,411)
Net loss (gain) on sale of securities available for sale	3,637	(649)	(1,605)
Net loss (gain) on sale of loans	610	(1,887)	(2,520)
Net loss on sale of other real estate owned	168	407	482
Net gain on owned property held for sale	0	0	(1,394)
Net gain on redemption of bank-owned life insurance	(1,895)	(266)	(1,594)
Net gain on repurchase of subordinated debt	(617)	0	0
Proceeds from sales of loans held for sale	28,414	123,566	159,309
Originations of loans held for sale	(8,391)	(112,833)	(165,569)
Increase in cash surrender value of bank-owned life insurance	(1,973)	(2,122)	(1,514)
Increase in accrued interest and dividends receivable	(12,621)	(4,850)	(4,882)
Decrease (increase) in other assets	19,114	7,445	11,041
Decrease in other liabilities	(5,767)	(11,071)	(4,131)
Net cash provided by operating activities	147,322	70,538	65,771
CASH FLOWS FROM INVESTING ACTIVITIES
Net decrease (increase) in loans	(826,273)	167,545	(36,599)
Purchase of securities available for sale	(678,910)	(1,220,727)	(683,688)
Purchase of securities held-to-maturity	(584,906)	(472,615)	(256,093)
Proceeds from sales of securities available for sale	249,936	111,274	94,698
Maturities, principal payments and redemptions of securities available for sale	325,614	508,211	278,524
Maturities, principal payments and redemptions of securities held-to-maturity	139,326	119,802	52,779
Decrease (increase) in resell agreements	203,264	(74,239)	(154,779)
Increase in equity method investments	(7,359)	(5,764)	(31,039)
Purchase of bank-owned life insurance	0	0	(25,000)
Decrease (increase) of FHLBNY stock, net	(25,887)	214	3,105
Purchases of premises and equipment, net	(1,668)	(2,396)	(1,612)
Proceeds from redemption of bank-owned life insurance	4,233	1,010	2,934
Proceeds from sale of owned assets	0	0	1,613
Proceeds from sale of other real estate owned	139	2,275	20
Net cash used in investing activities	(1,202,491)	(865,410)	(755,137)
CASH FLOWS FROM FINANCING ACTIVITIES
Net increase in deposits	238,782	1,017,544	697,729
Net increase (decrease) in FHLBNY advances	(580,000)	0	75,000
Net increase (decrease) in subordinated debt	(5,633)	83,831	0
Common stock issued under Employee Stock Purchase Plan	665	0	0
Redemption of AREMCO class B shares	0	0	(5)
Repurchase of shares	(12,478)	(2,920)	(7,001)
Dividends paid	(11,211)	(9,978)	(9,987)
Exercise of stock options, net of repurchases	(897)	(1,799)	(23)
Restricted stock units vesting, net of repurchases	(1,004)	(90)	(116)
Net cash provided by financing activities	788,224	1,086,588	605,597
Increase (decrease) in cash, cash equivalents, and restricted cash	(266,945)	291,716	(83,769)
Cash, cash equivalents, and restricted cash at beginning of year	330,485	38,769	122,538
Cash, cash equivalents, and restricted cash at end of year	63,540	330,485	38,769
Supplemental disclosures of cash flow information:
Interest paid during the year	18,000	6,039	11,476
Income taxes paid during the year	6,646	5,692	9,823
Supplemental non-cash investing activities:
Right-of-use assets obtained in exchange for lease liabilities	2,337	0	777
Loans transferred to held-for-sale	25,304	1,000	8,850
Loans transferred to other real estate owned	0	2,682	0
Purchase of securities available for sale, net not settled	14,000	0	12,080
Securities available for sale transferred to held-to-maturity	$ 260,112	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations and Principles of Consolidation Amalgamated Financial Corp., a Delaware public benefit corporation (the "Company"), was formed on August 25, 2020 to serve as the holding company for Amalgamated Bank and is a bank holding company registered with the Federal Reserve Board of Governors under the Bank Holding Company Act of 1956, as amended. On March 1, 2021 (the “Effective Date”), the Company acquired all of the outstanding stock of Amalgamated Bank, a New York state-chartered commercial bank in a statutory share exchange transaction (the “Reorganization”) effected under New York law and in accordance with the terms of a Plan of Acquisition dated September 4, 2020 (the “Agreement”). Pursuant to the Reorganization, the Bank became the sole subsidiary of the Company, the Company became the holding company for the Bank and the stockholders of the Bank became stockholders of the Company. The Bank was formed in 1923 as Amalgamated Bank of New York by the Amalgamated Clothing Workers of America, one of the country’s oldest labor unions. The audited consolidated financial statements presented in this Annual Report on Form 10-K include the collective results of the Holding Company and its wholly-owned subsidiary, the Bank, which are collectively herein referred to as the “Company.” Basis of Accounting and Changes in Significant Accounting Policies The accounting and reporting policies of the Company conform to generally accepted accounting principles ("GAAP") in the United States of America, or GAAP and predominant practices within the banking industry. The Company uses the accrual basis of accounting for financial statement purposes. The accompanying consolidated financial statements include the accounts of the Company and its majority-owned and wholly-owned subsidiaries. All significant inter-company transactions and balances are eliminated in consolidation. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. In particular, estimates and assumptions are used in measuring the fair value of certain financial instruments, determining the appropriateness of the allowance for loan and lease losses (“allowance”), evaluating potential other-than-temporary securities impairment, assessing the ability to realize deferred tax assets, and the valuation of share-based payment awards. Estimates and assumptions are based on available information and judgment; therefore actual results could differ from those estimates. Cash, Cash Equivalents and Restricted Cash For purposes of reporting cash flows, cash, cash equivalents, and restricted cash include cash, due from banks, interest-bearing deposits in other banks and federal funds sold with original maturities of three months or less. The Company had $0.4 million and $0.4 million in restricted cash as of December 31, 2022 and December 31, 2021, respectively and is included in total cash and cash equivalents on the Consolidated Statements of Financial Condition. The Company’s restricted cash reflects funds held in other financial institutions to secure business operating rights or contractually obligated minimum account funding requirements. Securities Purchases of investments in debt securities are designated as either trading, available for sale or held-to-maturity depending on the intent and ability to hold the securities. The initial designation is made at the time of purchase. As of December 31, 2022 and December 31, 2021, the Company had no securities designated as trading. Securities available for sale are carried at fair value, with any net unrealized appreciation or depreciation in fair value reported net of taxes as a component of accumulated other comprehensive income (loss) in stockholders’ equity. Debt securities held-to-maturity are carried at amortized cost provided management does not have the intent to sell these securities and does not anticipate that it will be necessary to sell these securities before the full recovery of principal and interest, which may be at maturity. The Company reported its investments in "Property Assessed Clean Energy" ("PACE") assessments as held-to-maturity securities. Management conducts a periodic evaluation of securities available for sale and held-to-maturity to determine if the amortized cost basis of a security has been other-than-temporarily impaired ("OTTI"). The evaluation of other-than-temporary impairment is a quantitative and qualitative process, which is subject to risks and uncertainties. If the amortized cost of an investment exceeds its fair value, management evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than amortized cost, the probability of a near-term recovery in value, whether management intends to sell the security and whether it is more likely than not that the Company will be required to sell the security before full recovery of the investment or maturity. Management also considers specific adverse conditions related to the financial health, projected cash flow and business outlook for the investee, including industry and sector performance, operational and financing cash flow factors and rating agency actions. For debt investment securities deemed to be other-than-temporarily impaired, the investment is written down to fair value with the estimated credit loss charged to current earnings and the noncredit-related impairment loss charged to other comprehensive income. If market, industry and/or investee conditions deteriorate, the Company may incur future impairments. Premiums (discounts) on debt securities are amortized (accreted) to income using the level yield method to the contractual maturity date adjusted for actual prepayment experience. Realized gains and losses on sale of securities are determined using the specific identification method and are reported in non-interest income. Loans Held for Sale Loans held for sale in the secondary market are carried at the lower of cost or estimated fair value in the aggregate. Net unrealized losses, if any, are recognized through a valuation allowance by charges to current earnings. Gains or losses resulting from sales of loans held for sale, net of unamortized deferred fees and costs, are recognized at the time of sale and are included in other non-interest income on the Consolidated Statements of Income. The Company had $7.9 million and $3.3 million of loans classified as held for sale as of December 31, 2022 and December 31, 2021, respectively. Loans and Loan Interest Income Recognition Loans are stated at the principal amount outstanding, net of charge-offs, deferred origination costs and fees and purchase premiums and discounts. Loan origination and commitment fees and certain direct and indirect costs incurred in connection with loan originations are deferred and amortized to income over the life of the related loans as an adjustment to yield. Premiums or discounts on purchased portfolios are amortized or accreted to income using the level yield method. Interest on loans is generally recognized on the accrual basis. Interest is not accrued on loans that are more than 90 days delinquent on payments, and any interest that was accrued but unpaid on such loans is reversed from interest income at that time, or when deemed to be uncollectible. Interest subsequently received on such loans is recorded as interest income or alternatively as a reduction in the amortized cost of the loan if there is significant doubt as to the collectability of the unpaid principal balance. Loans are returned to accrual status when principal and interest amounts contractually due are brought current and future payments are reasonably assured. A loan is impaired when, based on current information and events, it is probable that the Company will not be able to collect all amounts due, both principal and interest, according to the contractual terms. Individual loans which are deemed to be impaired are measured based on the present value of expected future cash flows discounted at the loan’s effective interest rate or at the loan’s observable market price or the fair value of the collateral net of estimated selling costs if the loan is collateral dependent. Individual loan impairment evaluation is generally limited to multifamily, commercial real estate ("CRE"), commercial and industrial ("C&I"), construction and certain restructured residential real estate loans. Smaller balance loans including home equity lines of credit ("HELOCs"), consumer and student loans, as well as non-restructured residential real estate loans, are considered homogeneous. When assessing homogenous loans for impairment, the Company considers regulatory guidance concerning the classification and management of retail credits. The aggregate amount of individually and collectively measured loan impairment is included as a component of the allowance. Loans are considered troubled debt restructurings ("TDRs") if the borrower is experiencing financial difficulty and is afforded a concession by the Company, such as, but not limited to: (i) payment deferral; (ii) a reduction of the stated interest rate for the remaining contractual life of the loan; (iii) an extension of the loan’s original contractual term at a stated interest rate lower than the current market rate for a new loan with similar risk; (iv) capitalization of interest; or (v) forgiveness of principal or interest. Generally, TDRs are placed on nonaccrual status (and reported as non-performing loans) until the loan qualifies for return to accrual status. A TDR loan is considered impaired. A loan extended or renewed at a stated interest rate equal to the market interest rate for new debt with similar risk is not considered to be a TDR. In accordance with the accounting guidance for business combinations, no allowance is brought forward on any of the loans we acquire. For purchased non-credit impaired loans, credit and interest rate discounts representing the principal losses expected over the life of the loan are a component of the initial fair value and the total combined discount is accreted to interest income over the life of the loan. Subsequent to the acquisition date, the method used to evaluate the sufficiency of the discount is similar to organic loans, and if necessary, additional reserves are recognized in the allowance. Allowance for Loan Losses The allowance for loan and lease losses (“allowance”) is a valuation allowance for probable incurred credit losses. The Company monitors its entire loan portfolio on a regular basis and considers numerous factors including (i) end-of-period loan levels and portfolio composition, (ii) observable trends in non-performing loans, (iii) the Company’s historical loan loss experience, (iv) known and inherent risks in the portfolio, (v) underwriting practices, (vi) adverse situations which may affect the borrower’s ability to repay, (vii) the estimated value and sufficiency of any underlying collateral, (viii) credit risk grading assessments, (ix) loan impairment, and (x) economic conditions. The allowance consists of specific and general components. The specific component relates to loans that are individually classified as impaired. Additions to the allowance are charged to expense, and realized losses, net of recoveries, are charged to the allowance. Based on the determination of management, the overall level of allowance is periodically adjusted to account for the inherent and specific risks within the entire portfolio. Based on review of the classified loans and the overall allowance levels as they relate to the entire loan portfolio at December 31, 2022, management believes the allowance is adequate. Generally, a loan is considered for charge-off when it is in default of either principal or interest after 90 days or more. In addition to delinquency criteria, other triggering events may include, but are not limited to, notice of bankruptcy by the borrower or guarantor, death of the borrower, and deficiency balance from the sale of collateral. Some financial instruments, such as loan commitments, credit lines, letters of credit, and overdraft protection, are issued to meet customer financing needs. These are agreements to provide credit or to support the credit of others, as long as conditions established in the contract are met, and usually have expiration dates. Commitments may expire without being used. Off-balance sheet risk to credit loss exists up to the face amount of these instruments, although material losses are not anticipated. The same credit policies are used to make such commitments as are used for loans, often including obtaining collateral at exercise of the commitment. An allowance is calculated and recorded in other liabilities within the Consolidated Statements of Financial Condition. While management uses available information to recognize losses on loans, future additions or reductions to the allowance may be necessary due to changes in one or more evaluation factors; management’s assumptions as to rates of default, loss or recovery, or management’s intent with regard to disposition. A shift in lending strategy may warrant a change in the allowance due to a changing credit risk profile. In addition, various regulatory agencies, as an integral part of the examination process, periodically review the Company’s allowance. Such agencies may require the Company to recognize additions to, or charge-offs against, the allowance based on their judgment about information available to them at the time of their examination. FHLBNY Stock As a condition of membership with the FHLBNY, the Company is required to hold FHLBNY stock in an amount equal to 0.125% of its aggregate mortgage related assets plus 4.5% of its outstanding FHLBNY advances. The Company’s holdings of FHLBNY stock are pledged against outstanding advances. FHLBNY stock is a non-marketable equity security and is, therefore, reported at cost, which equals par value (the amount at which shares have been redeemed in the past). The investment is periodically evaluated for impairment based on, among other things, the capital adequacy of the FHLBNY and its overall financial condition. Other Real Estate Owned Other real estate owned (“OREO”) properties acquired through, or in lieu of, foreclosure are recorded initially at fair value less costs to sell. Any write-down of the recorded investment in the related loan is charged to the allowance prior to transfer. OREO assets are subsequently accounted for at lower of cost or fair value less estimated costs to sell. If fair value declines subsequent to foreclosure, a valuation allowance is recorded through non-interest income. Costs relating to the development and improvement of other real estate owned are capitalized. Costs relating to holding other real estate owned, including real estate taxes, insurance and maintenance, are charged to expense as incurred. The balance of OREO was $0 at both December 31, 2022 and December 31, 2021. Goodwill and Intangible Assets Goodwill resulting from business combinations is generally determined as the excess of the fair value of the consideration transferred over the fair value of the net assets acquired and liabilities assumed as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized, but tested for impairment at least annually, or more frequently if events and circumstances exist that indicate the carrying amount of the asset may be impaired. The Company elected June 30 as the annual date for impairment testing. Other intangible assets with definite useful lives are amortized over their estimated useful lives to their estimated residual values. Core deposit intangible assets are amortized on an accelerated method over their estimated useful lives of ten years. Premises and Equipment Premises and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of furniture, fixtures, and equipment is computed by the straight-line method over the estimated useful lives of the related assets. Furniture and fixtures are generally depreciated over ten years. Equipment, computer hardware and computer software are normally depreciated over three Leases The Company determines whether a contract is or contains a lease at inception. For leases with terms greater than twelve months under which the Company is lessee, right-of-use ("ROU") assets and lease liabilities are recorded at the commencement date. Lease liabilities are initially recorded based on the present value of future lease payments over the lease term. ROU assets are initially recorded at the amount of the associated lease liabilities plus prepaid lease payments and initial direct costs, less any lease incentives received. The cost of short term leases is recognized on a straight line basis over the lease term. The lease term includes options to extend if the exercise of those options is reasonably certain and includes termination options if there is reasonable certainty the options will not be exercised. The Company uses its incremental borrowing rate (“IBR”) as the discount rate to the remaining lease payments to derive a present value calculation for initial measurement of lease liabilities. The IBR reflects the interest rate the Company would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. Leases are classified as financing or operating leases at commencement. All of the Company's leases are classified as operating leases as of December 31, 2022. Operating lease cost is recognized in the Consolidated Statements of Income on a straight line basis over the lease terms. Variable lease costs are recognized in the period in which the obligation for those costs is incurred. Bank-Owned Life Insurance The Company invests in bank-owned life insurance (“BOLI”). BOLI involves the purchase of life insurance policies by the Company on a chosen group of employees. The Company is the owner and beneficiary of the policies. The insurance and earnings thereon is used to offset a portion of future employee benefit costs. BOLI is carried at the cash surrender value of the underlying policies. Earnings from BOLI, as well as changes in cash surrender value, are recognized as non-interest income. Advertising Costs The Company expenses advertising and promotion costs as incurred. Income Taxes There are two components of income tax expense: current and deferred. Current income tax expense (benefit) approximates cash to be paid (refunded) for income taxes for the applicable period. Deferred income tax expense (benefit) results from differences between assets and liabilities measured for financial reporting and for income-tax return purposes. The Company records as a deferred tax asset on its Consolidated Statement of Financial Condition an amount equal to the tax credit and tax loss carry-forwards and tax deductions (tax benefits) that we believe will be available to us to offset or reduce the amounts of our income taxes in future periods. Under applicable federal and state income tax laws and regulations, such tax benefits will expire if not used within specified periods of time. Accordingly, the ability to fully utilize our deferred tax asset may depend on the amount of taxable income that we generate during those time periods. At least once each year, or more frequently, if warranted, we make estimates of future taxable income that we believe we are likely to generate during those future periods. If we conclude, on the basis of those estimates and the amount of the tax benefits available to us, that it is more likely than not that we will be able to fully utilize those tax benefits prior to their expiration, we recognize the deferred tax asset in full on our Consolidated Statement of Financial Condition. If, however, we conclude on the basis of those estimates and the amount of the tax benefits available to us that it has become more likely than not that we will be unable to utilize those tax benefits in full prior to their expiration, then we would establish (or increase any existing) a valuation allowance to reduce the deferred tax asset on our Consolidated Statement of Financial Condition to the amount which we believe we are more likely than not to be able to utilize. Such a reduction is implemented by recognizing a non-cash charge that would have the effect of increasing the provision, or reducing any benefit, for income taxes that we would otherwise have recorded in our Consolidated Statements of Income. The determination of whether and the extent to which we will be able to utilize our deferred tax asset involves management judgments and assumptions that are subject to period-to-period changes as a result of changes in tax laws, changes in the market, or economic conditions that could affect our operating results or variances between our actual operating results and our projected operating results, as well as other factors. When measuring the amount of current taxes to be paid (or refunded) management considers the merit of various tax treatments in the context of statutory, judicial and regulatory guidance. Management also considers results of recent tax audits and historical experience. While management considers the amount of income taxes payable (or receivable) to be appropriate based on information currently available, future additions or reductions to such amounts may be necessary due to unanticipated events or changes in circumstances. Management has not taken, and does not expect to take, any position in a tax return which it deems to be uncertain. The Company recognizes interest and penalties related to income tax matters in income tax expense. The deferral method of accounting is used for investments that generate investment tax credits. Under this method, the investment tax credits are recognized as a reduction of the related asset. Contributions made by the Company are recognized as an increase of the related asset, and distributions are recognized as a reduction. Income and loss generated by the investment is recognized as a corresponding increase or reduction in the related asset. Post-Retirement Benefit Plans The Company sponsors several post-retirement benefit plans for current and former employees and certain directors. Contributions to the trustee of a multi-employer defined benefit pension plan are recorded as expense in the period of contribution. Plan obligations and related expenses for other post retirement plans are calculated using actuarial methodologies. The measurement of such obligations and expenses requires management to make certain assumptions, in particular the discount rate, which is evaluated on an annual basis. Other factors include retirement patterns, mortality and turnover assumptions. The Company uses a December 31 measurement date for its post retirement benefit plans. Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 715-30 “Compensation – Retirement Benefits – Defined Benefit Plans – Pension” requires the Company to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial condition and to recognize changes in that funded status in the year the changes occur through comprehensive income. Comprehensive Income Comprehensive income includes net income and all other changes in equity during a period, except those resulting from investments by owners and distributions to owners. Other comprehensive income includes income, expenses, gains and losses that under generally accepted accounting principles are included in comprehensive income but excluded from net income. Other comprehensive income (loss) and accumulated other comprehensive income (loss) are reported net of deferred income taxes. Accumulated other comprehensive income for the Company includes unrealized holding gains or losses on available for sale securities, and actuarial gains or losses on the Company’s pension plans. FASB ASC 715‑30 “Compensation – Retirement Benefits – Defined Benefit Plans – Pension” requires employers to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year the changes occur through comprehensive income. Stock-Based Compensation Stock-based compensation is recorded in accordance with FASB ASC No. 718, “Accounting for Stock-Based Compensation” which requires the Company to record compensation cost for stock options and restricted stock granted to employees and directors in return for employee service. The cost is measured at the fair value of the options and restricted stock when granted, and this cost is expensed over the service period, which is normally the vesting period of the options and restricted stock. Forfeitures of options and restricted stock result in a retirement of the related award and a reversal of the cost previously incurred. The Company grants time-based restricted stock units (“RSUs”) that are subject to a time-based vesting schedule, and performance-based RSUs that are subject to the achievement of the Company's corporate goals. The Company's stock-based compensation plans are further described in Note 13, Employee Benefit Plans. Variable Interest Entities The consolidated financial statements include the accounts of certain variable interest entities (“VIEs”). The Company considers a voting rights entity to be a subsidiary and consolidates if the Company has a controlling financial interest in the entity. VIEs are consolidated if the Company has the power to direct the activities of the VIE that significantly impact financial performance and has the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (i.e., the Company is the primary beneficiary). Investments in VIEs where the Company is not the primary beneficiary of a VIE are accounted for using the equity method of accounting. The determination of whether the Company is the primary beneficiary of a VIE is reassessed on an ongoing basis. The consolidation status may change as a result of these reassessments. These investments are included in Equity Investments in the Company’s Consolidated Statements of Financial Condition. The maximum potential exposure to losses relative to investments in VIEs is generally limited to the sum of the outstanding balance, future funding commitments and any related loans to the entity, both funded and unfunded. Loans to these entities are underwritten in substantially the same manner as other loans and are generally secured. Additional disclosures regarding VIEs are further described in Note 18, Variable Interest Entities. Resell Agreements The Company enters into short-term resell agreements backed by residential first-lien mortgage loans. The Company obtains possession of collateral with a market value equal to or in excess of the principal amount loaned under resell agreements. The Company had $25.8 million and $229.0 million in resell agreements as of December 31, 2022 and December 31, 2021, respectively. The resell agreements were entered into at par, and earned $4.2 million, $1.9 million, and $0.8 million in interest income for the years ended December 31, 2022, 2021, and 2020 , respectively. Interest income on resell agreements is reported on the "securities interest income" line of the Consolidated Statements of Income. Segment Information Public companies are required to report certain financial information about significant revenue-producing segments of the business for which such information is available and utilized by the chief operating decision maker. Substantially all of our operations occur through the Bank and involve the delivery of loan and deposit products to customers. Management makes operating decisions and assesses performance based on an ongoing review of its banking operation, which constitutes our only operating segment for financial reporting purposes. We do not consider our trust and investment management business as a separate segment. Transfers of Financial Assets Transfers of financial assets are accounted for as sales when control over the assets has been relinquished. Control over transferred assets is deemed to be surrendered when the assets have been isolated from the Company, the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity. Reclassifications Certain reclassifications have been made to prior year amounts to conform to the current year presentation. The reclassifications had no impact to the Consolidated Statements of Income or the Consolidated Statements of Changes in Stockholders’ Equity.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS Accounting Standards Effective in 2022 and onward In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, “Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 significantly changes the impairment model for most financial assets that are measured at amortized cost and certain other instruments from an incurred loss model to an expected loss model and provides for recording credit losses on available for sale debt securities through an allowance account. ASU 2016-13 also requires certain incremental disclosures. In October 2019, the FASB voted to extend the adoption date for entities eligible to be smaller reporting companies, public business entities ("PBEs") that are not SEC filers, and entities that are not PBEs from January 1, 2020 to January 1, 2023. Based on the Company's election as an Emerging Growth Company under the Jumpstart Our Business Startups Act to use the extended transition period for complying with any new or revised financial accounting standards, we will adopt the standard on January 1, 2023. The Company’s CECL implementation efforts are continuing to focus on completion of model validation, developing new disclosures, establishing formal policies and procedures and other governance and control documentation. Based on the Company’s portfolio balances and forecasted economic conditions as of January 1, 2023, management believes the adoption of the CECL standard will result in a material increase to its total current reserves. However, the ultimate amount of the increase will be contingent upon continued validation of our model, testing and refinement of the model methodologies and judgments utilized to determine the estimate. Based on implementation progress to date, the Company believes the capital adequacy requirements to which it and the Bank are subject to, and its business strategies and practices, will not be materially impacted following the adoption on January 1, 2023. The Company measured its allowance under its current incurred loan loss model as of December 31, 2022. On March 31, 2022, the FASB issued ASU No. 2022-02, which eliminates the troubled debt restructuring ("TDR") accounting model for creditors that have adopted Topic 326, “Financial Instruments – Credit Losses.” Specifically, rather than applying the recognition and measurement guidance for TDRs, this ASU requires entities to evaluate receivable modifications, consistent with the accounting for other loan modifications, to determine whether a modification made to a borrower results is a new loan or a continuation of the existing loan. In addition, under the new ASU, entities are no longer required to use a discounted cash flow ("DCF") method to measure the ACL as a result of a modification or restructuring with a borrower experiencing financial difficulty. If a DCF method is used, the post-modification-derived effective interest rate is to be used, instead of the original interest rate as stipulated under the current GAAP. This ASU also enhances the disclosure requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. This ASU amends the guidance on “vintage disclosures” to require the disclosure of current-period gross write-offs by year of origination. The Company will continue to apply the current TDR accounting model until the adoption of ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326) on January 1, 2023. The adoption of ASU 2022-02 is not expected to have a material impact on the Company's operating results or financial condition. On January 7, 2021, the FASB has issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope. The new guidance amends the scope of ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which was aimed at easing the potential accounting burden expected when global capital markets move away from the London Interbank Offered Rate ("LIBOR") (the benchmark interest rate banks use to make short-term loans to each other) and provided temporary, optional expedients and exceptions for applying accounting guidance to contract modifications and hedging relationships, subject

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The Company records unrealized gains and losses, net of taxes, on securities available for sale in accumulated other comprehensive income (loss) in the Consolidated Statements of Changes in Stockholders’ Equity. Gains and losses on securities available for sale are reclassified to operations as the gains or losses are recognized. Other-than-temporary impairment losses on debt securities are reflected in earnings as realized losses to the extent the impairment is related to credit losses. The amount of the impairment related to other factors is recognized in other comprehensive income (loss). The Company also recognizes as a component of other comprehensive income (loss) the actuarial gains or losses as well as the prior service costs or credits that arise during the period from post-retirement benefit plans. Other comprehensive income (loss) components and related income tax effects were as follows: Year Ended December 31, 2022 2021 2020 (In thousands) Change in obligation for postretirement benefits and for prior service credit $ 297 $ 231 $ 198 Change in obligation for other benefits 338 (294) 164 Change in total obligation for postretirement benefits and for prior service credit and for other benefits 635 (63) 362 Income tax benefit (expense) (185) 17 (99) Net change in total obligation for postretirement benefits and prior service credit and for other benefits 450 (46) 263 Unrealized holding gains (losses) on available for sale securities (163,001) (15,438) 20,374 Reclassification adjustment for losses (gains) realized in income 3,621 (654) (1,604) Accretion of net unrealized loss on securities transferred to held-to-maturity 1,255 — — Change in unrealized gains (losses) on available for sale securities (158,125) (16,092) 18,770 Income tax benefit (expense) 43,559 4,371 (5,082) Net change in unrealized gains (losses) on securities (114,566) (11,721) 13,688 Total $ (114,116) $ (11,767) $ 13,951 The following is a summary of the accumulated other comprehensive income (loss) balances, net of income taxes: Balance as of January 1, Current Income Tax Balance as of December 31, 2022 (In thousands) Unrealized gains (losses) on benefits plans $ (2,102) $ 635 $ (185) $ (1,652) Unrealized gains (losses) on available for sale securities 7,511 (142,230) 39,180 (95,539) Unaccreted unrealized loss on securities transferred to held-to-maturity — (15,895) 4,379 (11,516) Total $ 5,409 $ (157,490) $ 43,374 $ (108,707) Balance as of January 1, 2021 Current Income Tax Balance as of December 31, 2021 (In thousands) Unrealized gains (losses) on benefits plans $ (2,056) $ (63) $ 17 $ (2,102) Unrealized gains (losses) on available for sale securities 19,232 (16,092) 4,371 7,511 Total $ 17,176 $ (16,155) $ 4,388 $ 5,409 The following represents the reclassifications out of accumulated other comprehensive income (loss): Year Ended December 31, Affected Line Item in the Consolidated Statements of Income 2022 2021 2020 (In thousands) Realized gains (losses) on sale of available for sale securities $ (3,637) $ 649 $ 1,605 Gain (loss) on sale of securities Recognized gains (losses) on OTTI securities 16 5 (1) Non-Interest Income - other Accretion of net unrealized loss on securities transferred to held-to-maturity (1,255) — — Interest income on securities Total reclassifications (4,876) 654 1,604 Income tax expense (benefit) (1,343) 180 438 Income tax expense (benefit) Total reclassifications, net of income tax $ (3,533) $ 474 $ 1,166 Prior service credit on pension plans and other postretirement benefits $ 29 $ 29 $ 28 Compensation and employee benefits Income tax benefit (8) (8) (8) Income tax expense (benefit) Total reclassifications, net of income tax $ 21 $ 21 $ 20 Total reclassifications, net of income tax $ (3,512) $ 495 $ 1,186

INVESTMENT SECURITIES

INVESTMENT SECURITIES	12 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	INVESTMENT SECURITIES The amortized cost and fair value of investment securities available for sale and held-to-maturity as of December 31, 2022 are as follows: December 31, 2022 (In thousands) Amortized Gross Gross Fair Available for sale: Mortgage-related: Government sponsored entities ("GSE") residential CMOs ("collateralized mortgage obligations") $ 427,529 $ 24 $ (38,293) $ 389,260 GSE commercial certificates & CMO 222,620 — (8,834) 213,786 Non-GSE residential certificates 123,139 — (16,059) 107,080 Non-GSE commercial certificates 108,286 — (10,804) 97,482 881,574 24 (73,990) 807,608 Other debt: U.S. Treasury 199 — (7) 192 Asset backed securities ("ABS") 901,746 34 (39,617) 862,163 Trust preferred 10,988 — (845) 10,143 Corporate 149,836 — (17,466) 132,370 1,062,769 34 (57,935) 1,004,868 Total available for sale $ 1,944,343 $ 58 $ (131,925) $ 1,812,476 Amortized Cost Gross Unrecognized Gains Gross Unrecognized Losses Fair Value Held-to-maturity: Mortgage-related: GSE residential CMOs $ 69,391 $ — $ (4,054) $ 65,337 GSE commercial certificates 90,335 — (11,186) 79,149 GSE residential certificates 428 — (17) 411 Non-GSE commercial certificates 32,635 9 (3,148) 29,496 Non-GSE residential certificates 50,468 — (5,245) 45,223 243,257 9 (23,650) 219,616 Other debt: ABS 288,682 — (15,175) 273,507 Commercial PACE 255,424 — (26,782) 228,642 Residential PACE 656,453 — (44,833) 611,620 Municipal 95,485 — (15,999) 79,486 Other 2,000 — — 2,000 1,298,044 — (102,789) 1,195,255 Total held-to-maturity $ 1,541,301 $ 9 $ (126,439) $ 1,414,871 As of December 31, 2022, available for sale securities with a fair value of $1.01 billion were pledged with $282.8 million held-to-maturity securities being pledged. The majority of the securities were pledged to the FHLBNY to secure outstanding advances, letters of credit and to provide additional borrowing potential. In addition, securities were pledged to provide capacity to borrow from the Federal Reserve Bank and to collateralize municipal deposits. The amortized cost and fair value of investment securities available for sale and held-to-maturity as of December 31, 2021 are as follows: December 31, 2021 (In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available for sale: Mortgage-related: GSE residential certificates $ 3,838 $ 129 $ — $ 3,967 GSE residential CMOs 460,571 5,697 (2,385) 463,883 GSE commercial certificates & CMO 364,274 6,855 (765) 370,364 Non-GSE residential certificates 66,756 29 (646) 66,139 Non-GSE commercial certificates 81,705 12 (616) 81,101 977,144 12,722 (4,412) 985,454 Other debt: U.S. Treasury 200 — — 200 ABS 988,061 3,351 (2,224) 989,188 Trust preferred 14,631 — (484) 14,147 Corporate 123,013 1,681 (273) 124,421 1,125,905 5,032 (2,981) 1,127,956 Total available for sale $ 2,103,049 $ 17,754 $ (7,393) $ 2,113,410 Amortized Cost Gross Unrecognized Gains Gross Unrecognized Losses Fair Value Held-to-maturity: Mortgage-related: GSE commercial certificates $ 30,742 $ — $ (489) $ 30,253 GSE residential certificates 442 19 — 461 Non-GSE commercial certificates 10,333 13 (288) 10,058 Non-GSE residential certificates 10,796 5 — 10,801 52,313 37 (777) 51,573 Other debt: ABS 75,800 1 (50) 75,751 Commercial PACE 175,712 2,434 — 178,146 Residential PACE 451,682 3,499 455,181 Municipal 84,962 2,045 (1,056) 85,951 Other 3,100 2 — 3,102 791,256 7,981 (1,106) 798,131 Total held-to-maturity $ 843,569 $ 8,018 $ (1,883) $ 849,704 As of December 31, 2021, available for sale securities with a fair value of $907.1 million were pledged; $126.6 million held-to-maturity securities were pledged. The majority of the securities were pledged to the FHLBNY to secure outstanding advances, letters of credit and to provide additional borrowing potential. In addition, securities were pledged to provide capacity to borrow from the Federal Reserve and to collateralize municipal deposits. The Company reassessed the classification of certain investments during the year ended December 31, 2022 and transferred securities with a book value of $277.3 million from available for sale to held-to-maturity. The transfer occurred at fair market value totaling $260.1 million. The related unrealized losses of $17.2 million were converted to a discount that is being accreted through interest income on a level-yield method over the term of the securities, while the unrealized losses recorded in other comprehensive income are amortized out of other comprehensive income through interest income on a level-yield method over the remaining term of the securities, with no net change to interest income. No gain or loss was recorded at the time of the transfer. During the year ended December 31, 2021, there were no transfers of securities between available for sale and held-to-maturity. The following table summarizes the amortized cost and fair value of debt securities available for sale and held-to-maturity, exclusive of mortgage-backed securities, by their contractual maturity as of December 31, 2022. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalty: Available for Sale Held-to-maturity (In thousands) Amortized Fair Value Amortized Fair Value Due within one year $ — $ — $ 2,000 $ 2,000 Due after one year through five years 67,979 60,511 9,419 8,919 Due after five years through ten years 425,938 409,079 10,561 9,590 Due after ten years 568,852 535,278 1,276,064 1,174,746 $ 1,062,769 $ 1,004,868 $ 1,298,044 $ 1,195,255 Year Ended December 31, (In thousands) 2022 2021 2020 Proceeds $ 249,936 $ 111,274 $ 94,698 Realized gains $ 168 $ 1,057 $ 2,111 Realized losses (3,805) (408) (506) Net realized gains (losses) $ (3,637) $ 649 $ 1,605 The Company controls and monitors inherent credit risk in its securities portfolio through due diligence, diversification, concentration limits, periodic securities reviews, and by investing in low risk securities. This includes high quality Non-Agency Securities, low LTV PACE Bonds and a significant portion of the securities portfolio in GSE obligations. GSEs include the Federal Home Loan Mortgage Corporation (“FHLMC”), the Federal National Mortgage Association (“FNMA”), the Government National Mortgage Association (“GNMA”) and the Small Business Administration (“SBA”). GNMA is a wholly owned U.S. Government corporation whereas FHLMC and FNMA are private. Mortgage-related securities may include mortgage pass-through certificates, participation certificates and CMOs. At December 31, 2022 and December 31, 2021, there were no holdings of securities of any one issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of stockholders' equity. The following summarizes the fair value and unrealized losses for those available for sale and held-to-maturity securities as of December 31, 2022 and December 31, 2021, respectively, segregated between securities that have been in an unrealized loss position for less than twelve months and those that have been in a continuous unrealized loss position for twelve months or longer at the respective dates: December 31, 2022 Less Than Twelve Months Twelve Months or Longer Total (In thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Available for sale: Mortgage-related: GSE residential CMOs $ 231,562 $ 13,937 $ 151,285 $ 24,356 $ 382,847 $ 38,293 GSE commercial certificates & CMO 153,325 6,729 60,461 2,105 213,786 8,834 Non-GSE residential certificates 72,527 8,969 34,553 7,090 107,080 16,059 Non-GSE commercial certificates 62,243 4,842 35,239 5,962 97,482 10,804 Other debt: US Treasury 192 7 — — 192 7 ABS 530,269 17,290 299,425 22,327 829,694 39,617 Trust preferred — — 10,143 845 10,143 845 Corporate 89,054 9,772 43,316 7,694 132,370 17,466 Total available for sale $ 1,139,172 $ 61,546 $ 634,422 $ 70,379 $ 1,773,594 $ 131,925 Less Than Twelve Months Twelve Months or Longer Total Fair Value Unrecognized Fair Value Unrecognized Fair Value Unrecognized Held-to-maturity: Mortgage-related: GSE CMOs $ 54,475 $ 2,891 $ 10,862 $ 1,163 $ 65,337 $ 4,054 GSE commercial certificates 48,934 3,404 30,215 7,782 79,149 11,186 GSE residential certificates 411 17 — — 411 17 Non GSE commercial certificates 11,192 656 18,283 2,492 29,475 3,148 Non GSE residential certificates 39,426 4,784 5,797 461 45,223 5,245 Other debt: ABS 224,279 11,078 49,228 4,097 273,507 15,175 Commercial PACE 228,642 26,782 — — 228,642 26,782 Residential PACE 611,620 44,833 — — 611,620 44,833 Municipal 48,190 5,866 31,296 10,133 79,486 15,999 Total held-to-maturity $ 1,267,169 $ 100,311 $ 145,681 $ 26,128 $ 1,412,850 $ 126,439 December 31, 2021 Less Than Twelve Months Twelve Months or Longer Total (In thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Available for sale: Mortgage-related: GSE residential CMOs $ 222,825 $ 2,385 $ — $ — $ 222,825 $ 2,385 GSE commercial certificates & CMO 28,695 271 159,681 494 188,376 765 Non-GSE residential certificates 55,284 646 — — 55,284 646 Non-GSE commercial certificates 42,530 247 23,124 369 65,654 616 Other debt: ABS 374,241 1,903 71,746 321 445,987 2,224 Trust preferred — — 14,147 484 14,147 484 Corporate 48,743 273 — — 48,743 273 Total available for sale $ 772,318 $ 5,725 $ 268,698 $ 1,668 $ 1,041,016 $ 7,393 Less Than Twelve Months Twelve Months or Longer Total Fair Value Unrecognized Fair Value Unrecognized Fair Value Unrecognized Held-to-maturity: Mortgage-related: GSE commercial certificates $ 30,253 $ 489 $ — $ — $ 30,253 $ 489 Non GSE commercial certificates 9,857 288 — — 9,857 288 Other debt: ABS 26,951 50 — — 26,951 50 Municipal 38,468 852 3,876 204 42,344 1,056 Total held-to-maturity $ 105,529 $ 1,679 $ 3,876 $ 204 $ 109,405 $ 1,883 The temporary impairment of fixed income securities is primarily attributable to changes in overall market interest rates and/or changes in credit spreads since the investments were acquired. In general, as market interest rates rise and/or credit spreads widen, the fair value of fixed rate securities will decrease, as market interest rates fall and/or credit spreads tighten, the fair value of fixed rate securities will increase. As of December 31, 2022, excluding GSE and U.S. Treasury securities., temporarily impaired securities totaled $2.57 billion with an unrealized loss of $205.5 million. These securities were rated investment grade by at least one Nationally Recognized Statistical Rating Organization ("NRSRO") with no ratings below investment grade. All issues were current as to their interest payments. The Company has had no losses on any PACE bonds and are not aware of any losses that could be material in the sector given the low LTV position. Management considers that the temporary impairment of these investments as of December 31, 2022 is primarily due to an increase in market spreads since the time these investments were acquired. With respect to the Company’s security investments that are temporarily impaired as of December 31, 2022, management does not intend to sell these investments and does not believe it will be necessary to do so before anticipated recovery. The Company expects to collect all amounts due according to the contractual terms of these investments. Therefore, the Company does not consider these securities to be other-than-temporarily impaired at December 31, 2022. None of these positions or other securities held in the portfolio or sold during the year were purchased with the intent of selling them or would otherwise be classified as trading securities under ASC No. 320, Investments – Debt Securities. For the years ended December 31, 2022, 2021 and 2020, the Company recorded an OTTI recovery of $15,900, compared to a recovery of $4,800 and a loss of $900, respectively. Events which may cause material declines in the fair value of debt investments may include, but are not limited to, deterioration of credit metrics, higher incidences of default, worsening liquidity, worsening global or domestic economic conditions or adverse regulatory action. Management does not believe that there are any cases of unrecorded OTTI as of December 31, 2022. FHLBNY Stock

LOANS RECEIVABLE, NET

LOANS RECEIVABLE, NET	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
LOANS RECEIVABLE, NET	LOANS RECEIVABLE, NET Loans receivable are summarized as follows: December 31, December 31, (In thousands) Commercial and industrial $ 925,641 $ 729,385 Multifamily 967,521 821,801 Commercial real estate 335,133 369,429 Construction and land development 37,696 31,539 Total commercial portfolio 2,265,991 1,952,154 Residential real estate lending 1,371,779 1,063,682 Consumer and other 463,999 291,818 Total retail portfolio 1,835,778 1,355,500 Total loans receivable 4,101,769 3,307,654 Net deferred loan origination costs 4,233 4,570 Total loans receivable, net of deferred loan origination costs (fees) 4,106,002 3,312,224 Allowance for loan losses (45,031) (35,866) Total loans receivable, net $ 4,060,971 $ 3,276,358 Lending Risk The principal business of the Company is lending in commercial and industrial loans, multifamily mortgage loans, commercial real estate loans, construction and land development loans, residential real estate mortgage loans, and consumer and other loans. The Company considers its primary lending area to be the states of New York, and California, and Washington, D.C. A substantial portion of the Company’s loans are secured by real estate in these areas. Accordingly, the ultimate collectability of the loan portfolio is susceptible to changes in market and economic conditions in this region. Commercial and Industrial Loans Loans in this classification are made to businesses and include term loans, lines of credit, and senior secured loans to corporations. Generally, these loans are secured by assets of the business and repayment is expected from the cash flows of the business. A weakened economy, and resultant decreased consumer and/or business spending, will have an effect on the credit quality in this loan class. Multifamily Mortgage Loans Loans in this classification include income producing residential investment properties of five or more families. Loans are made to established owners with a proven and demonstrable record of strong performance. Repayment is derived generally from the rental income generated from the property and may be supplemented by the owners’ personal cash flow. Credit risk arises with an increase in vacancy rates, property mismanagement and the predominance of non-recourse loans that are customary in the industry. Commercial Real Estate Loans Loans in this classification include income producing investment properties and owner-occupied real estate used for business purposes. The underlying properties are located largely in the Company’s primary market area. The cash flows of the income producing investment properties are adversely impacted by a downturn in the economy as evidenced by increased vacancy rates, which in turn, will have an effect on credit quality. In the case of owner-occupied real estate used for business purposes, a weakened economy and resultant decreased consumer and/or business spending will have an adverse effect on credit quality. Construction and Land Development Loans Loans in this classification primarily include land loans to local individuals, contractors and developers for developing the land for sale or for the purpose of making improvements thereon. Repayment is derived primarily from sale of the lots/units including any pre-sold units. Credit risk is affected by market conditions, time to sell at an adequate price and cost overruns. To a lesser extent, this class includes commercial development projects that the Company finances, which in most cases require interest only during construction, and then convert to permanent financing. Construction delays, cost overruns, market conditions and the availability of permanent financing, to the extent such permanent financing is not being provided by the Bank, all affect the credit risk in this loan class. Residential Real Estate Loans Loans in this classification are generally secured by owner-occupied residential real estate and repayment is dependent on the credit quality of the individual borrower. Loans in this class are secured by both first liens and second liens. The overall health of the economy, including unemployment rates and housing prices, can have an effect on the credit quality in this loan class. Consumer and Other Loans Loans in this classification may be either secured or unsecured. Residential solar loans compose the majority of this portfolio, with student loans and other consumer products composing the remainder. Repayment is dependent on the credit quality of the individual borrower and, if applicable, sale of the collateral securing the loan. Therefore, the overall health of the economy, including unemployment rates and housing prices, will have an effect on the credit quality in this loan class. The following table presents information regarding the quality of the Company’s loans as of December 31, 2022: 30-89 Days Non- 90 Days or Total Past Current Total Loans (In thousands) Commercial and industrial $ 27 $ 9,629 $ — $ 9,656 $ 915,985 $ 925,641 Multifamily — 3,828 — 3,828 963,693 967,521 Commercial real estate 11,718 4,851 — 16,569 318,564 335,133 Construction and land development 16,426 — — 16,426 21,270 37,696 Total commercial portfolio 28,171 18,308 — 46,479 2,219,512 2,265,991 Residential real estate lending 1,185 1,807 — 2,992 1,368,787 1,371,779 Consumer and other 3,545 1,584 — 5,129 458,870 463,999 Total retail portfolio 4,730 3,391 — 8,121 1,827,657 1,835,778 $ 32,901 $ 21,699 $ — $ 54,600 $ 4,047,169 $ 4,101,769 The following table presents information regarding the quality of the Company’s loans as of December 31, 2021: 30-89 Days Past Due Non- Accrual 90 Days or More Delinquent and Still Accruing Interest Total Past Due Current Total Loans Receivable (In thousands) Commercial and industrial $ — $ 8,313 $ — $ 8,313 $ 721,072 $ 729,385 Multifamily 13,537 2,907 — 16,444 805,357 821,801 Commercial real estate 21,599 4,054 — 25,653 343,776 369,429 Construction and land development 26,482 — — 26,482 5,057 31,539 Total commercial portfolio 61,618 15,274 — 76,892 1,875,262 1,952,154 Residential real estate lending 4,811 12,525 — 17,336 1,046,346 1,063,682 Consumer and other 1,590 420 — 2,010 289,808 291,818 Total retail portfolio 6,401 12,945 — 19,346 1,336,154 1,355,500 $ 68,019 $ 28,219 $ — $ 96,238 $ 3,211,416 $ 3,307,654 The Company has certain non-performing loans included in the balance of Loans held for sale on the Consolidated Statements of Financial Condition. There were $6.9 million and $1.0 million such loans as of December 31, 2022 and December 31, 2021, respectively. For a loan modification to be considered a TDR in accordance with ASC 310-40, both of the following conditions must be met: the borrower is experiencing financial difficulty, and the creditor has granted a concession (except for an “insignificant delay in payment”, defined as six months or less). Loans modified as TDRs are placed on nonaccrual status until the Company determines that future collection of principal and interest is reasonably assured, which generally requires that the borrower demonstrate performance according to the restructured terms for a period of at least six months. The Company’s TDRs primarily involve rate reductions, forbearance of arrears or extension of maturity. TDRs are included in total impaired loans as of the respective date. The following table presents information regarding the Company’s TDRs as of December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 (In thousands) Accruing Nonaccrual Total Accruing Nonaccrual Total Commercial and industrial $ 3,503 $ 9,629 $ 13,132 $ 4,052 $ 8,313 $ 12,365 Commercial real estate — 2,900 2,900 — 3,166 3,166 Construction and land development 2,424 — 2,424 7,476 — 7,476 Residential real estate lending 175 973 1,148 13,469 2,018 15,487 $ 6,102 $ 13,502 $ 19,604 $ 24,997 $ 13,497 $ 38,494 The financial effects of TDRs granted for the year ended December 31, 2022 are as follows: Weighted Average Interest Rate (In thousands) Number Recorded Pre-Modification Post-Modification Charge-off Commercial and industrial 2 $ 8,171 6.79 % 6.79 % $ — Commercial real estate 4 10,647 3.85 % 3.85 % — 6 $ 18,818 5.13 % 5.13 % $ — The financial effects of TDRs granted for the year ended December 31, 2021 are as follows: Weighted Average Interest Rate (In thousands) Number Recorded Pre-Modification Post-Modification Charge-off Commercial and industrial 1 $ 2,536 6.50 % 4.00 % $ — Construction and land development 2 7,477 4.30 % 4.30 % — 3 $ 10,013 4.86 % 4.22 % $ — The following tables summarize the Company’s loan portfolio by credit quality indicator as of December 31, 2022: (In thousands) Pass Special Mention Substandard Doubtful Total Commercial and industrial $ 893,637 $ 6,983 $ 23,275 $ 1,746 $ 925,641 Multifamily 947,661 13,696 6,164 — 967,521 Commercial real estate 299,953 24,679 10,501 — 335,133 Construction and land development 21,270 14,002 2,424 — 37,696 Residential real estate lending 1,369,972 — 1,807 — 1,371,779 Consumer and other 462,415 — 1,584 — 463,999 Total loans $ 3,994,908 $ 59,360 $ 45,755 $ 1,746 $ 4,101,769 The following tables summarize the Company’s loan portfolio by credit quality indicator as of December 31, 2021: (In thousands) Pass Special Mention Substandard Doubtful Total Commercial and industrial $ 693,312 $ 10,165 $ 25,908 $ — $ 729,385 Multifamily 721,869 48,804 51,128 — 821,801 Commercial real estate 295,261 13,947 60,221 — 369,429 Construction and land development 24,063 — 7,476 — 31,539 Residential real estate lending 1,050,865 292 12,525 — 1,063,682 Consumer and other 291,398 — 420 — 291,818 Total loans $ 3,076,768 $ 73,208 $ 157,678 $ — $ 3,307,654 The above classifications follow regulatory guidelines and can be generally described as follows: • pass loans are of satisfactory quality; • special mention loans have a potential weakness or risk that may result in the deterioration of future repayment; • substandard loans are inadequately protected by the current net worth and paying capacity of the borrower or of the collateral pledged (these loans have a well-defined weakness, and there is a distinct possibility that the Company will sustain some loss); and • doubtful loans, based on existing circumstances, have weaknesses that make collection or liquidation in full highly questionable and improbable. In addition, consumer and residential loans are classified utilizing an inter-agency methodology that incorporates the extent of delinquency. Assigned risk rating grades are continuously updated as new information is obtained. The following table provides information regarding the methods used to evaluate the Company’s loans for impairment by portfolio, and the Company’s allowance by portfolio based upon the method of evaluating loan impairment as of December 31, 2022: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Loans: Individually evaluated for impairment $ 14,716 $ 3,828 $ 4,851 $ 2,424 $ 1,982 $ — $ 27,801 Collectively evaluated for impairment 910,925 963,693 330,282 35,272 1,369,797 463,999 4,073,968 Total loans $ 925,641 $ 967,521 $ 335,133 $ 37,696 $ 1,371,779 $ 463,999 $ 4,101,769 Allowance for loan losses: Individually evaluated for impairment $ 5,433 $ 180 $ — $ — $ 55 $ — $ 5,668 Collectively evaluated for impairment 7,483 6,924 3,627 825 11,283 9,221 39,363 Total allowance for loan losses $ 12,916 $ 7,104 $ 3,627 $ 825 $ 11,338 $ 9,221 $ 45,031 The following table provides information regarding the methods used to evaluate the Company’s loans for impairment by portfolio, and the Company’s allowance by portfolio based upon the method of evaluating loan impairment as of December 31, 2021: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Loans: Individually evaluated for impairment $ 12,785 $ 2,907 $ 4,054 $ 7,476 $ 25,994 $ — $ 53,216 Collectively evaluated for impairment 716,600 818,894 365,375 24,063 1,037,688 291,818 3,254,438 Total loans $ 729,385 $ 821,801 $ 369,429 $ 31,539 $ 1,063,682 $ 291,818 $ 3,307,654 Allowance for loan losses: Individually evaluated for impairment $ 4,350 $ — $ — $ — $ 755 $ — $ 5,105 Collectively evaluated for impairment 6,302 4,760 7,273 405 8,253 3,768 30,761 Total allowance for loan losses $ 10,652 $ 4,760 $ 7,273 $ 405 $ 9,008 $ 3,768 $ 35,866 The activities in the allowance by portfolio for the year ended December 31, 2022 are as follows: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Allowance for loan losses: Beginning balance $ 10,652 $ 4,760 $ 7,273 $ 405 $ 9,008 $ 3,768 $ 35,866 Provision for (recovery of) loan losses 1,990 2,760 (3,646) 807 2,978 10,113 15,002 Charge-offs — (416) — (389) (2,448) (5,143) (8,396) Recoveries 274 — — 2 1,800 483 2,559 Ending Balance $ 12,916 $ 7,104 $ 3,627 $ 825 $ 11,338 $ 9,221 $ 45,031 The activities in the allowance by portfolio for the year ended December 31, 2021 are as follows: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Allowance for loan losses: Beginning balance $ 9,065 $ 10,324 $ 6,213 $ 2,077 $ 12,330 $ 1,580 $ 41,589 Provision for (recovery of) loan losses 2,179 (1,483) 1,374 (1,675) (5,409) 4,727 (287) Charge-offs (813) (4,081) (314) — (1,081) (2,699) (8,988) Recoveries 221 — — 3 3,168 160 3,552 Ending Balance $ 10,652 $ 4,760 $ 7,273 $ 405 $ 9,008 $ 3,768 $ 35,866 The activities in the allowance by portfolio for the year ended December 31, 2020 are as follows: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Allowance for loan losses: Beginning balance $ 11,126 $ 5,210 $ 2,492 $ 808 $ 14,149 $ 62 $ 33,847 Provision for (recovery of) loan losses 9,175 5,114 7,508 2,238 (2,302) 3,058 24,791 Charge-offs (11,293) — (3,787) (970) (492) (1,691) (18,233) Recoveries 57 — — 1 975 151 1,184 Ending Balance $ 9,065 $ 10,324 $ 6,213 $ 2,077 $ 12,330 $ 1,580 $ 41,589 The following is additional information regarding the Company’s impaired loans and the allowance related to such loans as of and for the year ended December 31, 2022 and December 31, 2021: December 31, 2022 (In thousands) Recorded Average Unpaid Related Loans without a related allowance: Residential real estate lending $ 764 $ 5,636 $ 1,761 $ — Multifamily 334 167 334 — Construction and land development 2,424 4,950 7,476 — Commercial real estate 4,851 4,453 5,023 — Commercial and industrial 3,791 1,896 3,881 — 12,164 17,102 18,475 — Loans with a related allowance: Residential real estate lending 1,218 8,352 1,278 55 Multifamily 3,494 3,201 3,494 180 Commercial and industrial 10,925 11,855 11,975 5,433 15,637 23,408 16,747 5,668 Total impaired loans: Residential real estate lending 1,982 13,988 3,039 55 Multifamily 3,828 3,368 3,828 180 Construction and land development 2,424 4,950 7,476 — Commercial real estate 4,851 4,453 5,023 — Commercial and industrial 14,716 13,751 15,856 5,433 $ 27,801 $ 40,510 $ 35,222 $ 5,668 December 31, 2021 (In thousands) Recorded Investment Average Recorded Investment Unpaid Principal Balance Related Allowance Loans without a related allowance: Residential real estate lending $ 10,507 $ 15,666 $ 11,896 $ — Construction and land development 7,476 9,330 7,476 — Commercial real estate 4,054 3,744 4,953 — 22,037 28,740 24,325 — Loans with a related allowance: Residential real estate lending 15,487 18,120 19,306 755 Multifamily 2,907 6,241 8,024 — Commercial and industrial 12,785 13,746 13,207 4,350 31,179 38,107 40,537 5,105 Total impaired loans: Residential real estate lending 25,994 33,786 31,202 755 Multifamily 2,907 6,241 8,024 — Construction and land development 7,476 9,330 7,476 — Commercial real estate 4,054 3,744 4,953 — Commercial and industrial 12,785 13,746 13,207 4,350 $ 53,216 $ 66,847 $ 64,862 $ 5,105

PREMISES AND EQUIPMENT

PREMISES AND EQUIPMENT	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
PREMISES AND EQUIPMENT	PREMISES AND EQUIPMENT Premises and equipment are summarized as follows: December 31, 2022 2021 (In thousands) Buildings, premises and improvements $ 28,150 $ 29,935 Furniture, fixtures and equipment 6,787 7,020 Projects in process 561 — 35,498 36,955 Accumulated depreciation and amortization (25,642) (25,220) $ 9,856 $ 11,735

DEPOSITS

DEPOSITS	12 Months Ended
	Dec. 31, 2022
Statistical Disclosure for Banks [Abstract]
DEPOSITS	DEPOSITS Deposits are summarized as follows: December 31, 2022 December 31, 2021 Amount Weighted Average Rate Amount Weighted Average Rate (In thousands) Non-interest-bearing demand deposit accounts $ 3,331,067 0.00 % $ 3,335,005 0.00 % NOW accounts 206,434 0.73 % 210,844 0.08 % Money market deposit accounts 2,445,396 0.94 % 2,227,953 0.12 % Savings accounts 386,190 0.75 % 375,301 0.11 % Time deposits 151,699 2.57 % 207,152 0.32 % Brokered CD 74,251 3.84 % — 0.00 % $ 6,595,037 0.52 % $ 6,356,255 0.06 % Scheduled maturities of time deposits and brokered CDs as of December 31, 2022 are as follows: (In thousands) Balance 2023 $ 208,231 2024 10,866 2025 4,482 2026 1,776 2027 595 Thereafter — $ 225,950 Time deposits of $250,000 or more totaled $110.4 million as of December 31, 2022 and $43.7 million as of December 31, 2021. From time to time the Company will issue time deposits through the Certificate of Deposit Account Registry Service (“CDARS”) for the purpose of providing FDIC insurance to bank customers with balances in excess of FDIC insurance limits. CDARS deposits totaled approximately $28.3 million and $56.0 million as of December 31, 2022 and December 31, 2021, respectively, and are included in Time deposits above. Our total deposits included deposits from Workers United and its related entities in the amounts of $52.2 million as of December 31, 2022 and $99.9 million as of December 31, 2021. Included in total deposits are state and municipal deposits totaling $88.3 million and $65.5 million as of December 31, 2022 and December 31, 2021, respectively. Such deposits are secured by letters of credit issued by the FHLBNY or by securities pledged with the FHLBNY.

FHLBNY ADVANCES

FHLBNY ADVANCES	12 Months Ended
	Dec. 31, 2022
Advance from Federal Home Loan Bank [Abstract]
FHLBNY ADVANCES	FHLBNY ADVANCES There were $580 million in outstanding FHLBNY advances as of December 31, 2022, and no outstanding FHLBNY advances as of December 31, 2021. There were $580 million of FHLBNY advances with an overnight contractual maturity, and the average interest rate on outstanding FHLBNY advances was 4.58% at December 31, 2022. FHLBNY advances are collateralized by the FHLBNY stock owned by the Company plus a pledge of other eligible assets comprised of securities and mortgage loans. Assets are pledged to collateral capacity. As of December 31, 2022, the value of the other eligible assets had an estimated market value net of haircut tota ling $1.40 billion (comprised of securities of $760.3 million and mortgage loans of $616.9 million). The fair value of assets pledged to the FHLBNY is required to be not less than 110% of the outstanding advances. On Novem ber 8, 2021, the Company completed a public offering of $85.0 million of aggregated principal amount of 3.250% Fixed-to-Floating Rate subordinated notes due 2031 (the "Notes"). The fixed rate period is defined from and including November 8, 2021 to, but excluding, November 15, 2026, or the date of earlier redemption. The floating rate period is defined from and including November 15, 2026 to, but excluding, November 15, 2031, or the date of earlier redemption. The floating rate per annum is equal to three-month term SOFR (the "benchmark rate") plus a spread of 230 basis points for each quarterly interest period during the floating rate period, provided however, that if the benchmark rate is less than zero, the benchmark rate shall be deemed to be zero. The subordinated notes will mature on November 15, 2031. The Company may, at its option, beginning with the interest payment date of November 15, 2026, and on any interest payment date thereafter, redeem the Notes, in whole or in part, from time to time, subject to obtaining prior approval of the Board of Governors of the Federal Reserve System (the "Federal Reserve Board") to the extent such approval is then required under the capital adequacy rules of the Federal Reserve Board, at a redemption price equal to 100% of the principal amount of the Notes being redeemed, plus accrued and unpaid interest to, but excluding, the date of redemption. During the year ended December 31, 2022, the Company repurchased $5.6 million of the subordinated notes, resulting in a gain on repurchase of $0.6 million, included in other non-interest income on the Consolidated Statement of Income. There were no repurchases of subordinated notes during the year ended December 31, 2021.

SUBORDINATED DEBT

SUBORDINATED DEBT	12 Months Ended
	Dec. 31, 2022
Federal Home Loan Banks [Abstract]
SUBORDINATED DEBT	FHLBNY ADVANCES There were $580 million in outstanding FHLBNY advances as of December 31, 2022, and no outstanding FHLBNY advances as of December 31, 2021. There were $580 million of FHLBNY advances with an overnight contractual maturity, and the average interest rate on outstanding FHLBNY advances was 4.58% at December 31, 2022. FHLBNY advances are collateralized by the FHLBNY stock owned by the Company plus a pledge of other eligible assets comprised of securities and mortgage loans. Assets are pledged to collateral capacity. As of December 31, 2022, the value of the other eligible assets had an estimated market value net of haircut tota ling $1.40 billion (comprised of securities of $760.3 million and mortgage loans of $616.9 million). The fair value of assets pledged to the FHLBNY is required to be not less than 110% of the outstanding advances. On Novem ber 8, 2021, the Company completed a public offering of $85.0 million of aggregated principal amount of 3.250% Fixed-to-Floating Rate subordinated notes due 2031 (the "Notes"). The fixed rate period is defined from and including November 8, 2021 to, but excluding, November 15, 2026, or the date of earlier redemption. The floating rate period is defined from and including November 15, 2026 to, but excluding, November 15, 2031, or the date of earlier redemption. The floating rate per annum is equal to three-month term SOFR (the "benchmark rate") plus a spread of 230 basis points for each quarterly interest period during the floating rate period, provided however, that if the benchmark rate is less than zero, the benchmark rate shall be deemed to be zero. The subordinated notes will mature on November 15, 2031. The Company may, at its option, beginning with the interest payment date of November 15, 2026, and on any interest payment date thereafter, redeem the Notes, in whole or in part, from time to time, subject to obtaining prior approval of the Board of Governors of the Federal Reserve System (the "Federal Reserve Board") to the extent such approval is then required under the capital adequacy rules of the Federal Reserve Board, at a redemption price equal to 100% of the principal amount of the Notes being redeemed, plus accrued and unpaid interest to, but excluding, the date of redemption. During the year ended December 31, 2022, the Company repurchased $5.6 million of the subordinated notes, resulting in a gain on repurchase of $0.6 million, included in other non-interest income on the Consolidated Statement of Income. There were no repurchases of subordinated notes during the year ended December 31, 2021.

REGULATORY CAPITAL

REGULATORY CAPITAL	12 Months Ended
	Dec. 31, 2022
Regulatory Capital [Abstract]
REGULATORY CAPITAL	REGULATORY CAPITAL The Company and the Bank are subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can result in certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s consolidated financial statements. Under capital adequacy guidelines and, additionally for the Bank, the regulatory framework for prompt corrective action, the Company and the Bank must meet specific capital requirements that involve quantitative measures of the Company and the Bank’s assets, liabilities, and certain off-balance sheet items calculated under regulatory accounting practices. The Company and the Bank’s capital amounts and classifications also are subject to qualitative judgments by the regulators about components, risk weightings, and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Company and the Bank to maintain minimum amounts and ratios (set forth in the following table) of total, tier 1, and common equity tier 1 capital (as defined in the regulations) to risk weighted assets, and of tier 1 capital (as defined in the regulations) to average assets. Management believes as of December 31, 2022 and 2021, the Company and the Bank met all capital adequacy requirements. As of December 31, 2022, the most recent notification from the Federal Deposit Insurance Corporation categorized the Bank as “well capitalized” under the regulatory framework for prompt corrective action. To be categorized as “well capitalized,” the Bank must maintain minimum total risk-based, tier 1 risk-based, common equity tier 1 risk-based, tier 1 leverage ratios as set forth in the table below. Since that notification, there are no conditions or events that management believes have changed the institution’s category. The Company’s actual capital amounts and ratios are presented in the following table: Actual For Capital Adequacy Purposes (1) To Be Considered (In thousands) Amount Ratio Amount Ratio Amount Ratio December 31, 2022 Total capital to risk weighted assets $ 721,324 14.87 % $ 387,957 8.00 % N/A N/A Tier 1 capital to risk weighted assets 597,022 12.31 % 290,967 6.00 % N/A N/A Tier 1 capital to average assets 597,022 7.52 % 317,738 4.00 % N/A N/A Common equity tier 1 to risk weighted assets 597,022 12.31 % 218,226 4.50 % N/A N/A December 31, 2021 Total capital to risk weighted assets $ 656,719 15.95 % $ 329,471 8.00 % N/A N/A Tier 1 capital to risk weighted assets 534,381 12.98 % 247,103 6.00 % N/A N/A Tier 1 capital to average assets 534,381 7.62 % 280,454 4.00 % N/A N/A Common equity tier 1 to risk weighted assets 534,381 12.98 % 185,327 4.50 % N/A N/A (1) Amounts are shown exclusive of the applicable capital conservation buffer of 2.50%. The Bank’s actual capital amounts and ratios are presented in the following table: Actual For Capital Adequacy Purposes (1) To Be Considered (In thousands) Amount Ratio Amount Ratio Amount Ratio December 31, 2022 Total capital to risk weighted assets $ 715,458 14.75 % $ 388,107 8.00 % $ 485,134 10.00 % Tier 1 capital to risk weighted assets 668,864 13.79 % 291,080 6.00 % 388,107 8.00 % Tier 1 capital to average assets 668,864 8.44 % 317,111 4.00 % 396,389 5.00 % Common equity tier 1 to risk weighted assets 668,864 13.79 % 218,310 4.50 % 315,337 6.50 % December 31, 2021 Total capital to risk weighted assets $ 613,030 14.89 % $ 329,376 8.00 % $ 411,720 10.00 % Tier 1 capital to risk weighted assets 575,692 13.98 % 247,032 6.00 % 329,376 8.00 % Tier 1 capital to average assets 575,692 8.21 % 280,433 4.00 % 205,860 5.00 % Common equity tier 1 to risk weighted assets 575,692 13.98 % 185,274 4.50 % 267,618 6.50 % (1) Amounts are shown exclusive of the applicable capital conservation buffer of 2.50%.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The components of the provision for income taxes for the years ended December 31, 2022, 2021, and 2020 are as follows: Year Ended December 31, (In thousands) 2022 2021 2020 Current: Federal $ 9,201 $ 9,349 $ 15,010 State and local 3,111 1,389 1,152 12,312 10,738 16,162 Deferred: Federal 10,709 4,409 (3,497) State and local 3,666 2,641 3,090 14,375 7,050 (407) Total income tax provision $ 26,687 $ 17,788 $ 15,755 A reconciliation of the expected income tax expense at the statutory federal income tax rate of 21% to the Company’s actual income tax benefit and effective tax rate for the years ended December 31, 2022, 2021, and 2020 and is as follows: Year Ended December 31, 2022 2021 2020 (In thousands) Amount % Amount % Amount % Tax expense at federal income tax rate $ 22,714 21.00 % $ 14,852 21.00 % $ 13,008 21.00 % Increase (decrease) resulting from: Tax exempt income (497) (0.46) % (317) (0.45) % (862) (1.39) % Change in DTA rate 84 0.08 % (199) (0.28) % 333 0.54 % State tax, net of federal benefit 5,354 4.95 % 3,184 4.50 % 3,551 5.73 % Stock options windfall (363) (0.34) % (94) (0.13) % (3) (0.01) % Other (605) (0.56) % 362 0.51 % (272) (0.44) % Total $ 26,687 24.67 % $ 17,788 25.15 % $ 15,755 25.43 % As of December 31, 2022 the Company had remaining federal, state and local net operating loss carryforwards of approximately $1.3 million, $42.8 million and $18.7 million, respectively, which are available to offset future federal, state and local income and which expire over varying periods from 2028 through 2037. Deferred income tax assets and liabilities result from temporary differences between the carrying value of assets and liabilities for financial reporting purposes and for income tax return purposes. These assets and liabilities are measured using the enacted tax rates and laws that are currently in effect and are reported net in the accompanying Consolidated Statement of Financial Condition. The significant components of the net deferred tax assets and liabilities as of December 31, 2022 and 2021, are as follows: December 31, 2022 2021 (In thousands) Deferred tax assets: Excess tax basis over carrying value of assets: Allowance for loan losses $ 13,237 $ 16,300 Nonaccrual interest income 106 389 Postretirement and other employee benefits 1,563 242 Available for sale securities carried at fair value for financial statement purposes 36,330 — Depreciation and amortization 1,418 1,123 Operating leases 10,976 13,250 Federal, state and local net operating loss carryforward 4,468 7,285 Transfer of available for sale securities to held-to-maturity 4,379 — Other, net 600 3,258 Gross deferred tax asset 73,077 41,847 Deferred tax liabilities: Available for sale securities carried at fair value for financial statement purposes — (2,850) Unrealized loss on investment (150) — Purchase accounting adjustments, net (676) (874) Operating leases (8,575) (10,142) Net deferred loan fees (1,169) (1,262) Gross deferred tax liabilities (10,570) (15,128) Deferred tax asset, net $ 62,507 $ 26,719 As of December 31, 2022, the Company’s deferred tax assets were valued without an allowance as management concluded that it is more likely than not that the entire amount may be realized. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Management reassesses the need for a valuation allowance on an annual basis, or more frequently if warranted. If it is later determined that a valuation allowance is required, it generally will be an expense to the income tax provision in the period such determination is made. The Company has no uncertain tax positions. The Company and its subsidiaries are subject to Federal, New York State, California, Colorado, District of Columbia, Florida, New Jersey, Massachusetts, Minnesota, North Carolina, Pennsylvania, Virginia and New York City income taxes. A tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination; with a tax examination presumably to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. As of December 31, 2022, the Company is generally subject to possible examination by federal, state, and local taxing authorities for 2019 and subsequent tax years. Income tax receivable, which is included in other assets, totaled $12.1 million and $20.8 million as of December 31, 2022 and 2021, respectively.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Following is a table setting forth the factors used in the earnings per share computation follow: Year Ended 2022 2021 2020 (In thousands, except per share amounts) Net income attributable to Amalgamated Financial Corp. $ 81,477 $ 52,937 $ 46,188 Dividends paid on preferred stock (22) (22) (22) Income attributable to common stock $ 81,455 $ 52,915 $ 46,166 Weighted average common shares outstanding, basic 30,818 31,104 31,133 Basic earnings per common share $ 2.64 $ 1.70 $ 1.48 Income attributable to common stock $ 81,455 $ 52,915 $ 46,166 Weighted average common shares outstanding, basic 30,818 31,104 31,133 Incremental shares from assumed conversion of options and RSUs 375 408 96 Weighted average common shares outstanding, diluted 31,193 31,512 31,229 Diluted earnings per common share $ 2.61 $ 1.68 $ 1.48

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS The Company offers various pension and retirement benefit plans, as well as a long-term incentive plan to eligible employees and directors. Significant benefit plans are described as follows: Pension Plan The Company participates in a multi-employer non-contributory pension plan which covers substantially all full-time employees, both unionized and non-unionized. Employees generally qualify for participation in the plan on the first January 1 st or July 1 st after attaining age 21 and completing 1,000 Hours of Service in a 12 consecutive month period. The collective bargaining agreement covering the unionized employees was last renewed in March 2020. Under the terms of this plan, participants vest 100% upon completion of five years of service, as defined in the plan document. Plan assets are invested in the Consolidated Retirement Fund ("CRF"). The Employer Identification Number of the CRF is 13-3177000 and the Plan Number is 001. As a multi-employer plan, the Administrator of the CRF does not make separate actuarial valuations with respect to each employer, nor are plan assets so segregated. The benefits provided by the CRF are being funded by the Company and other participating employers through contributions to the Administrator, which are necessary to maintain the CRF on a sound actuarial basis. Contributions are calculated based on a percentage of participants’ qualifying base salary, which percentage is determined from time to time by the CRF Board of Trustees. The Pension Protection Act of 2006 ("PPA") ranks the funded status of multi-employer plans depending upon a plan’s current and projected funding. A plan is in the Red Zone (Critical Status) if it has a current funded percentage (as defined) of less than 65%. A plan is in the Yellow Zone (Endangered Status) if it has a current funded percentage of less than 80%, or projects a credit balance deficit within seven years. A plan is in the Green Zone if it has a current funded percentage greater than 80% and does not have a projected credit balance deficit within seven years. For the 2022 and 2021 plan years, pursuant to the PPA, the CRF was certified to be in the Green Zone (i.e. neither Critical Status nor Endangered Status). The following table summarizes certain information regarding contributions made by the Company to the CRF: (In thousands) Contributions Company contributions greater than 5% of total contributions received by the CRF? Year Ended December 31, 2022 $ 6,321 Yes 2021 6,193 Yes 2020 6,278 Yes The amounts of contributions presented in the preceding table represent expense recorded by the Company during the respective periods and are included in Compensation and Employee Benefits expense on the Consolidated Statements of Income. Retirement Benefit Plans The Company offers a post-retirement health plan, a life insurance plan, and provides for two other non-qualifying supplemental retirement plan benefits; one for certain former directors, and one for certain former employees. The Company’s policy is to fund the cost of health and life benefits in amounts determined in accordance with the plan provisions. The other retirement benefit plans generally contain vesting provisions and service requirements. These plans are unfunded and represent a general obligation of the Company. The following table summarizes the plans’ benefit obligation, the changes in the plans’ benefit obligation, changes in plan assets and the plan’s funded status: Year Ended December 31, (In thousands) 2022 2021 Change in benefit obligation: Benefit obligation at beginning of year $ 3,658 $ 4,094 Service cost — — Interest cost 71 58 Amendments — — Actuarial gain (397) (16) Benefits paid (477) (478) Benefit obligation at end of year $ 2,855 $ 3,658 Change in plan assets: Employer contributions $ 477 $ 478 Benefits paid (477) (478) Plan assets at end of year $ — $ — Benefit obligation, included in other liabilities $ 2,855 $ 3,658 (In thousands) 2022 2021 2020 Net actuarial loss $ 2,572 $ 3,235 $ 3,200 Prior service credit (292) (320) (349) Total amount recognized $ 2,280 $ 2,915 $ 2,851 The following table summarizes the components of net periodic benefit cost and other amounts recognized in other comprehensive income (In thousands) 2022 2021 2020 Components of net periodic benefit cost: Service cost $ — $ — $ — Interest cost 71 58 118 Prior service credit amortization (29) (29) (29) Prior service credit due to curtailments — — — Recognized actuarial loss 267 400 320 Net periodic benefit $ 309 $ 429 $ 409 Components of other amounts: Net regular actuarial (gain) loss $ (397) $ (16) $ 379 Recognized actuarial loss (267) (400) (320) Prior service credit amortization 29 29 29 Prior service credit due to curtailments — 450 (450) Prior service credit due to amendment — — — Total recognized in other comprehensive income $ (635) $ 63 $ (362) Total recognized in comprehensive income $ (326) $ 492 $ 47 The following table summarizes certain weighted average assumptions used to measure the plans’ obligation at the end of the year as well as net periodic benefit expense during the year: 2022 2021 2020 Weighted average assumptions used to determine benefit obligations: Discount rate 4.75 % 2.07 % 1.50 % Weighted average assumptions used to determine net periodic benefit cost: Discount rate 2.14 % 1.66 % 3.13 % The net actuarial loss and prior service credit that is expected to be amortized from accumulated other comprehensive income (loss) and into net periodic (benefit) expense during the year ended December 31, 2023 is $0.2 million. Future estimated benefit payments are expected to be approximately $0.3 million per annum during the period 2023 through 2031. 401(k) Plans The Company also offers 2 retirement savings plans which are qualified under Section 401(k) of the Internal Revenue Code ("401(k) Plan"). Substantially all employees are eligible to participate, and participants can contribute up to 15% of their salary subject to certain limitations. The Company does not make contributions to the 401(k) Plan and as such does not incur any direct compensation expense related to the 401(k) Plan. Long Term Incentive Plans Stock Options: The Company has granted stock options in previous years to employees and directors. As of December 31, 2020, all options have vested and are exercisable at the option of the vested holders until the termination of each tranche after 10 years from the grant date or earlier if the employee or director has changed their employment status. The Company does not currently have an active stock option plan that is available for issuing new options. A summary of the status of the Company’s options as of December 31, 2022 follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Intrinsic Value (in thousands) Outstanding, December 31, 2021 847,560 $ 13.19 4.3 years Granted — — — Forfeited/ Expired (18,260) 12.69 — Exercised (402,420) 13.31 — Outstanding, December 31, 2022 426,880 13.09 3.3 years $ 4,246 Vested and Exercisable, December 31, 2022 426,880 $ 13.09 3.3 years $ 4,246 The range of exercise prices is $11.00 to $14.65 per share. There were no options compensation costs to employees and directors for the year ended December 31, 2022 and December 31, 2021 as all options had been fully expensed as of December 31, 2020. Total options compensation costs for the year ended 2020 was $0.7 million, and is recorded within compensation and employee benefits expense on the Consolidated Statements of Income. The fair value of all awards outstanding as of December 31, 2022 and December 31, 2021 was $4.2 million and $2.9 million, respectively. No cash was received for options exercised in the years ended December 31, 2022 and December 31, 2021. The Company repurchased 310,176 shares and 920,948 shares for options exercised in the years ended December 31, 2022 and December 31, 2021, respectively. Restricted Stock Units: The Amalgamated Financial Corp. 2021 Equity Incentive Plan (the “Equity Plan”) provides for the grant of stock-based incentive awards to employees and directors of the Company. The number of shares of common stock of the Company available for stock-based awards in the Equity Plan is 1,250,000 of which 434,907 shares were available for issuance as of December 31, 2022. Restricted stock units ("RSUs") represent an obligation to deliver shares to an employee or director at a future date if certain vesting conditions are met. RSUs are subject to a time-based vesting schedule, the satisfaction of performance conditions, or the satisfaction of market conditions, and are settled in shares of the Company’s common stock. RSUs do not provide dividend equivalent rights from the date of grant and do not provide voting rights. RSUs accrue dividends based on dividends paid on common shares, but those dividends are paid in cash upon satisfaction of the specified vesting requirements on the underlying RSU. A summary of the status of the Company’s time-based vesting RSUs as of December 31, 2022 follows: Shares Grant Date Fair Value Unvested, December 31, 2021 326,521 $ 15.66 Awarded 193,339 19.31 Forfeited/Expired (42,885) 15.69 Vested (145,952) 15.83 Unvested, December 31, 2022 331,023 $ 17.72 A summary of the status of the Company’s performance-based RSUs as of December 31, 2022 follows: Shares Grant Date Fair Value Unvested, December 31, 2021 103,774 $ 15.84 Awarded 62,794 17.69 Forfeited/Expired (46,137) 16.18 Vested (23,461) 17.91 Unvested, December 31, 2022 96,970 $ 16.37 During the year ended December 31, 2022, the Company granted 16,536, 14,376 and 866 performance-based RSUs at a fair value of $17.34, $17.39 and $21.64 per share, respectively which vest subject to the achievement of the Company’s corporate goal for the three-year period from January 1, 2022 to December 31, 2024. The corporate goal is based on the Company achieving a target increase in Tangible Book Value, adjusted for certain factors. The minimum and maximum awards that are achievable are 0 and 47,667 shares, respectively. During the year ended December 31, 2022, the Company granted 31,016 market-based RSUs at a fair value of $17.91 per share which vest subject to the Bank’s relative total shareholder return compared to a group of peer banks over a three-year period from February 3, 2022 to February 2, 2025. The minimum and maximum awards that are achievable are 0 and 46,524 shares, respectively. As of December 31, 2022, the Company reserved 145,455 shares for issuance upon vesting of performance-based RSUs assuming the Company’s employees achieve the maximum share payout. The Company repurchased 54,191 shares and 21,624 shares for RSUs vested in the years ended December 31, 2022 and 2021, respectively. Of the 427,993 unvested RSUs as of December 31, 2022, the minimum units that will vest, solely due to a service test, are 331,023. The maximum units that will vest, assuming the highest payout on performance and market-based units, are 476,478. Compensation expense attributable to the employee RSUs was $2.2 million, $1.8 million, and $1.2 million for the years ended December 31, 2022, 2021, and 2020, respectively. The Company recorded an expense of $0.5 million, $0.3 million, and $0.5 million attributable to RSUs granted to directors for the years ended December 31, 2022, 2021, and 2020, respectively. As of December 31, 2022, there was $4.2 million of total unrecognized compensation cost related to the non-vested RSUs granted to employees and directors. This expense may increase or decrease depending on the expected number of performance-based shares to be issued. This expense is expected to be recognized over 2.1 years.

FAIR VALUE OF FINANCIAL INSTRUM

FAIR VALUE OF FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assumptions are developed based on prioritizing information within a fair value hierarchy that gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. A description of the disclosure hierarchy and the types of financial instruments recorded at fair value that management believes would generally qualify for each category are as follows: Level 1 - Valuations are based on quoted prices in active markets for identical assets or liabilities. Accordingly, valuation of these assets and liabilities does not entail a significant degree of judgment. Examples include most U.S. Government securities and exchange-traded equity securities. Level 2 - Valuations are based on either quoted prices in markets that are not considered to be active or significant inputs to the methodology that are observable, either directly or indirectly. Financial instruments in this level would generally include mortgage-related securities and other debt issued by GSEs, non-GSE mortgage-related securities, corporate debt, certain redeemable fund investments and certain trust preferred securities. Level 3 - Valuations are based on inputs to the methodology that are unobservable and significant to the fair value measurement. These inputs reflect management’s own judgments about the assumptions that market participants would use in pricing the assets and liabilities. Assets Measured at Fair Value on a Recurring Basis Available for sale securities The Company’s available for sale securities are reported at fair value. Investments in fixed income securities are generally valued based on evaluations provided by an independent pricing service. These evaluations represent an exit price or their opinion as to what a buyer would pay for a security, typically in an institutional round lot position, in a current sale. The pricing service utilizes evaluated pricing techniques that vary by asset class and incorporate available market information and, because many fixed income securities do not trade on a daily basis, applies available information through processes such as benchmark curves, benchmarking of available securities, sector groupings and matrix pricing. Model processes, such as option adjusted spread models, are used to value securities that have prepayment features. In those limited cases where pricing service evaluations are not available for a fixed income security, management will typically value those instruments using observable market inputs in a discounted cash flow analysis. The following summarizes those financial instruments measured at fair value on a recurring basis in the Consolidated Statements of Financial Condition as of the dates indicated, categorized by the relevant class of investment and level of the fair value hierarchy: December 31, 2022 (In thousands) Level 1 Level 2 Level 3 Total Available for sale securities: Mortgage-related: GSE residential CMOs $ — $ 389,260 $ — $ 389,260 GSE commercial certificates & CMO — 213,786 — 213,786 Non-GSE residential certificates — 107,080 — 107,080 Non-GSE commercial certificates — 97,482 — 97,482 Other debt: U.S. Treasury 192 — — 192 ABS — 862,163 — 862,163 Trust preferred — 10,143 — 10,143 Corporate — 132,370 — 132,370 Total assets carried at fair value $ 192 $ 1,812,284 $ — $ 1,812,476 December 31, 2021 (In thousands) Level 1 Level 2 Level 3 Total Available for sale securities: Mortgage-related: GSE residential certificates $ — $ 3,967 $ — $ 3,967 GSE residential CMOs — 463,883 — 463,883 GSE commercial certificates & CMO — 370,364 — 370,364 Non-GSE residential certificates — 66,139 — 66,139 Non-GSE commercial certificates — 81,101 — 81,101 Other Debt: U.S. Treasury 200 — — 200 ABS — 989,188 — 989,188 Trust preferred — 14,147 — 14,147 Corporate — 124,421 — 124,421 Total assets carried at fair value $ 200 $ 2,113,210 $ — $ 2,113,410 During the years ended December 31, 2022 and 2021, there were no transfers of financial instruments between Level 1 and Level 2. There were no financial instruments measured at fair value on a recurring basis and categorized as Level 3 in the Consolidated Statement of Financial Condition during the years ended December 31, 2022 and 2021. Assets Measured at Fair Value on a Non-recurring Basis Certain financial assets are measured at fair value on a non-recurring basis. That is, they are subject to fair value adjustments in certain circumstances. Impaired loans Fair values for loans considered impaired are based on discounted cash flows using the loan’s initial effective interest rate or the fair value of the underlying collateral in the case of collateral dependent loans. The methods used to estimate the fair value of loans are extremely sensitive to the assumptions and estimates used. While management has attempted to use assumptions and estimates that best reflect the Company’s loan portfolio and current market conditions, a greater degree of subjectivity is inherent in these values than in those determined in active markets. Other real estate owned Other real estate owned, representing property acquired through foreclosure or deed in lieu of foreclosure, are carried at fair value less estimated disposal costs of the acquired property. Fair value on other real estate owned is based on the appraised value of the collateral using discount rates or capitalization rates similar to those used in impaired loan valuation. The following tables summarize assets measured at fair value on a non-recurring basis in the Consolidated Statements of Financial Condition as of the dates indicated, categorized by the relevant class of investment and level of the fair value hierarchy: December 31, 2022 (In thousands) Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value Fair Value Measurements: Impaired loans $ 3,315 $ — $ — $ 3,315 $ 3,315 $ 3,315 $ — $ — $ 3,315 $ 3,315 December 31, 2021 (In thousands) Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value Fair Value Measurements: Impaired loans $ 48,111 $ — $ — $ 48,111 $ 48,111 Other real estate owned $ 307 $ — $ — $ 335 $ 335 $ 48,418 $ — $ — $ 48,446 $ 48,446 Financial Instruments Not Measured at Fair Value A description of the methods, factors and significant assumptions utilized in estimating the fair values for significant categories of financial instruments not measured at fair value follows: • Held-to-maturity securities – Investments in fixed income securities are generally valued based on evaluations provided by an independent pricing service. These evaluations represent an exit price or their opinion as to what a buyer would pay for a security, typically in an institutional round lot position, in a current sale. The pricing service utilizes evaluated pricing techniques that vary by asset class and incorporate available market information and, because many fixed income securities do not trade on a daily basis, applies available information through processes such as benchmark curves, benchmarking of available securities, sector groupings and matrix pricing. Model processes, such as option adjusted spread models, are used to value securities that have prepayment features. In those limited cases where pricing service evaluations are not available for a fixed income security, management will typically value those instruments using observable market inputs in a discounted cash flow analysis. Held-to-maturity securities, with the exception of PACE securities which are categorized as Level 3, are generally categorized as Level 2. • Loans held for sale – Loans held for sale are carried at the lower of cost or fair value. The fair value of loans held for sale is determined using the price we expect to receive for the loans based on commitments received from third party investors. Loans held on our balance sheet greater than 90 days are evaluated to determine if a valuation allowance is required to adjust for a decline in fair value below the carrying amount, and then subject to quarterly evaluation going forward. Loans held for sale are generally categorized as Level 3. • Loans receivable – Loans are valued using a present value technique that incorporates management’s assumptions as to what a market participant would assume given the attributes of the loans. The observable U.S. Treasury yield curve is a significant input to the valuation. Assumptions, including prepayment speeds and credit spreads, are based on observable market data where possible or alternatively are based on terms currently offered on loans to borrowers of similar credit quality. The methods used to estimate the fair value of loans are extremely sensitive to the assumptions and estimates used. While management has attempted to use assumptions and estimates that best reflect the Company’s loan portfolio and current market conditions, a greater degree of subjectivity is inherent in these values than in those determined in active markets. Loans would generally be categorized as Level 3. • Resell agreements – Resell agreements are carried at fair value, as these are short term agreements. All existing trades are done at the current rate for new trades, so there is no market value adjustment. The agreements are generally categorized as Level 3, as we have limited market information. • Deposits – Deposits without a defined maturity date are valued at the amount payable on demand, and are categorized as Level 2. Certificates of deposit, which are categorized as Level 2, are valued using a present value technique that incorporates current rates offered by the Company for certificates of comparable remaining maturity. • FHLBNY Advances – FHLBNY advances are valued using a present value technique that incorporates current rates offered by the FHLBNY for advances of comparable remaining maturity. FHLBNY advances are categorized as Level 2. • Subordinated debt – Bank issued subordinated debt is valued based on recent trades for similar issues and or values provided by firms that transact in our bonds. Subordinated debt is categorized as Level 2. • Other – The Company holds or issues other financial instruments for which management considers the carrying value to approximate fair value. Such items include cash and cash equivalents, accrued interest receivable and payable. Many of these items are short term in nature with minimal risk characteristics. For those financial instruments that are not recorded at fair value in the consolidated statements of financial condition, but are measured at fair value for disclosure purposes, management follows the same fair value measurement principles and guidance as for instruments recorded at fair value. There are significant limitations in estimating the fair value of financial instruments for which an active market does not exist. Due to the degree of management judgment that is often required, such estimates tend to be subjective, sensitive to changes in assumptions and imprecise. Such estimates are made as of a point in time and are impacted by then-current observable market conditions; also such estimates do not give consideration to transaction costs or tax effects if estimated unrealized gains or losses were to become realized in the future. Because of inherent uncertainties of valuation, the estimated fair value may differ significantly from the value that would have been used had a ready market for the investment existed and the difference could be material. Lastly, consideration is not given to nonfinancial instruments, including various intangible assets, which could represent substantial value. Fair value estimates are not necessarily representative of the Company’s total enterprise value. The following table summarizes the financial statement basis and estimated fair values for significant categories of financial instruments: December 31, 2022 Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value (In thousands) Financial assets: Cash and cash equivalents $ 63,540 $ 63,540 $ — $ — $ 63,540 Held-to-maturity securities 1,541,301 — 574,609 840,262 1,414,871 Loans held for sale 7,943 — 7,943 7,943 Loans receivable, net 4,060,971 — — 3,718,308 3,718,308 Resell agreements 25,754 — — 25,754 25,754 Accrued interest and dividends receivable 41,441 17 12,197 29,227 41,441 Financial liabilities: Deposits payable on demand 6,369,087 — 6,369,087 — 6,369,087 Time deposits 225,950 — 225,805 — 225,805 FHLBNY advances 580,000 — 580,000 — 580,000 Subordinated debt 77,708 — 68,966 — 68,966 Accrued interest payable 1,218 — 1,218 — 1,218 December 31, 2021 (In thousands) Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value Financial assets: Cash and cash equivalents $ 330,485 $ 330,485 $ — $ — $ 330,485 Held-to-maturity securities 843,569 — 216,377 633,327 849,704 Loans held for sale 3,279 — — 3,279 3,279 Loans receivable, net 3,276,358 — — 3,291,377 3,291,377 Resell agreements 229,018 — — 229,018 229,018 Accrued interest and dividends receivable 28,820 — 28,820 — 28,820 Financial liabilities: Deposits payable on demand 6,149,103 — 6,149,103 — 6,149,103 Time deposits 207,152 — 207,369 — 207,369 Subordinated Debt 83,831 — 85,000 — 85,000 Accrued interest payable 569 — 569 — 569

COMMITMENTS, CONTINGENCIES AND

COMMITMENTS, CONTINGENCIES AND OFF BALANCE SHEET RISK	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, CONTINGENCIES AND OFF BALANCE SHEET RISK	COMMITMENTS, CONTINGENCIES AND OFF BALANCE SHEET RISK Credit Commitments The Company is party to various credit related financial instruments with off balance sheet risk. The Company, in the normal course of business, issues such financial instruments in order to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. Such commitments involve, to varying degrees, elements of credit and interest rate risk in excess of the amounts recognized in the consolidated statements of financial condition. The following financial instruments were outstanding whose contract amounts represent credit risk as of the related periods: December 31, 2022 December 31, 2021 (In thousands) Commitments to extend credit $ 723,902 $ 927,428 Standby letters of credit 29,568 18,752 Total $ 753,470 $ 946,180 Commitments to extend credit are contracts to lend to a customer as long as there is no violation of any condition established in the contract. These commitments have fixed expiration dates and other termination clauses and generally require the payment of nonrefundable fees. Since a portion of the commitments are expected to expire without being drawn upon, the contractual principal amounts do not necessarily represent future cash requirements. The Company’s maximum exposure to credit risk is represented by the contractual amount of these instruments. These instruments represent ultimate exposure to credit risk only to the extent they are subsequently drawn upon by customers. Standby letters of credit are conditional lending commitments issued by the Company to guarantee the financial performance of a customer to a third party. The credit risk involved in issuing standby letters of credit is essentially the same as that involved in extending loan facilities to customers. The balance sheet carrying value of standby letters of credit approximates any nonrefundable fees received but not yet recorded as income. The Company considers this carrying value, which is not material, to approximate the estimated fair value of these financial instruments. The Company reserves for the credit risk inherent in off balance sheet credit commitments. This reserve, which is included in other liabilities, amounted to approximately $1.6 million as of December 31, 2022 and $1.5 million as of December 31, 2021. Other Commitments and Contingencies In the ordinary course of business, there are various legal proceedings pending against the Company. Based on the opinion of counsel, management believes that the aggregate liabilities, if any, arising from such actions would not have a material adverse effect on the consolidated financial position or results of operations of the Company. Investment Obligations The Company is party to agreements with Pace Funding Group LLC, which operates Home Run Financing, for the purchase of property assessed clean energy, or PACE, assessment securities until the end of July 2023. These investments are to be held in the Company's held-to-maturity investment portfolio. As of December 31, 2022, we had purchased $451.7 million of PACE assessment securities from Pace Funding Group LLC and had a remaining commitment of $150.0 million. Separately, the Company is party to agreements with Petros PACE Finance for the purchase of PACE assessment securities until February 16, 2023. As of December 31, 2022, we had purchased $53.5 million of these obligations and had an estimated remaining commitment of $14.3 million. The PACE assessments have equal-lien priority with property taxes and generally rank senior to first lien mortgages. These investments are currently held in the Company's held-to-maturity investment portfolio.

LEASES

LEASES	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
LEASES	LEASES The Company as a lessee has operating leases primarily consisting of real estate arrangements where the Company operates its headquarters, branches and business production offices. All leases identified as in scope are accounted for as operating leases as of December 31, 2022 and December 31, 2021. These leases are typically long-term leases and generally are not complicated arrangements or structures. Several of the leases contain renewal options at a rate comparable to the fair market value based on comparable analysis to similar properties in the Company’s geographies. Real estate operating leases are presented as a right-of-use asset and a related operating lease liability on the Consolidated Statements of Financial Condition. The ROU asset represents the Company’s right to use the underlying asset for the lease term and the operating lease liabilities represent the obligation to make lease payments arising from the lease. The Company applied its incremental borrowing rate as the discount rate to the remaining lease payments to derive a present value calculation for initial measurement of the operating lease liability. The IBR reflects the interest rate the Company would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. Lease expense is recognized on a straight-line basis over the lease term. The following table summarizes our lease cost and other operating lease information: Year Ended December 31, 2022 2021 (In thousands) Operating lease cost $ 7,216 $ 8,219 Cash paid for amounts included in the measurement of Operating leases liability $ 10,745 $ 10,193 Weighted average remaining lease term on operating leases (in years) 3.9 4.7 Weighted average discount rate used for operating leases liability 3.25 % 3.25 % Note: Sublease income and variable income or expense considered immaterial The following table presents the remaining commitments for operating lease payments for the next five years and thereafter, as well as a reconciliation to the discounted operating leases liability recorded in the Consolidated Statements of Financial Condition as of December 31, 2022: (In thousands) As of December 31, 2022 2023 $ 11,285 2024 11,310 2025 10,574 2026 9,176 2027 955 Thereafter — Total undiscounted operating lease payments 43,300 Less: present value adjustment 2,521 Total Operating leases liability $ 40,779

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS Goodwill In accordance with GAAP, the Company performs an annual test as of June 30 to identify potential impairment of goodwill, or more frequently if events or circumstances indicate a potential impairment may exist. If the carrying amount of the Company, as a sole reporting unit, including goodwill, exceeds its fair value, an impairment loss is recognized in an amount equal to that excess up to the amount of the recorded goodwill. The Company performed its annual test based upon market data as of June 30, 2022 and estimates and assumptions that the Company believes most appropriate for the analysis. Based on the qualitative analysis performed in accordance with ASC 350, the Company determined it more likely than not that goodwill was not impaired as of June 30, 2022. Changes in certain assumptions used in the Company's assessment could result in significant differences in the results of the impairment test. Should market conditions or management’s assumptions change significantly in the future, an impairment to goodwill is possible. At December 31, 2022 and December 31, 2021, the carrying amount of goodwill was $12.9 million. Intangible Assets The following table reflects the estimated amortization expense, comprised entirely by the Company’s core deposit intangible asset, for the next five years and thereafter: (In thousands) Total 2023 $ 888 2024 730 2025 574 2026 419 2027 265 Thereafter 229 Total $ 3,105 Accumulated amortization of the core deposit intangible was $5.9 million as of December 31, 2022. Amortization expense recognized on the core deposit intangible was $1.0 million, $1.2 million, and $1.4 million for the years ended December 31, 2022, December 31, 2021, and December 31, 2020, respectively.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
VARIABLE INTEREST ENTITIES	VARIABLE INTEREST ENTITIES Tax Credit Investments The Company makes investments in unconsolidated entities that construct, own and operate solar generation facilities. An unrelated third party is the managing member and has control over the significant activities of the variable interest entities ("VIE"). The Company generates a return through the receipt of tax credits allocated to the projects, as well as operational distributions. The primary risk of loss is generally mitigated by policies requiring that the project qualify for the expected tax credits prior to the Company making its investment. Any loans to the VIE are secured. As of December 31, 2022, the Company's maximum exposure to loss is $64.2 million. December 31, 2022 December 31, 2021 (In thousands) Unconsolidated Variable Interest Entities Tax credit investments included in equity investments $ 3,299 $ 1,681 Loans and letters of credit commitments 60,857 52,813 Funded portion of loans and letters of credit commitments 47,683 15,512 The following table summarizes the tax benefits conveyed by the Company’s solar generation VIE investments: Year Ended December 31, 2022 2021 (In thousands) Tax credits and other tax benefits recognized $ 2,672 $ 11,571

PARENT COMPANY ONLY CONDENSED F

PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION	PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION Condensed financial information of Amalgamated Financial Corp. follows: CONDENSED BALANCE SHEET December 31, 2022 December 31, 2021 (in thousands) ASSETS Cash and cash equivalents $ 10,884 $ 42,886 Investment in banking subsidiary 580,664 605,074 Other assets 113 12 Total assets $ 591,661 $ 647,972 LIABILITIES AND EQUITY Subordinated debt $ 77,708 $ 83,831 Accrued expense and other liabilities 5,131 399 Stockholders' equity 508,822 563,742 Total liabilities and stockholders' equity $ 591,661 $ 647,972 CONDENSED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Year Ended December 31, 2022 2021 (in thousands) Other income $ 617 $ 11,800 Equity in undistributed subsidiary income 84,321 41,684 Interest expense 2,693 399 Other expense 768 148 Net income $ 81,477 $ 52,937 Comprehensive income (loss) $ (32,639) $ 41,170 CONDENSED STATEMENT OF CASH FLOWS Year Ended December 31, 2022 2021 (in thousands) Cash flows from operating activities Net income $ 81,477 $ 52,937 Adjustments: Equity in undistributed subsidiary income (84,321) (41,684) Net gain on repurchase of subordinated debt (617) — Change in other assets 726 (12) Change in other liabilities (610) 399 Net cash provided (used) by operating activities (3,345) 11,640 Cash flows from investing activities Payments for investments in subsidiaries — (42,490) Net cash provided (used) by investing activities — (42,490) Cash flows from financing activities Dividends paid (11,211) (7,597) Repurchase of shares (12,478) (2,498) Net increase (decrease) in subordinated debt (5,633) 83,831 Proceeds from common stock issued under Employee Stock Purchase Plan 665 — Net cash provided (used) by financing activities (28,657) 73,736 Net change in cash and cash equivalents (32,002) 42,886 Beginning cash and cash equivalents 42,886 — Ending cash and cash equivalents $ 10,884 $ 42,886 Equity exchange for the outstanding common stock of Amalgamated Bank $ — $ 541,093

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Accounting	The accounting and reporting policies of the Company conform to generally accepted accounting principles ("GAAP") in the United States of America, or GAAP and predominant practices within the banking industry. The Company uses the accrual basis of accounting for financial statement purposes.
Consolidation	The accompanying consolidated financial statements include the accounts of the Company and its majority-owned and wholly-owned subsidiaries. All significant inter-company transactions and balances are eliminated in consolidation.
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. In particular, estimates and assumptions are used in measuring the fair value of certain financial instruments, determining the appropriateness of the allowance for loan and lease losses (“allowance”), evaluating potential other-than-temporary securities impairment, assessing the ability to realize deferred tax assets, and the valuation of share-based payment awards. Estimates and assumptions are based on available information and judgment; therefore actual results could differ from those estimates.
Cash, Cash Equivalents and Restricted Cash	For purposes of reporting cash flows, cash, cash equivalents, and restricted cash include cash, due from banks, interest-bearing deposits in other banks and federal funds sold with original maturities of three months or less. The Company had $0.4 million and $0.4 million in restricted cash as of December 31, 2022 and December 31, 2021, respectively and is included in total cash and cash equivalents on the Consolidated Statements of Financial Condition. The Company’s restricted cash reflects funds held in other financial institutions to secure business operating rights or contractually obligated minimum account funding requirements.
Securities	Purchases of investments in debt securities are designated as either trading, available for sale or held-to-maturity depending on the intent and ability to hold the securities. The initial designation is made at the time of purchase. As of December 31, 2022 and December 31, 2021, the Company had no securities designated as trading. Securities available for sale are carried at fair value, with any net unrealized appreciation or depreciation in fair value reported net of taxes as a component of accumulated other comprehensive income (loss) in stockholders’ equity. Debt securities held-to-maturity are carried at amortized cost provided management does not have the intent to sell these securities and does not anticipate that it will be necessary to sell these securities before the full recovery of principal and interest, which may be at maturity. The Company reported its investments in "Property Assessed Clean Energy" ("PACE") assessments as held-to-maturity securities. Management conducts a periodic evaluation of securities available for sale and held-to-maturity to determine if the amortized cost basis of a security has been other-than-temporarily impaired ("OTTI"). The evaluation of other-than-temporary impairment is a quantitative and qualitative process, which is subject to risks and uncertainties. If the amortized cost of an investment exceeds its fair value, management evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than amortized cost, the probability of a near-term recovery in value, whether management intends to sell the security and whether it is more likely than not that the Company will be required to sell the security before full recovery of the investment or maturity. Management also considers specific adverse conditions related to the financial health, projected cash flow and business outlook for the investee, including industry and sector performance, operational and financing cash flow factors and rating agency actions. For debt investment securities deemed to be other-than-temporarily impaired, the investment is written down to fair value with the estimated credit loss charged to current earnings and the noncredit-related impairment loss charged to other comprehensive income. If market, industry and/or investee conditions deteriorate, the Company may incur future impairments. Premiums (discounts) on debt securities are amortized (accreted) to income using the level yield method to the contractual maturity date adjusted for actual prepayment experience. Realized gains and losses on sale of securities are determined using the specific identification method and are reported in non-interest income.
Loans Held for Sale	Loans held for sale in the secondary market are carried at the lower of cost or estimated fair value in the aggregate. Net unrealized losses, if any, are recognized through a valuation allowance by charges to current earnings. Gains or losses resulting from sales of loans held for sale, net of unamortized deferred fees and costs, are recognized at the time of sale and are included in other non-interest income on the Consolidated Statements of Income. The Company had $7.9 million and $3.3 million of loans classified as held for sale as of December 31, 2022 and December 31, 2021, respectively.
Loans and Loan Interest Income Recognition	Loans are stated at the principal amount outstanding, net of charge-offs, deferred origination costs and fees and purchase premiums and discounts. Loan origination and commitment fees and certain direct and indirect costs incurred in connection with loan originations are deferred and amortized to income over the life of the related loans as an adjustment to yield. Premiums or discounts on purchased portfolios are amortized or accreted to income using the level yield method. Interest on loans is generally recognized on the accrual basis. Interest is not accrued on loans that are more than 90 days delinquent on payments, and any interest that was accrued but unpaid on such loans is reversed from interest income at that time, or when deemed to be uncollectible. Interest subsequently received on such loans is recorded as interest income or alternatively as a reduction in the amortized cost of the loan if there is significant doubt as to the collectability of the unpaid principal balance. Loans are returned to accrual status when principal and interest amounts contractually due are brought current and future payments are reasonably assured. A loan is impaired when, based on current information and events, it is probable that the Company will not be able to collect all amounts due, both principal and interest, according to the contractual terms. Individual loans which are deemed to be impaired are measured based on the present value of expected future cash flows discounted at the loan’s effective interest rate or at the loan’s observable market price or the fair value of the collateral net of estimated selling costs if the loan is collateral dependent. Individual loan impairment evaluation is generally limited to multifamily, commercial real estate ("CRE"), commercial and industrial ("C&I"), construction and certain restructured residential real estate loans. Smaller balance loans including home equity lines of credit ("HELOCs"), consumer and student loans, as well as non-restructured residential real estate loans, are considered homogeneous. When assessing homogenous loans for impairment, the Company considers regulatory guidance concerning the classification and management of retail credits. The aggregate amount of individually and collectively measured loan impairment is included as a component of the allowance. Loans are considered troubled debt restructurings ("TDRs") if the borrower is experiencing financial difficulty and is afforded a concession by the Company, such as, but not limited to: (i) payment deferral; (ii) a reduction of the stated interest rate for the remaining contractual life of the loan; (iii) an extension of the loan’s original contractual term at a stated interest rate lower than the current market rate for a new loan with similar risk; (iv) capitalization of interest; or (v) forgiveness of principal or interest. Generally, TDRs are placed on nonaccrual status (and reported as non-performing loans) until the loan qualifies for return to accrual status. A TDR loan is considered impaired. A loan extended or renewed at a stated interest rate equal to the market interest rate for new debt with similar risk is not considered to be a TDR. In accordance with the accounting guidance for business combinations, no allowance is brought forward on any of the loans we acquire. For purchased non-credit impaired loans, credit and interest rate discounts representing the principal losses expected over the life of the loan are a component of the initial fair value and the total combined discount is accreted to interest income over the life of the loan. Subsequent to the acquisition date, the method used to evaluate the sufficiency of the discount is similar to organic loans, and if necessary, additional reserves are recognized in the allowance.
Allowance for Loan Losses	The allowance for loan and lease losses (“allowance”) is a valuation allowance for probable incurred credit losses. The Company monitors its entire loan portfolio on a regular basis and considers numerous factors including (i) end-of-period loan levels and portfolio composition, (ii) observable trends in non-performing loans, (iii) the Company’s historical loan loss experience, (iv) known and inherent risks in the portfolio, (v) underwriting practices, (vi) adverse situations which may affect the borrower’s ability to repay, (vii) the estimated value and sufficiency of any underlying collateral, (viii) credit risk grading assessments, (ix) loan impairment, and (x) economic conditions. The allowance consists of specific and general components. The specific component relates to loans that are individually classified as impaired. Additions to the allowance are charged to expense, and realized losses, net of recoveries, are charged to the allowance. Based on the determination of management, the overall level of allowance is periodically adjusted to account for the inherent and specific risks within the entire portfolio. Based on review of the classified loans and the overall allowance levels as they relate to the entire loan portfolio at December 31, 2022, management believes the allowance is adequate. Generally, a loan is considered for charge-off when it is in default of either principal or interest after 90 days or more. In addition to delinquency criteria, other triggering events may include, but are not limited to, notice of bankruptcy by the borrower or guarantor, death of the borrower, and deficiency balance from the sale of collateral. Some financial instruments, such as loan commitments, credit lines, letters of credit, and overdraft protection, are issued to meet customer financing needs. These are agreements to provide credit or to support the credit of others, as long as conditions established in the contract are met, and usually have expiration dates. Commitments may expire without being used. Off-balance sheet risk to credit loss exists up to the face amount of these instruments, although material losses are not anticipated. The same credit policies are used to make such commitments as are used for loans, often including obtaining collateral at exercise of the commitment. An allowance is calculated and recorded in other liabilities within the Consolidated Statements of Financial Condition. While management uses available information to recognize losses on loans, future additions or reductions to the allowance may be necessary due to changes in one or more evaluation factors; management’s assumptions as to rates of default, loss or recovery, or management’s intent with regard to disposition. A shift in lending strategy may warrant a change in the allowance due to a changing credit risk profile. In addition, various regulatory agencies, as an integral part of the examination process, periodically review the Company’s allowance. Such agencies may require the Company to recognize additions to, or charge-offs against, the allowance based on their judgment about information available to them at the time of their examination.
Other Real Estate Owned	Other real estate owned (“OREO”) properties acquired through, or in lieu of, foreclosure are recorded initially at fair value less costs to sell. Any write-down of the recorded investment in the related loan is charged to the allowance prior to transfer. OREO assets are subsequently accounted for at lower of cost or fair value less estimated costs to sell. If fair value declines subsequent to foreclosure, a valuation allowance is recorded through non-interest income. Costs relating to the development and improvement of other real estate owned are capitalized. Costs relating to holding other real estate owned, including real estate taxes, insurance and maintenance, are charged to expense as incurred. The balance of OREO was $0 at both December 31, 2022 and December 31, 2021.
Goodwill and Intangible Assets	Goodwill resulting from business combinations is generally determined as the excess of the fair value of the consideration transferred over the fair value of the net assets acquired and liabilities assumed as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized, but tested for impairment at least annually, or more frequently if events and circumstances exist that indicate the carrying amount of the asset may be impaired. The Company elected June 30 as the annual date for impairment testing. Other intangible assets with definite useful lives are amortized over their estimated useful lives to their estimated residual values. Core deposit intangible assets are amortized on an accelerated method over their estimated useful lives of ten years.
Premises and Equipment	Premises and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of furniture, fixtures, and equipment is computed by the straight-line method over the estimated useful lives of the related assets. Furniture and fixtures are generally depreciated over ten years. Equipment, computer hardware and computer software are normally depreciated over three
Leases	The Company determines whether a contract is or contains a lease at inception. For leases with terms greater than twelve months under which the Company is lessee, right-of-use ("ROU") assets and lease liabilities are recorded at the commencement date. Lease liabilities are initially recorded based on the present value of future lease payments over the lease term. ROU assets are initially recorded at the amount of the associated lease liabilities plus prepaid lease payments and initial direct costs, less any lease incentives received. The cost of short term leases is recognized on a straight line basis over the lease term. The lease term includes options to extend if the exercise of those options is reasonably certain and includes termination options if there is reasonable certainty the options will not be exercised. The Company uses its incremental borrowing rate (“IBR”) as the discount rate to the remaining lease payments to derive a present value calculation for initial measurement of lease liabilities. The IBR reflects the interest rate the Company would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. Leases are classified as financing or operating leases at commencement. All of the Company's leases are classified as operating leases as of December 31, 2022. Operating lease cost is recognized in the Consolidated Statements of Income on a straight line basis over the lease terms. Variable lease costs are recognized in the period in which the obligation for those costs is incurred.
Bank-Owned Life Insurance	The Company invests in bank-owned life insurance (“BOLI”). BOLI involves the purchase of life insurance policies by the Company on a chosen group of employees. The Company is the owner and beneficiary of the policies. The insurance and earnings thereon is used to offset a portion of future employee benefit costs. BOLI is carried at the cash surrender value of the underlying policies. Earnings from BOLI, as well as changes in cash surrender value, are recognized as non-interest income.
Advertising Costs	The Company expenses advertising and promotion costs as incurred.
Income Taxes	There are two components of income tax expense: current and deferred. Current income tax expense (benefit) approximates cash to be paid (refunded) for income taxes for the applicable period. Deferred income tax expense (benefit) results from differences between assets and liabilities measured for financial reporting and for income-tax return purposes. The Company records as a deferred tax asset on its Consolidated Statement of Financial Condition an amount equal to the tax credit and tax loss carry-forwards and tax deductions (tax benefits) that we believe will be available to us to offset or reduce the amounts of our income taxes in future periods. Under applicable federal and state income tax laws and regulations, such tax benefits will expire if not used within specified periods of time. Accordingly, the ability to fully utilize our deferred tax asset may depend on the amount of taxable income that we generate during those time periods. At least once each year, or more frequently, if warranted, we make estimates of future taxable income that we believe we are likely to generate during those future periods. If we conclude, on the basis of those estimates and the amount of the tax benefits available to us, that it is more likely than not that we will be able to fully utilize those tax benefits prior to their expiration, we recognize the deferred tax asset in full on our Consolidated Statement of Financial Condition. If, however, we conclude on the basis of those estimates and the amount of the tax benefits available to us that it has become more likely than not that we will be unable to utilize those tax benefits in full prior to their expiration, then we would establish (or increase any existing) a valuation allowance to reduce the deferred tax asset on our Consolidated Statement of Financial Condition to the amount which we believe we are more likely than not to be able to utilize. Such a reduction is implemented by recognizing a non-cash charge that would have the effect of increasing the provision, or reducing any benefit, for income taxes that we would otherwise have recorded in our Consolidated Statements of Income. The determination of whether and the extent to which we will be able to utilize our deferred tax asset involves management judgments and assumptions that are subject to period-to-period changes as a result of changes in tax laws, changes in the market, or economic conditions that could affect our operating results or variances between our actual operating results and our projected operating results, as well as other factors. When measuring the amount of current taxes to be paid (or refunded) management considers the merit of various tax treatments in the context of statutory, judicial and regulatory guidance. Management also considers results of recent tax audits and historical experience. While management considers the amount of income taxes payable (or receivable) to be appropriate based on information currently available, future additions or reductions to such amounts may be necessary due to unanticipated events or changes in circumstances. Management has not taken, and does not expect to take, any position in a tax return which it deems to be uncertain. The Company recognizes interest and penalties related to income tax matters in income tax expense. The deferral method of accounting is used for investments that generate investment tax credits. Under this method, the investment tax credits are recognized as a reduction of the related asset. Contributions made by the Company are recognized as an increase of the related asset, and distributions are recognized as a reduction. Income and loss generated by the investment is recognized as a corresponding increase or reduction in the related asset.
Post-Retirement Benefit Plans	The Company sponsors several post-retirement benefit plans for current and former employees and certain directors. Contributions to the trustee of a multi-employer defined benefit pension plan are recorded as expense in the period of contribution. Plan obligations and related expenses for other post retirement plans are calculated using actuarial methodologies. The measurement of such obligations and expenses requires management to make certain assumptions, in particular the discount rate, which is evaluated on an annual basis. Other factors include retirement patterns, mortality and turnover assumptions. The Company uses a December 31 measurement date for its post retirement benefit plans. Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 715-30 “Compensation – Retirement Benefits – Defined Benefit Plans – Pension” requires the Company to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial condition and to recognize changes in that funded status in the year the changes occur through comprehensive income.
Comprehensive Income	Comprehensive income includes net income and all other changes in equity during a period, except those resulting from investments by owners and distributions to owners. Other comprehensive income includes income, expenses, gains and losses that under generally accepted accounting principles are included in comprehensive income but excluded from net income. Other comprehensive income (loss) and accumulated other comprehensive income (loss) are reported net of deferred income taxes. Accumulated other comprehensive income for the Company includes unrealized holding gains or losses on available for sale securities, and actuarial gains or losses on the Company’s pension plans. FASB ASC 715‑30 “Compensation – Retirement Benefits – Defined Benefit Plans – Pension” requires employers to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year the changes occur through comprehensive income.
Stock-Based Compensation	Stock-based compensation is recorded in accordance with FASB ASC No. 718, “Accounting for Stock-Based Compensation” which requires the Company to record compensation cost for stock options and restricted stock granted to employees and directors in return for employee service. The cost is measured at the fair value of the options and restricted stock when granted, and this cost is expensed over the service period, which is normally the vesting period of the options and restricted stock. Forfeitures of options and restricted stock result in a retirement of the related award and a reversal of the cost previously incurred. The Company grants time-based restricted stock units (“RSUs”) that are subject to a time-based vesting schedule, and performance-based RSUs that are subject to the achievement of the Company's corporate goals. The Company's stock-based compensation plans are further described in Note 13, Employee Benefit Plans.
Variable Interest Entities	The consolidated financial statements include the accounts of certain variable interest entities (“VIEs”). The Company considers a voting rights entity to be a subsidiary and consolidates if the Company has a controlling financial interest in the entity. VIEs are consolidated if the Company has the power to direct the activities of the VIE that significantly impact financial performance and has the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (i.e., the Company is the primary beneficiary). Investments in VIEs where the Company is not the primary beneficiary of a VIE are accounted for using the equity method of accounting. The determination of whether the Company is the primary beneficiary of a VIE is reassessed on an ongoing basis. The consolidation status may change as a result of these reassessments. These investments are included in Equity Investments in the Company’s Consolidated Statements of Financial Condition. The maximum potential exposure to losses relative to investments in VIEs is generally limited to the sum of the outstanding balance, future funding commitments and any related loans to the entity, both funded and unfunded. Loans to these entities are underwritten in substantially the same manner as other loans and are generally secured. Additional disclosures regarding VIEs are further described in Note 18, Variable Interest Entities.
Resell Agreements	The Company enters into short-term resell agreements backed by residential first-lien mortgage loans. The Company obtains possession of collateral with a market value equal to or in excess of the principal amount loaned under resell agreements. The Company had $25.8 million and $229.0 million in resell agreements as of December 31, 2022 and December 31, 2021, respectively. The resell agreements were entered into at par, and earned $4.2 million, $1.9 million, and $0.8 million in interest income for the years ended December 31, 2022, 2021, and 2020 , respectively. Interest income on resell agreements is reported on the "securities interest income" line of the Consolidated Statements of Income.
Segment Information	Public companies are required to report certain financial information about significant revenue-producing segments of the business for which such information is available and utilized by the chief operating decision maker. Substantially all of our operations occur through the Bank and involve the delivery of loan and deposit products to customers. Management makes operating decisions and assesses performance based on an ongoing review of its banking operation, which constitutes our only operating segment for financial reporting purposes. We do not consider our trust and investment management business as a separate segment. Transfers of Financial Assets Transfers of financial assets are accounted for as sales when control over the assets has been relinquished. Control over transferred assets is deemed to be surrendered when the assets have been isolated from the Company, the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity.
Reclassifications	Certain reclassifications have been made to prior year amounts to conform to the current year presentation. The reclassifications had no impact to the Consolidated Statements of Income or the Consolidated Statements of Changes in Stockholders’ Equity.
Recent Accounting Pronouncements	Accounting Standards Effective in 2022 and onward In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, “Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 significantly changes the impairment model for most financial assets that are measured at amortized cost and certain other instruments from an incurred loss model to an expected loss model and provides for recording credit losses on available for sale debt securities through an allowance account. ASU 2016-13 also requires certain incremental disclosures. In October 2019, the FASB voted to extend the adoption date for entities eligible to be smaller reporting companies, public business entities ("PBEs") that are not SEC filers, and entities that are not PBEs from January 1, 2020 to January 1, 2023. Based on the Company's election as an Emerging Growth Company under the Jumpstart Our Business Startups Act to use the extended transition period for complying with any new or revised financial accounting standards, we will adopt the standard on January 1, 2023. The Company’s CECL implementation efforts are continuing to focus on completion of model validation, developing new disclosures, establishing formal policies and procedures and other governance and control documentation. Based on the Company’s portfolio balances and forecasted economic conditions as of January 1, 2023, management believes the adoption of the CECL standard will result in a material increase to its total current reserves. However, the ultimate amount of the increase will be contingent upon continued validation of our model, testing and refinement of the model methodologies and judgments utilized to determine the estimate. Based on implementation progress to date, the Company believes the capital adequacy requirements to which it and the Bank are subject to, and its business strategies and practices, will not be materially impacted following the adoption on January 1, 2023. The Company measured its allowance under its current incurred loan loss model as of December 31, 2022. On March 31, 2022, the FASB issued ASU No. 2022-02, which eliminates the troubled debt restructuring ("TDR") accounting model for creditors that have adopted Topic 326, “Financial Instruments – Credit Losses.” Specifically, rather than applying the recognition and measurement guidance for TDRs, this ASU requires entities to evaluate receivable modifications, consistent with the accounting for other loan modifications, to determine whether a modification made to a borrower results is a new loan or a continuation of the existing loan. In addition, under the new ASU, entities are no longer required to use a discounted cash flow ("DCF") method to measure the ACL as a result of a modification or restructuring with a borrower experiencing financial difficulty. If a DCF method is used, the post-modification-derived effective interest rate is to be used, instead of the original interest rate as stipulated under the current GAAP. This ASU also enhances the disclosure requirements related to certain modifications of receivables made to borrowers experiencing financial difficulty. This ASU amends the guidance on “vintage disclosures” to require the disclosure of current-period gross write-offs by year of origination. The Company will continue to apply the current TDR accounting model until the adoption of ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326) on January 1, 2023. The adoption of ASU 2022-02 is not expected to have a material impact on the Company's operating results or financial condition. On January 7, 2021, the FASB has issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope. The new guidance amends the scope of ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which was aimed at easing the potential accounting burden expected when global capital markets move away from the London Interbank Offered Rate ("LIBOR") (the benchmark interest rate banks use to make short-term loans to each other) and provided temporary, optional expedients and exceptions for applying accounting guidance to contract modifications and hedging relationships, subject
Fair Value of Financial Instruments	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assumptions are developed based on prioritizing information within a fair value hierarchy that gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. A description of the disclosure hierarchy and the types of financial instruments recorded at fair value that management believes would generally qualify for each category are as follows: Level 1 - Valuations are based on quoted prices in active markets for identical assets or liabilities. Accordingly, valuation of these assets and liabilities does not entail a significant degree of judgment. Examples include most U.S. Government securities and exchange-traded equity securities. Level 2 - Valuations are based on either quoted prices in markets that are not considered to be active or significant inputs to the methodology that are observable, either directly or indirectly. Financial instruments in this level would generally include mortgage-related securities and other debt issued by GSEs, non-GSE mortgage-related securities, corporate debt, certain redeemable fund investments and certain trust preferred securities. Level 3 - Valuations are based on inputs to the methodology that are unobservable and significant to the fair value measurement. These inputs reflect management’s own judgments about the assumptions that market participants would use in pricing the assets and liabilities. Assets Measured at Fair Value on a Recurring Basis Available for sale securities The Company’s available for sale securities are reported at fair value. Investments in fixed income securities are generally valued based on evaluations provided by an independent pricing service. These evaluations represent an exit price or their opinion as to what a buyer would pay for a security, typically in an institutional round lot position, in a current sale. The pricing service utilizes evaluated pricing techniques that vary by asset class and incorporate available market information and, because many fixed income securities do not trade on a daily basis, applies available information through processes such as benchmark curves, benchmarking of available securities, sector groupings and matrix pricing. Model processes, such as option adjusted spread models, are used to value securities that have prepayment features. In those limited cases where pricing service evaluations are not available for a fixed income security, management will typically value those instruments using observable market inputs in a discounted cash flow analysis.

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Schedule Other Comprehensive Income (Loss)	Other comprehensive income (loss) components and related income tax effects were as follows: Year Ended December 31, 2022 2021 2020 (In thousands) Change in obligation for postretirement benefits and for prior service credit $ 297 $ 231 $ 198 Change in obligation for other benefits 338 (294) 164 Change in total obligation for postretirement benefits and for prior service credit and for other benefits 635 (63) 362 Income tax benefit (expense) (185) 17 (99) Net change in total obligation for postretirement benefits and prior service credit and for other benefits 450 (46) 263 Unrealized holding gains (losses) on available for sale securities (163,001) (15,438) 20,374 Reclassification adjustment for losses (gains) realized in income 3,621 (654) (1,604) Accretion of net unrealized loss on securities transferred to held-to-maturity 1,255 — — Change in unrealized gains (losses) on available for sale securities (158,125) (16,092) 18,770 Income tax benefit (expense) 43,559 4,371 (5,082) Net change in unrealized gains (losses) on securities (114,566) (11,721) 13,688 Total $ (114,116) $ (11,767) $ 13,951
Schedule of Accumulated Other Comprehensive Income (Loss)	The following is a summary of the accumulated other comprehensive income (loss) balances, net of income taxes: Balance as of January 1, Current Income Tax Balance as of December 31, 2022 (In thousands) Unrealized gains (losses) on benefits plans $ (2,102) $ 635 $ (185) $ (1,652) Unrealized gains (losses) on available for sale securities 7,511 (142,230) 39,180 (95,539) Unaccreted unrealized loss on securities transferred to held-to-maturity — (15,895) 4,379 (11,516) Total $ 5,409 $ (157,490) $ 43,374 $ (108,707) Balance as of January 1, 2021 Current Income Tax Balance as of December 31, 2021 (In thousands) Unrealized gains (losses) on benefits plans $ (2,056) $ (63) $ 17 $ (2,102) Unrealized gains (losses) on available for sale securities 19,232 (16,092) 4,371 7,511 Total $ 17,176 $ (16,155) $ 4,388 $ 5,409
Schedule of Reclassifications out of Accumulated Other Comprehensive Income (Loss)	The following represents the reclassifications out of accumulated other comprehensive income (loss): Year Ended December 31, Affected Line Item in the Consolidated Statements of Income 2022 2021 2020 (In thousands) Realized gains (losses) on sale of available for sale securities $ (3,637) $ 649 $ 1,605 Gain (loss) on sale of securities Recognized gains (losses) on OTTI securities 16 5 (1) Non-Interest Income - other Accretion of net unrealized loss on securities transferred to held-to-maturity (1,255) — — Interest income on securities Total reclassifications (4,876) 654 1,604 Income tax expense (benefit) (1,343) 180 438 Income tax expense (benefit) Total reclassifications, net of income tax $ (3,533) $ 474 $ 1,166 Prior service credit on pension plans and other postretirement benefits $ 29 $ 29 $ 28 Compensation and employee benefits Income tax benefit (8) (8) (8) Income tax expense (benefit) Total reclassifications, net of income tax $ 21 $ 21 $ 20 Total reclassifications, net of income tax $ (3,512) $ 495 $ 1,186

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost and Fair Value of Available for Sale Securities	The amortized cost and fair value of investment securities available for sale and held-to-maturity as of December 31, 2022 are as follows: December 31, 2022 (In thousands) Amortized Gross Gross Fair Available for sale: Mortgage-related: Government sponsored entities ("GSE") residential CMOs ("collateralized mortgage obligations") $ 427,529 $ 24 $ (38,293) $ 389,260 GSE commercial certificates & CMO 222,620 — (8,834) 213,786 Non-GSE residential certificates 123,139 — (16,059) 107,080 Non-GSE commercial certificates 108,286 — (10,804) 97,482 881,574 24 (73,990) 807,608 Other debt: U.S. Treasury 199 — (7) 192 Asset backed securities ("ABS") 901,746 34 (39,617) 862,163 Trust preferred 10,988 — (845) 10,143 Corporate 149,836 — (17,466) 132,370 1,062,769 34 (57,935) 1,004,868 Total available for sale $ 1,944,343 $ 58 $ (131,925) $ 1,812,476 Amortized Cost Gross Unrecognized Gains Gross Unrecognized Losses Fair Value Held-to-maturity: Mortgage-related: GSE residential CMOs $ 69,391 $ — $ (4,054) $ 65,337 GSE commercial certificates 90,335 — (11,186) 79,149 GSE residential certificates 428 — (17) 411 Non-GSE commercial certificates 32,635 9 (3,148) 29,496 Non-GSE residential certificates 50,468 — (5,245) 45,223 243,257 9 (23,650) 219,616 Other debt: ABS 288,682 — (15,175) 273,507 Commercial PACE 255,424 — (26,782) 228,642 Residential PACE 656,453 — (44,833) 611,620 Municipal 95,485 — (15,999) 79,486 Other 2,000 — — 2,000 1,298,044 — (102,789) 1,195,255 Total held-to-maturity $ 1,541,301 $ 9 $ (126,439) $ 1,414,871 The amortized cost and fair value of investment securities available for sale and held-to-maturity as of December 31, 2021 are as follows: December 31, 2021 (In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available for sale: Mortgage-related: GSE residential certificates $ 3,838 $ 129 $ — $ 3,967 GSE residential CMOs 460,571 5,697 (2,385) 463,883 GSE commercial certificates & CMO 364,274 6,855 (765) 370,364 Non-GSE residential certificates 66,756 29 (646) 66,139 Non-GSE commercial certificates 81,705 12 (616) 81,101 977,144 12,722 (4,412) 985,454 Other debt: U.S. Treasury 200 — — 200 ABS 988,061 3,351 (2,224) 989,188 Trust preferred 14,631 — (484) 14,147 Corporate 123,013 1,681 (273) 124,421 1,125,905 5,032 (2,981) 1,127,956 Total available for sale $ 2,103,049 $ 17,754 $ (7,393) $ 2,113,410 Amortized Cost Gross Unrecognized Gains Gross Unrecognized Losses Fair Value Held-to-maturity: Mortgage-related: GSE commercial certificates $ 30,742 $ — $ (489) $ 30,253 GSE residential certificates 442 19 — 461 Non-GSE commercial certificates 10,333 13 (288) 10,058 Non-GSE residential certificates 10,796 5 — 10,801 52,313 37 (777) 51,573 Other debt: ABS 75,800 1 (50) 75,751 Commercial PACE 175,712 2,434 — 178,146 Residential PACE 451,682 3,499 455,181 Municipal 84,962 2,045 (1,056) 85,951 Other 3,100 2 — 3,102 791,256 7,981 (1,106) 798,131 Total held-to-maturity $ 843,569 $ 8,018 $ (1,883) $ 849,704
Schedule of Amortized Cost and Fair Value of Held to Maturity Securities	The amortized cost and fair value of investment securities available for sale and held-to-maturity as of December 31, 2022 are as follows: December 31, 2022 (In thousands) Amortized Gross Gross Fair Available for sale: Mortgage-related: Government sponsored entities ("GSE") residential CMOs ("collateralized mortgage obligations") $ 427,529 $ 24 $ (38,293) $ 389,260 GSE commercial certificates & CMO 222,620 — (8,834) 213,786 Non-GSE residential certificates 123,139 — (16,059) 107,080 Non-GSE commercial certificates 108,286 — (10,804) 97,482 881,574 24 (73,990) 807,608 Other debt: U.S. Treasury 199 — (7) 192 Asset backed securities ("ABS") 901,746 34 (39,617) 862,163 Trust preferred 10,988 — (845) 10,143 Corporate 149,836 — (17,466) 132,370 1,062,769 34 (57,935) 1,004,868 Total available for sale $ 1,944,343 $ 58 $ (131,925) $ 1,812,476 Amortized Cost Gross Unrecognized Gains Gross Unrecognized Losses Fair Value Held-to-maturity: Mortgage-related: GSE residential CMOs $ 69,391 $ — $ (4,054) $ 65,337 GSE commercial certificates 90,335 — (11,186) 79,149 GSE residential certificates 428 — (17) 411 Non-GSE commercial certificates 32,635 9 (3,148) 29,496 Non-GSE residential certificates 50,468 — (5,245) 45,223 243,257 9 (23,650) 219,616 Other debt: ABS 288,682 — (15,175) 273,507 Commercial PACE 255,424 — (26,782) 228,642 Residential PACE 656,453 — (44,833) 611,620 Municipal 95,485 — (15,999) 79,486 Other 2,000 — — 2,000 1,298,044 — (102,789) 1,195,255 Total held-to-maturity $ 1,541,301 $ 9 $ (126,439) $ 1,414,871 The amortized cost and fair value of investment securities available for sale and held-to-maturity as of December 31, 2021 are as follows: December 31, 2021 (In thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Available for sale: Mortgage-related: GSE residential certificates $ 3,838 $ 129 $ — $ 3,967 GSE residential CMOs 460,571 5,697 (2,385) 463,883 GSE commercial certificates & CMO 364,274 6,855 (765) 370,364 Non-GSE residential certificates 66,756 29 (646) 66,139 Non-GSE commercial certificates 81,705 12 (616) 81,101 977,144 12,722 (4,412) 985,454 Other debt: U.S. Treasury 200 — — 200 ABS 988,061 3,351 (2,224) 989,188 Trust preferred 14,631 — (484) 14,147 Corporate 123,013 1,681 (273) 124,421 1,125,905 5,032 (2,981) 1,127,956 Total available for sale $ 2,103,049 $ 17,754 $ (7,393) $ 2,113,410 Amortized Cost Gross Unrecognized Gains Gross Unrecognized Losses Fair Value Held-to-maturity: Mortgage-related: GSE commercial certificates $ 30,742 $ — $ (489) $ 30,253 GSE residential certificates 442 19 — 461 Non-GSE commercial certificates 10,333 13 (288) 10,058 Non-GSE residential certificates 10,796 5 — 10,801 52,313 37 (777) 51,573 Other debt: ABS 75,800 1 (50) 75,751 Commercial PACE 175,712 2,434 — 178,146 Residential PACE 451,682 3,499 455,181 Municipal 84,962 2,045 (1,056) 85,951 Other 3,100 2 — 3,102 791,256 7,981 (1,106) 798,131 Total held-to-maturity $ 843,569 $ 8,018 $ (1,883) $ 849,704
Schedule of Investments by Contractual Maturity	Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalty: Available for Sale Held-to-maturity (In thousands) Amortized Fair Value Amortized Fair Value Due within one year $ — $ — $ 2,000 $ 2,000 Due after one year through five years 67,979 60,511 9,419 8,919 Due after five years through ten years 425,938 409,079 10,561 9,590 Due after ten years 568,852 535,278 1,276,064 1,174,746 $ 1,062,769 $ 1,004,868 $ 1,298,044 $ 1,195,255
Schedule of Proceeds Received and Gains (Losses) on Sale of Available for Sale Securities	Year Ended December 31, (In thousands) 2022 2021 2020 Proceeds $ 249,936 $ 111,274 $ 94,698 Realized gains $ 168 $ 1,057 $ 2,111 Realized losses (3,805) (408) (506) Net realized gains (losses) $ (3,637) $ 649 $ 1,605
Schedule of Unrealized Losses	The following summarizes the fair value and unrealized losses for those available for sale and held-to-maturity securities as of December 31, 2022 and December 31, 2021, respectively, segregated between securities that have been in an unrealized loss position for less than twelve months and those that have been in a continuous unrealized loss position for twelve months or longer at the respective dates: December 31, 2022 Less Than Twelve Months Twelve Months or Longer Total (In thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Available for sale: Mortgage-related: GSE residential CMOs $ 231,562 $ 13,937 $ 151,285 $ 24,356 $ 382,847 $ 38,293 GSE commercial certificates & CMO 153,325 6,729 60,461 2,105 213,786 8,834 Non-GSE residential certificates 72,527 8,969 34,553 7,090 107,080 16,059 Non-GSE commercial certificates 62,243 4,842 35,239 5,962 97,482 10,804 Other debt: US Treasury 192 7 — — 192 7 ABS 530,269 17,290 299,425 22,327 829,694 39,617 Trust preferred — — 10,143 845 10,143 845 Corporate 89,054 9,772 43,316 7,694 132,370 17,466 Total available for sale $ 1,139,172 $ 61,546 $ 634,422 $ 70,379 $ 1,773,594 $ 131,925 Less Than Twelve Months Twelve Months or Longer Total Fair Value Unrecognized Fair Value Unrecognized Fair Value Unrecognized Held-to-maturity: Mortgage-related: GSE CMOs $ 54,475 $ 2,891 $ 10,862 $ 1,163 $ 65,337 $ 4,054 GSE commercial certificates 48,934 3,404 30,215 7,782 79,149 11,186 GSE residential certificates 411 17 — — 411 17 Non GSE commercial certificates 11,192 656 18,283 2,492 29,475 3,148 Non GSE residential certificates 39,426 4,784 5,797 461 45,223 5,245 Other debt: ABS 224,279 11,078 49,228 4,097 273,507 15,175 Commercial PACE 228,642 26,782 — — 228,642 26,782 Residential PACE 611,620 44,833 — — 611,620 44,833 Municipal 48,190 5,866 31,296 10,133 79,486 15,999 Total held-to-maturity $ 1,267,169 $ 100,311 $ 145,681 $ 26,128 $ 1,412,850 $ 126,439 December 31, 2021 Less Than Twelve Months Twelve Months or Longer Total (In thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Available for sale: Mortgage-related: GSE residential CMOs $ 222,825 $ 2,385 $ — $ — $ 222,825 $ 2,385 GSE commercial certificates & CMO 28,695 271 159,681 494 188,376 765 Non-GSE residential certificates 55,284 646 — — 55,284 646 Non-GSE commercial certificates 42,530 247 23,124 369 65,654 616 Other debt: ABS 374,241 1,903 71,746 321 445,987 2,224 Trust preferred — — 14,147 484 14,147 484 Corporate 48,743 273 — — 48,743 273 Total available for sale $ 772,318 $ 5,725 $ 268,698 $ 1,668 $ 1,041,016 $ 7,393 Less Than Twelve Months Twelve Months or Longer Total Fair Value Unrecognized Fair Value Unrecognized Fair Value Unrecognized Held-to-maturity: Mortgage-related: GSE commercial certificates $ 30,253 $ 489 $ — $ — $ 30,253 $ 489 Non GSE commercial certificates 9,857 288 — — 9,857 288 Other debt: ABS 26,951 50 — — 26,951 50 Municipal 38,468 852 3,876 204 42,344 1,056 Total held-to-maturity $ 105,529 $ 1,679 $ 3,876 $ 204 $ 109,405 $ 1,883

LOANS RECEIVABLE, NET (Tables)

LOANS RECEIVABLE, NET (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of Loans Receivable	Loans receivable are summarized as follows: December 31, December 31, (In thousands) Commercial and industrial $ 925,641 $ 729,385 Multifamily 967,521 821,801 Commercial real estate 335,133 369,429 Construction and land development 37,696 31,539 Total commercial portfolio 2,265,991 1,952,154 Residential real estate lending 1,371,779 1,063,682 Consumer and other 463,999 291,818 Total retail portfolio 1,835,778 1,355,500 Total loans receivable 4,101,769 3,307,654 Net deferred loan origination costs 4,233 4,570 Total loans receivable, net of deferred loan origination costs (fees) 4,106,002 3,312,224 Allowance for loan losses (45,031) (35,866) Total loans receivable, net $ 4,060,971 $ 3,276,358
Schedule of Quality of Bank's Loans	The following table presents information regarding the quality of the Company’s loans as of December 31, 2022: 30-89 Days Non- 90 Days or Total Past Current Total Loans (In thousands) Commercial and industrial $ 27 $ 9,629 $ — $ 9,656 $ 915,985 $ 925,641 Multifamily — 3,828 — 3,828 963,693 967,521 Commercial real estate 11,718 4,851 — 16,569 318,564 335,133 Construction and land development 16,426 — — 16,426 21,270 37,696 Total commercial portfolio 28,171 18,308 — 46,479 2,219,512 2,265,991 Residential real estate lending 1,185 1,807 — 2,992 1,368,787 1,371,779 Consumer and other 3,545 1,584 — 5,129 458,870 463,999 Total retail portfolio 4,730 3,391 — 8,121 1,827,657 1,835,778 $ 32,901 $ 21,699 $ — $ 54,600 $ 4,047,169 $ 4,101,769 The following table presents information regarding the quality of the Company’s loans as of December 31, 2021: 30-89 Days Past Due Non- Accrual 90 Days or More Delinquent and Still Accruing Interest Total Past Due Current Total Loans Receivable (In thousands) Commercial and industrial $ — $ 8,313 $ — $ 8,313 $ 721,072 $ 729,385 Multifamily 13,537 2,907 — 16,444 805,357 821,801 Commercial real estate 21,599 4,054 — 25,653 343,776 369,429 Construction and land development 26,482 — — 26,482 5,057 31,539 Total commercial portfolio 61,618 15,274 — 76,892 1,875,262 1,952,154 Residential real estate lending 4,811 12,525 — 17,336 1,046,346 1,063,682 Consumer and other 1,590 420 — 2,010 289,808 291,818 Total retail portfolio 6,401 12,945 — 19,346 1,336,154 1,355,500 $ 68,019 $ 28,219 $ — $ 96,238 $ 3,211,416 $ 3,307,654
Schedule of Troubled Debt Restructurings	The following table presents information regarding the Company’s TDRs as of December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 (In thousands) Accruing Nonaccrual Total Accruing Nonaccrual Total Commercial and industrial $ 3,503 $ 9,629 $ 13,132 $ 4,052 $ 8,313 $ 12,365 Commercial real estate — 2,900 2,900 — 3,166 3,166 Construction and land development 2,424 — 2,424 7,476 — 7,476 Residential real estate lending 175 973 1,148 13,469 2,018 15,487 $ 6,102 $ 13,502 $ 19,604 $ 24,997 $ 13,497 $ 38,494 The financial effects of TDRs granted for the year ended December 31, 2022 are as follows: Weighted Average Interest Rate (In thousands) Number Recorded Pre-Modification Post-Modification Charge-off Commercial and industrial 2 $ 8,171 6.79 % 6.79 % $ — Commercial real estate 4 10,647 3.85 % 3.85 % — 6 $ 18,818 5.13 % 5.13 % $ — The financial effects of TDRs granted for the year ended December 31, 2021 are as follows: Weighted Average Interest Rate (In thousands) Number Recorded Pre-Modification Post-Modification Charge-off Commercial and industrial 1 $ 2,536 6.50 % 4.00 % $ — Construction and land development 2 7,477 4.30 % 4.30 % — 3 $ 10,013 4.86 % 4.22 % $ —
Schedule of Loans by Credit Quality Indicator	The following tables summarize the Company’s loan portfolio by credit quality indicator as of December 31, 2022: (In thousands) Pass Special Mention Substandard Doubtful Total Commercial and industrial $ 893,637 $ 6,983 $ 23,275 $ 1,746 $ 925,641 Multifamily 947,661 13,696 6,164 — 967,521 Commercial real estate 299,953 24,679 10,501 — 335,133 Construction and land development 21,270 14,002 2,424 — 37,696 Residential real estate lending 1,369,972 — 1,807 — 1,371,779 Consumer and other 462,415 — 1,584 — 463,999 Total loans $ 3,994,908 $ 59,360 $ 45,755 $ 1,746 $ 4,101,769 The following tables summarize the Company’s loan portfolio by credit quality indicator as of December 31, 2021: (In thousands) Pass Special Mention Substandard Doubtful Total Commercial and industrial $ 693,312 $ 10,165 $ 25,908 $ — $ 729,385 Multifamily 721,869 48,804 51,128 — 821,801 Commercial real estate 295,261 13,947 60,221 — 369,429 Construction and land development 24,063 — 7,476 — 31,539 Residential real estate lending 1,050,865 292 12,525 — 1,063,682 Consumer and other 291,398 — 420 — 291,818 Total loans $ 3,076,768 $ 73,208 $ 157,678 $ — $ 3,307,654
Schedule of Method for Evaluating Impairment and Allowance for Credit Loss Activity	The following table provides information regarding the methods used to evaluate the Company’s loans for impairment by portfolio, and the Company’s allowance by portfolio based upon the method of evaluating loan impairment as of December 31, 2022: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Loans: Individually evaluated for impairment $ 14,716 $ 3,828 $ 4,851 $ 2,424 $ 1,982 $ — $ 27,801 Collectively evaluated for impairment 910,925 963,693 330,282 35,272 1,369,797 463,999 4,073,968 Total loans $ 925,641 $ 967,521 $ 335,133 $ 37,696 $ 1,371,779 $ 463,999 $ 4,101,769 Allowance for loan losses: Individually evaluated for impairment $ 5,433 $ 180 $ — $ — $ 55 $ — $ 5,668 Collectively evaluated for impairment 7,483 6,924 3,627 825 11,283 9,221 39,363 Total allowance for loan losses $ 12,916 $ 7,104 $ 3,627 $ 825 $ 11,338 $ 9,221 $ 45,031 The following table provides information regarding the methods used to evaluate the Company’s loans for impairment by portfolio, and the Company’s allowance by portfolio based upon the method of evaluating loan impairment as of December 31, 2021: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Loans: Individually evaluated for impairment $ 12,785 $ 2,907 $ 4,054 $ 7,476 $ 25,994 $ — $ 53,216 Collectively evaluated for impairment 716,600 818,894 365,375 24,063 1,037,688 291,818 3,254,438 Total loans $ 729,385 $ 821,801 $ 369,429 $ 31,539 $ 1,063,682 $ 291,818 $ 3,307,654 Allowance for loan losses: Individually evaluated for impairment $ 4,350 $ — $ — $ — $ 755 $ — $ 5,105 Collectively evaluated for impairment 6,302 4,760 7,273 405 8,253 3,768 30,761 Total allowance for loan losses $ 10,652 $ 4,760 $ 7,273 $ 405 $ 9,008 $ 3,768 $ 35,866 The activities in the allowance by portfolio for the year ended December 31, 2022 are as follows: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Allowance for loan losses: Beginning balance $ 10,652 $ 4,760 $ 7,273 $ 405 $ 9,008 $ 3,768 $ 35,866 Provision for (recovery of) loan losses 1,990 2,760 (3,646) 807 2,978 10,113 15,002 Charge-offs — (416) — (389) (2,448) (5,143) (8,396) Recoveries 274 — — 2 1,800 483 2,559 Ending Balance $ 12,916 $ 7,104 $ 3,627 $ 825 $ 11,338 $ 9,221 $ 45,031 The activities in the allowance by portfolio for the year ended December 31, 2021 are as follows: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Allowance for loan losses: Beginning balance $ 9,065 $ 10,324 $ 6,213 $ 2,077 $ 12,330 $ 1,580 $ 41,589 Provision for (recovery of) loan losses 2,179 (1,483) 1,374 (1,675) (5,409) 4,727 (287) Charge-offs (813) (4,081) (314) — (1,081) (2,699) (8,988) Recoveries 221 — — 3 3,168 160 3,552 Ending Balance $ 10,652 $ 4,760 $ 7,273 $ 405 $ 9,008 $ 3,768 $ 35,866 The activities in the allowance by portfolio for the year ended December 31, 2020 are as follows: (In thousands) Commercial and Industrial Multifamily Commercial Real Estate Construction and Land Development Residential Real Estate Lending Consumer and Other Total Allowance for loan losses: Beginning balance $ 11,126 $ 5,210 $ 2,492 $ 808 $ 14,149 $ 62 $ 33,847 Provision for (recovery of) loan losses 9,175 5,114 7,508 2,238 (2,302) 3,058 24,791 Charge-offs (11,293) — (3,787) (970) (492) (1,691) (18,233) Recoveries 57 — — 1 975 151 1,184 Ending Balance $ 9,065 $ 10,324 $ 6,213 $ 2,077 $ 12,330 $ 1,580 $ 41,589
Schedule of Additional Information for Individually Impaired Loans and Allowances	The following is additional information regarding the Company’s impaired loans and the allowance related to such loans as of and for the year ended December 31, 2022 and December 31, 2021: December 31, 2022 (In thousands) Recorded Average Unpaid Related Loans without a related allowance: Residential real estate lending $ 764 $ 5,636 $ 1,761 $ — Multifamily 334 167 334 — Construction and land development 2,424 4,950 7,476 — Commercial real estate 4,851 4,453 5,023 — Commercial and industrial 3,791 1,896 3,881 — 12,164 17,102 18,475 — Loans with a related allowance: Residential real estate lending 1,218 8,352 1,278 55 Multifamily 3,494 3,201 3,494 180 Commercial and industrial 10,925 11,855 11,975 5,433 15,637 23,408 16,747 5,668 Total impaired loans: Residential real estate lending 1,982 13,988 3,039 55 Multifamily 3,828 3,368 3,828 180 Construction and land development 2,424 4,950 7,476 — Commercial real estate 4,851 4,453 5,023 — Commercial and industrial 14,716 13,751 15,856 5,433 $ 27,801 $ 40,510 $ 35,222 $ 5,668 December 31, 2021 (In thousands) Recorded Investment Average Recorded Investment Unpaid Principal Balance Related Allowance Loans without a related allowance: Residential real estate lending $ 10,507 $ 15,666 $ 11,896 $ — Construction and land development 7,476 9,330 7,476 — Commercial real estate 4,054 3,744 4,953 — 22,037 28,740 24,325 — Loans with a related allowance: Residential real estate lending 15,487 18,120 19,306 755 Multifamily 2,907 6,241 8,024 — Commercial and industrial 12,785 13,746 13,207 4,350 31,179 38,107 40,537 5,105 Total impaired loans: Residential real estate lending 25,994 33,786 31,202 755 Multifamily 2,907 6,241 8,024 — Construction and land development 7,476 9,330 7,476 — Commercial real estate 4,054 3,744 4,953 — Commercial and industrial 12,785 13,746 13,207 4,350 $ 53,216 $ 66,847 $ 64,862 $ 5,105

PREMISES AND EQUIPMENT (Tables)

PREMISES AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Premises and Equipment	Premises and equipment are summarized as follows: December 31, 2022 2021 (In thousands) Buildings, premises and improvements $ 28,150 $ 29,935 Furniture, fixtures and equipment 6,787 7,020 Projects in process 561 — 35,498 36,955 Accumulated depreciation and amortization (25,642) (25,220) $ 9,856 $ 11,735

DEPOSITS (Tables)

DEPOSITS (Tables)	12 Months Ended
	Dec. 31, 2022
Statistical Disclosure for Banks [Abstract]
Schedule of Deposits	Deposits are summarized as follows: December 31, 2022 December 31, 2021 Amount Weighted Average Rate Amount Weighted Average Rate (In thousands) Non-interest-bearing demand deposit accounts $ 3,331,067 0.00 % $ 3,335,005 0.00 % NOW accounts 206,434 0.73 % 210,844 0.08 % Money market deposit accounts 2,445,396 0.94 % 2,227,953 0.12 % Savings accounts 386,190 0.75 % 375,301 0.11 % Time deposits 151,699 2.57 % 207,152 0.32 % Brokered CD 74,251 3.84 % — 0.00 % $ 6,595,037 0.52 % $ 6,356,255 0.06 %
Schedule of Maturities of Time Deposits	Scheduled maturities of time deposits and brokered CDs as of December 31, 2022 are as follows: (In thousands) Balance 2023 $ 208,231 2024 10,866 2025 4,482 2026 1,776 2027 595 Thereafter — $ 225,950

REGULATORY CAPITAL (Tables)

REGULATORY CAPITAL (Tables)	12 Months Ended
	Dec. 31, 2022
Regulatory Capital [Abstract]
Schedule of Bank's Capital and Ratio Amounts	The Company’s actual capital amounts and ratios are presented in the following table: Actual For Capital Adequacy Purposes (1) To Be Considered (In thousands) Amount Ratio Amount Ratio Amount Ratio December 31, 2022 Total capital to risk weighted assets $ 721,324 14.87 % $ 387,957 8.00 % N/A N/A Tier 1 capital to risk weighted assets 597,022 12.31 % 290,967 6.00 % N/A N/A Tier 1 capital to average assets 597,022 7.52 % 317,738 4.00 % N/A N/A Common equity tier 1 to risk weighted assets 597,022 12.31 % 218,226 4.50 % N/A N/A December 31, 2021 Total capital to risk weighted assets $ 656,719 15.95 % $ 329,471 8.00 % N/A N/A Tier 1 capital to risk weighted assets 534,381 12.98 % 247,103 6.00 % N/A N/A Tier 1 capital to average assets 534,381 7.62 % 280,454 4.00 % N/A N/A Common equity tier 1 to risk weighted assets 534,381 12.98 % 185,327 4.50 % N/A N/A (1) Amounts are shown exclusive of the applicable capital conservation buffer of 2.50%. The Bank’s actual capital amounts and ratios are presented in the following table: Actual For Capital Adequacy Purposes (1) To Be Considered (In thousands) Amount Ratio Amount Ratio Amount Ratio December 31, 2022 Total capital to risk weighted assets $ 715,458 14.75 % $ 388,107 8.00 % $ 485,134 10.00 % Tier 1 capital to risk weighted assets 668,864 13.79 % 291,080 6.00 % 388,107 8.00 % Tier 1 capital to average assets 668,864 8.44 % 317,111 4.00 % 396,389 5.00 % Common equity tier 1 to risk weighted assets 668,864 13.79 % 218,310 4.50 % 315,337 6.50 % December 31, 2021 Total capital to risk weighted assets $ 613,030 14.89 % $ 329,376 8.00 % $ 411,720 10.00 % Tier 1 capital to risk weighted assets 575,692 13.98 % 247,032 6.00 % 329,376 8.00 % Tier 1 capital to average assets 575,692 8.21 % 280,433 4.00 % 205,860 5.00 % Common equity tier 1 to risk weighted assets 575,692 13.98 % 185,274 4.50 % 267,618 6.50 % (1) Amounts are shown exclusive of the applicable capital conservation buffer of 2.50%.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Components of Provision (Benefit) for Income Taxes	The components of the provision for income taxes for the years ended December 31, 2022, 2021, and 2020 are as follows: Year Ended December 31, (In thousands) 2022 2021 2020 Current: Federal $ 9,201 $ 9,349 $ 15,010 State and local 3,111 1,389 1,152 12,312 10,738 16,162 Deferred: Federal 10,709 4,409 (3,497) State and local 3,666 2,641 3,090 14,375 7,050 (407) Total income tax provision $ 26,687 $ 17,788 $ 15,755
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the expected income tax expense at the statutory federal income tax rate of 21% to the Company’s actual income tax benefit and effective tax rate for the years ended December 31, 2022, 2021, and 2020 and is as follows: Year Ended December 31, 2022 2021 2020 (In thousands) Amount % Amount % Amount % Tax expense at federal income tax rate $ 22,714 21.00 % $ 14,852 21.00 % $ 13,008 21.00 % Increase (decrease) resulting from: Tax exempt income (497) (0.46) % (317) (0.45) % (862) (1.39) % Change in DTA rate 84 0.08 % (199) (0.28) % 333 0.54 % State tax, net of federal benefit 5,354 4.95 % 3,184 4.50 % 3,551 5.73 % Stock options windfall (363) (0.34) % (94) (0.13) % (3) (0.01) % Other (605) (0.56) % 362 0.51 % (272) (0.44) % Total $ 26,687 24.67 % $ 17,788 25.15 % $ 15,755 25.43 %
Schedule of Net Deferred Tax Assets and Liabilities	The significant components of the net deferred tax assets and liabilities as of December 31, 2022 and 2021, are as follows: December 31, 2022 2021 (In thousands) Deferred tax assets: Excess tax basis over carrying value of assets: Allowance for loan losses $ 13,237 $ 16,300 Nonaccrual interest income 106 389 Postretirement and other employee benefits 1,563 242 Available for sale securities carried at fair value for financial statement purposes 36,330 — Depreciation and amortization 1,418 1,123 Operating leases 10,976 13,250 Federal, state and local net operating loss carryforward 4,468 7,285 Transfer of available for sale securities to held-to-maturity 4,379 — Other, net 600 3,258 Gross deferred tax asset 73,077 41,847 Deferred tax liabilities: Available for sale securities carried at fair value for financial statement purposes — (2,850) Unrealized loss on investment (150) — Purchase accounting adjustments, net (676) (874) Operating leases (8,575) (10,142) Net deferred loan fees (1,169) (1,262) Gross deferred tax liabilities (10,570) (15,128) Deferred tax asset, net $ 62,507 $ 26,719

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Factors Used in Earnings Per Share Calculation	Following is a table setting forth the factors used in the earnings per share computation follow: Year Ended 2022 2021 2020 (In thousands, except per share amounts) Net income attributable to Amalgamated Financial Corp. $ 81,477 $ 52,937 $ 46,188 Dividends paid on preferred stock (22) (22) (22) Income attributable to common stock $ 81,455 $ 52,915 $ 46,166 Weighted average common shares outstanding, basic 30,818 31,104 31,133 Basic earnings per common share $ 2.64 $ 1.70 $ 1.48 Income attributable to common stock $ 81,455 $ 52,915 $ 46,166 Weighted average common shares outstanding, basic 30,818 31,104 31,133 Incremental shares from assumed conversion of options and RSUs 375 408 96 Weighted average common shares outstanding, diluted 31,193 31,512 31,229 Diluted earnings per common share $ 2.61 $ 1.68 $ 1.48

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
Schedule of Employer Contributions	The following table summarizes certain information regarding contributions made by the Company to the CRF: (In thousands) Contributions Company contributions greater than 5% of total contributions received by the CRF? Year Ended December 31, 2022 $ 6,321 Yes 2021 6,193 Yes 2020 6,278 Yes
Schedule of Changes in Benefit Obligations and Plan Assets	The following table summarizes the plans’ benefit obligation, the changes in the plans’ benefit obligation, changes in plan assets and the plan’s funded status: Year Ended December 31, (In thousands) 2022 2021 Change in benefit obligation: Benefit obligation at beginning of year $ 3,658 $ 4,094 Service cost — — Interest cost 71 58 Amendments — — Actuarial gain (397) (16) Benefits paid (477) (478) Benefit obligation at end of year $ 2,855 $ 3,658 Change in plan assets: Employer contributions $ 477 $ 478 Benefits paid (477) (478) Plan assets at end of year $ — $ — Benefit obligation, included in other liabilities $ 2,855 $ 3,658
Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Loss)	(In thousands) 2022 2021 2020 Net actuarial loss $ 2,572 $ 3,235 $ 3,200 Prior service credit (292) (320) (349) Total amount recognized $ 2,280 $ 2,915 $ 2,851
Schedule of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income	The following table summarizes the components of net periodic benefit cost and other amounts recognized in other comprehensive income (In thousands) 2022 2021 2020 Components of net periodic benefit cost: Service cost $ — $ — $ — Interest cost 71 58 118 Prior service credit amortization (29) (29) (29) Prior service credit due to curtailments — — — Recognized actuarial loss 267 400 320 Net periodic benefit $ 309 $ 429 $ 409 Components of other amounts: Net regular actuarial (gain) loss $ (397) $ (16) $ 379 Recognized actuarial loss (267) (400) (320) Prior service credit amortization 29 29 29 Prior service credit due to curtailments — 450 (450) Prior service credit due to amendment — — — Total recognized in other comprehensive income $ (635) $ 63 $ (362) Total recognized in comprehensive income $ (326) $ 492 $ 47
Schedule of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income	The following table summarizes the components of net periodic benefit cost and other amounts recognized in other comprehensive income (In thousands) 2022 2021 2020 Components of net periodic benefit cost: Service cost $ — $ — $ — Interest cost 71 58 118 Prior service credit amortization (29) (29) (29) Prior service credit due to curtailments — — — Recognized actuarial loss 267 400 320 Net periodic benefit $ 309 $ 429 $ 409 Components of other amounts: Net regular actuarial (gain) loss $ (397) $ (16) $ 379 Recognized actuarial loss (267) (400) (320) Prior service credit amortization 29 29 29 Prior service credit due to curtailments — 450 (450) Prior service credit due to amendment — — — Total recognized in other comprehensive income $ (635) $ 63 $ (362) Total recognized in comprehensive income $ (326) $ 492 $ 47
Assumptions Used to Measure Plans' Benefit Obligation and Net Periodic Benefit Expense	The following table summarizes certain weighted average assumptions used to measure the plans’ obligation at the end of the year as well as net periodic benefit expense during the year: 2022 2021 2020 Weighted average assumptions used to determine benefit obligations: Discount rate 4.75 % 2.07 % 1.50 % Weighted average assumptions used to determine net periodic benefit cost: Discount rate 2.14 % 1.66 % 3.13 %
Schedule of Stock Option Activity	A summary of the status of the Company’s options as of December 31, 2022 follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Intrinsic Value (in thousands) Outstanding, December 31, 2021 847,560 $ 13.19 4.3 years Granted — — — Forfeited/ Expired (18,260) 12.69 — Exercised (402,420) 13.31 — Outstanding, December 31, 2022 426,880 13.09 3.3 years $ 4,246 Vested and Exercisable, December 31, 2022 426,880 $ 13.09 3.3 years $ 4,246
Schedule of Restricted Stock Unit Activity	A summary of the status of the Company’s time-based vesting RSUs as of December 31, 2022 follows: Shares Grant Date Fair Value Unvested, December 31, 2021 326,521 $ 15.66 Awarded 193,339 19.31 Forfeited/Expired (42,885) 15.69 Vested (145,952) 15.83 Unvested, December 31, 2022 331,023 $ 17.72 A summary of the status of the Company’s performance-based RSUs as of December 31, 2022 follows: Shares Grant Date Fair Value Unvested, December 31, 2021 103,774 $ 15.84 Awarded 62,794 17.69 Forfeited/Expired (46,137) 16.18 Vested (23,461) 17.91 Unvested, December 31, 2022 96,970 $ 16.37

FAIR VALUE OF FINANCIAL INSTR_2

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Assets Measured on Recurring Basis	The following summarizes those financial instruments measured at fair value on a recurring basis in the Consolidated Statements of Financial Condition as of the dates indicated, categorized by the relevant class of investment and level of the fair value hierarchy: December 31, 2022 (In thousands) Level 1 Level 2 Level 3 Total Available for sale securities: Mortgage-related: GSE residential CMOs $ — $ 389,260 $ — $ 389,260 GSE commercial certificates & CMO — 213,786 — 213,786 Non-GSE residential certificates — 107,080 — 107,080 Non-GSE commercial certificates — 97,482 — 97,482 Other debt: U.S. Treasury 192 — — 192 ABS — 862,163 — 862,163 Trust preferred — 10,143 — 10,143 Corporate — 132,370 — 132,370 Total assets carried at fair value $ 192 $ 1,812,284 $ — $ 1,812,476 December 31, 2021 (In thousands) Level 1 Level 2 Level 3 Total Available for sale securities: Mortgage-related: GSE residential certificates $ — $ 3,967 $ — $ 3,967 GSE residential CMOs — 463,883 — 463,883 GSE commercial certificates & CMO — 370,364 — 370,364 Non-GSE residential certificates — 66,139 — 66,139 Non-GSE commercial certificates — 81,101 — 81,101 Other Debt: U.S. Treasury 200 — — 200 ABS — 989,188 — 989,188 Trust preferred — 14,147 — 14,147 Corporate — 124,421 — 124,421 Total assets carried at fair value $ 200 $ 2,113,210 $ — $ 2,113,410
Schedule of Assets Measured on Nonrecurring Basis	The following tables summarize assets measured at fair value on a non-recurring basis in the Consolidated Statements of Financial Condition as of the dates indicated, categorized by the relevant class of investment and level of the fair value hierarchy: December 31, 2022 (In thousands) Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value Fair Value Measurements: Impaired loans $ 3,315 $ — $ — $ 3,315 $ 3,315 $ 3,315 $ — $ — $ 3,315 $ 3,315 December 31, 2021 (In thousands) Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value Fair Value Measurements: Impaired loans $ 48,111 $ — $ — $ 48,111 $ 48,111 Other real estate owned $ 307 $ — $ — $ 335 $ 335 $ 48,418 $ — $ — $ 48,446 $ 48,446
Schedule of Basis and Estimated Fair Values of Financial Instruments	The following table summarizes the financial statement basis and estimated fair values for significant categories of financial instruments: December 31, 2022 Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value (In thousands) Financial assets: Cash and cash equivalents $ 63,540 $ 63,540 $ — $ — $ 63,540 Held-to-maturity securities 1,541,301 — 574,609 840,262 1,414,871 Loans held for sale 7,943 — 7,943 7,943 Loans receivable, net 4,060,971 — — 3,718,308 3,718,308 Resell agreements 25,754 — — 25,754 25,754 Accrued interest and dividends receivable 41,441 17 12,197 29,227 41,441 Financial liabilities: Deposits payable on demand 6,369,087 — 6,369,087 — 6,369,087 Time deposits 225,950 — 225,805 — 225,805 FHLBNY advances 580,000 — 580,000 — 580,000 Subordinated debt 77,708 — 68,966 — 68,966 Accrued interest payable 1,218 — 1,218 — 1,218 December 31, 2021 (In thousands) Carrying Value Level 1 Level 2 Level 3 Estimated Fair Value Financial assets: Cash and cash equivalents $ 330,485 $ 330,485 $ — $ — $ 330,485 Held-to-maturity securities 843,569 — 216,377 633,327 849,704 Loans held for sale 3,279 — — 3,279 3,279 Loans receivable, net 3,276,358 — — 3,291,377 3,291,377 Resell agreements 229,018 — — 229,018 229,018 Accrued interest and dividends receivable 28,820 — 28,820 — 28,820 Financial liabilities: Deposits payable on demand 6,149,103 — 6,149,103 — 6,149,103 Time deposits 207,152 — 207,369 — 207,369 Subordinated Debt 83,831 — 85,000 — 85,000 Accrued interest payable 569 — 569 — 569

COMMITMENTS, CONTINGENCIES AN_2

COMMITMENTS, CONTINGENCIES AND OFF BALANCE SHEET RISK (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Financial Instruments Outstanding Representing Credit Risk	The following financial instruments were outstanding whose contract amounts represent credit risk as of the related periods: December 31, 2022 December 31, 2021 (In thousands) Commitments to extend credit $ 723,902 $ 927,428 Standby letters of credit 29,568 18,752 Total $ 753,470 $ 946,180

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Schedule of Lease Cost and Other Information	The following table summarizes our lease cost and other operating lease information: Year Ended December 31, 2022 2021 (In thousands) Operating lease cost $ 7,216 $ 8,219 Cash paid for amounts included in the measurement of Operating leases liability $ 10,745 $ 10,193 Weighted average remaining lease term on operating leases (in years) 3.9 4.7 Weighted average discount rate used for operating leases liability 3.25 % 3.25 % Note: Sublease income and variable income or expense considered immaterial
Schedule of Remaining Commitments of Operating Lease Payments	The following table presents the remaining commitments for operating lease payments for the next five years and thereafter, as well as a reconciliation to the discounted operating leases liability recorded in the Consolidated Statements of Financial Condition as of December 31, 2022: (In thousands) As of December 31, 2022 2023 $ 11,285 2024 11,310 2025 10,574 2026 9,176 2027 955 Thereafter — Total undiscounted operating lease payments 43,300 Less: present value adjustment 2,521 Total Operating leases liability $ 40,779

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Estimated Amortization Expense	The following table reflects the estimated amortization expense, comprised entirely by the Company’s core deposit intangible asset, for the next five years and thereafter: (In thousands) Total 2023 $ 888 2024 730 2025 574 2026 419 2027 265 Thereafter 229 Total $ 3,105

VARIABLE INTEREST ENTITIES (Tab

VARIABLE INTEREST ENTITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	December 31, 2022 December 31, 2021 (In thousands) Unconsolidated Variable Interest Entities Tax credit investments included in equity investments $ 3,299 $ 1,681 Loans and letters of credit commitments 60,857 52,813 Funded portion of loans and letters of credit commitments 47,683 15,512 The following table summarizes the tax benefits conveyed by the Company’s solar generation VIE investments: Year Ended December 31, 2022 2021 (In thousands) Tax credits and other tax benefits recognized $ 2,672 $ 11,571

PARENT COMPANY ONLY CONDENSED_2

PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Condensed Balance Sheet	Condensed financial information of Amalgamated Financial Corp. follows: CONDENSED BALANCE SHEET December 31, 2022 December 31, 2021 (in thousands) ASSETS Cash and cash equivalents $ 10,884 $ 42,886 Investment in banking subsidiary 580,664 605,074 Other assets 113 12 Total assets $ 591,661 $ 647,972 LIABILITIES AND EQUITY Subordinated debt $ 77,708 $ 83,831 Accrued expense and other liabilities 5,131 399 Stockholders' equity 508,822 563,742 Total liabilities and stockholders' equity $ 591,661 $ 647,972
Condensed Statements of Income	CONDENSED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Year Ended December 31, 2022 2021 (in thousands) Other income $ 617 $ 11,800 Equity in undistributed subsidiary income 84,321 41,684 Interest expense 2,693 399 Other expense 768 148 Net income $ 81,477 $ 52,937 Comprehensive income (loss) $ (32,639) $ 41,170
Condensed Statements of Comprehensive Income	CONDENSED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Year Ended December 31, 2022 2021 (in thousands) Other income $ 617 $ 11,800 Equity in undistributed subsidiary income 84,321 41,684 Interest expense 2,693 399 Other expense 768 148 Net income $ 81,477 $ 52,937 Comprehensive income (loss) $ (32,639) $ 41,170
Condensed Statement of Cash Flows	CONDENSED STATEMENT OF CASH FLOWS Year Ended December 31, 2022 2021 (in thousands) Cash flows from operating activities Net income $ 81,477 $ 52,937 Adjustments: Equity in undistributed subsidiary income (84,321) (41,684) Net gain on repurchase of subordinated debt (617) — Change in other assets 726 (12) Change in other liabilities (610) 399 Net cash provided (used) by operating activities (3,345) 11,640 Cash flows from investing activities Payments for investments in subsidiaries — (42,490) Net cash provided (used) by investing activities — (42,490) Cash flows from financing activities Dividends paid (11,211) (7,597) Repurchase of shares (12,478) (2,498) Net increase (decrease) in subordinated debt (5,633) 83,831 Proceeds from common stock issued under Employee Stock Purchase Plan 665 — Net cash provided (used) by financing activities (28,657) 73,736 Net change in cash and cash equivalents (32,002) 42,886 Beginning cash and cash equivalents 42,886 — Ending cash and cash equivalents $ 10,884 $ 42,886 Equity exchange for the outstanding common stock of Amalgamated Bank $ — $ 541,093

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Restricted cash	$ 400	$ 400
Loans held for sale	$ 7,943	3,279
Estimated useful life of intangible assets	10 years
Property, Plant and Equipment [Line Items]
Real estate acquired through foreclosure	$ 0	0
Resell agreements	25,754	229,018
Interest income from resell agreements	$ 4,200	$ 1,900	$ 800
Furniture and Fixtures
Property, Plant and Equipment [Line Items]
Useful life of premises and equipment	10 years
Computer Equipment, Hardware and Software | Minimum
Property, Plant and Equipment [Line Items]
Useful life of premises and equipment	3 years
Computer Equipment, Hardware and Software | Maximum
Property, Plant and Equipment [Line Items]
Useful life of premises and equipment	7 years

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Change in unrealized gains (losses) on available for sale securities	$ (157,490)	$ (16,155)	$ 19,132
Income tax benefit (expense)	(43,374)	(4,388)	5,181
Other comprehensive loss, net of taxes	(114,116)	(11,767)	13,951
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	635	(63)	362
Income tax benefit (expense)	(185)	17	(99)
Other comprehensive loss, net of taxes	450	(46)	263
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest | Postemployment Retirement Benefits
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	297	231	198
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest | Other Postretirement Benefits Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	338	(294)	164
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, before tax	(163,001)	(15,438)	20,374
Reclassification from accumulated other comprehensive income, before tax	3,621	(654)	(1,604)
Change in unrealized gains (losses) on available for sale securities	(158,125)	(16,092)	18,770
Income tax benefit (expense)	43,559	4,371	(5,082)
Other comprehensive loss, net of taxes	(114,566)	(11,721)	13,688
Unaccreted unrealized loss on securities transferred to held-to-maturity
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from accumulated other comprehensive income, before tax	1,255	$ 0	$ 0
Change in unrealized gains (losses) on available for sale securities	(15,895)
Income tax benefit (expense)	$ 4,379

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 563,875	$ 535,821	$ 490,544
Current Period Change	(157,490)	(16,155)	19,132
Income tax benefit (expense)	(43,374)	(4,388)	5,181
Ending balance	508,955	563,875	535,821
Unrealized gains (losses) on benefits plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(2,102)	(2,056)
Current Period Change	635	(63)
Income tax benefit (expense)	(185)	17
Ending balance	(1,652)	(2,102)	(2,056)
Unrealized gains (losses) on available for sale securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	7,511	19,232
Current Period Change	(142,230)	(16,092)
Income tax benefit (expense)	39,180	4,371
Ending balance	(95,539)	7,511	19,232
Unaccreted unrealized loss on securities transferred to held-to-maturity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0
Current Period Change	(15,895)
Income tax benefit (expense)	4,379
Ending balance	(11,516)	0
Total
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	5,409	17,176	3,225
Current Period Change	(157,490)	(16,155)
Income tax benefit (expense)	43,374	4,388
Ending balance	$ (108,707)	$ 5,409	$ 17,176

ACCUMULATED OTHER COMPREHENSI_5

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gain (loss) on sale of securities	$ (3,637)	$ 649	$ 1,605
Non-Interest Income - other	1,769	1,015	2,042
Accretion of net unrealized loss on securities transferred to held-to-maturity	110,654	56,557	47,815
Total reclassifications	108,164	70,725	61,943
Income tax expense (benefit)	26,687	17,788	15,755
Compensation and employee benefits	74,712	69,844	69,421
Total reclassifications, net of income tax	81,477	52,937	46,188
Reclassification out of accumulated other comprehensive income (loss)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications, net of income tax	(3,512)	495	1,186
Reclassification out of accumulated other comprehensive income (loss) | Realized and recognized gains (losses) on sale of AFS and OTTI securities
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gain (loss) on sale of securities	(3,637)	649	1,605
Non-Interest Income - other	16	5	(1)
Accretion of net unrealized loss on securities transferred to held-to-maturity	(1,255)	0	0
Total reclassifications	(4,876)	654	1,604
Income tax expense (benefit)	(1,343)	180	438
Total reclassifications, net of income tax	(3,533)	474	1,166
Reclassification out of accumulated other comprehensive income (loss) | Prior service credit on pension plans and other postretirement benefits
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income tax expense (benefit)	(8)	(8)	(8)
Compensation and employee benefits	29	29	28
Total reclassifications, net of income tax	$ 21	$ 21	$ 20

INVESTMENT SECURITIES - Amortiz

INVESTMENT SECURITIES - Amortized Cost and Fair Value of AFS Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 1,944,343	$ 2,103,049
Gross Unrealized Gains	58	17,754
Gross Unrealized Losses	(131,925)	(7,393)
Fair Value	1,812,476	2,113,410
Mortgage-related
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	881,574	977,144
Gross Unrealized Gains	24	12,722
Gross Unrealized Losses	(73,990)	(4,412)
Fair Value	807,608	985,454
GSE residential certificates
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		3,838
Gross Unrealized Gains		129
Gross Unrealized Losses		0
Fair Value		3,967
GSE residential CMOs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	427,529	460,571
Gross Unrealized Gains	24	5,697
Gross Unrealized Losses	(38,293)	(2,385)
Fair Value	389,260	463,883
GSE commercial certificates & CMO
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	222,620	364,274
Gross Unrealized Gains	0	6,855
Gross Unrealized Losses	(8,834)	(765)
Fair Value	213,786	370,364
Non-GSE residential certificates
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	123,139	66,756
Gross Unrealized Gains	0	29
Gross Unrealized Losses	(16,059)	(646)
Fair Value	107,080	66,139
Non-GSE commercial certificates
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	108,286	81,705
Gross Unrealized Gains	0	12
Gross Unrealized Losses	(10,804)	(616)
Fair Value	97,482	81,101
Other debt:
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,062,769	1,125,905
Gross Unrealized Gains	34	5,032
Gross Unrealized Losses	(57,935)	(2,981)
Fair Value	1,004,868	1,127,956
U.S. Treasury
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	199	200
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(7)	0
Fair Value	192	200
ABS
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	901,746	988,061
Gross Unrealized Gains	34	3,351
Gross Unrealized Losses	(39,617)	(2,224)
Fair Value	862,163	989,188
Trust preferred
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	10,988	14,631
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(845)	(484)
Fair Value	10,143	14,147
Corporate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	149,836	123,013
Gross Unrealized Gains	0	1,681
Gross Unrealized Losses	(17,466)	(273)
Fair Value	$ 132,370	$ 124,421

INVESTMENT SECURITIES - Amort_2

INVESTMENT SECURITIES - Amortized Cost and Fair Value of HTM Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	$ 1,541,301	$ 843,569
Gross Unrealized Gains	9	8,018
Gross Unrealized Losses	(126,439)	(1,883)
Fair Value	1,414,871	849,704
Mortgage-related
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	243,257	52,313
Gross Unrealized Gains	9	37
Gross Unrealized Losses	(23,650)	(777)
Fair Value	219,616	51,573
GSE residential CMOs
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	69,391
Gross Unrealized Gains	0
Gross Unrealized Losses	(4,054)
Fair Value	65,337
GSE commercial certificates
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	90,335	30,742
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(11,186)	(489)
Fair Value	79,149	30,253
GSE residential certificates
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	428	442
Gross Unrealized Gains	0	19
Gross Unrealized Losses	(17)	0
Fair Value	411	461
Non-GSE commercial certificates
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	32,635	10,333
Gross Unrealized Gains	9	13
Gross Unrealized Losses	(3,148)	(288)
Fair Value	29,496	10,058
Non-GSE residential certificates
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	50,468	10,796
Gross Unrealized Gains	0	5
Gross Unrealized Losses	(5,245)	0
Fair Value	45,223	10,801
Other debt:
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	1,298,044	791,256
Gross Unrealized Gains	0	7,981
Gross Unrealized Losses	(102,789)	(1,106)
Fair Value	1,195,255	798,131
ABS
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	288,682	75,800
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(15,175)	(50)
Fair Value	273,507	75,751
Property Assessed Clean Energy Assessment
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost		175,712
Gross Unrealized Gains		2,434
Gross Unrealized Losses		0
Fair Value		178,146
Commercial PACE
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	255,424
Gross Unrealized Gains	0
Gross Unrealized Losses	(26,782)
Fair Value	228,642
Residential PACE
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	656,453	451,682
Gross Unrealized Gains	0	3,499
Gross Unrealized Losses	(44,833)
Fair Value	611,620	455,181
Municipal
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	95,485	84,962
Gross Unrealized Gains	0	2,045
Gross Unrealized Losses	(15,999)	(1,056)
Fair Value	79,486	85,951
Other
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	2,000	3,100
Gross Unrealized Gains	0	2
Gross Unrealized Losses	0	0
Fair Value	$ 2,000	$ 3,102

INVESTMENT SECURITIES - Narrati

INVESTMENT SECURITIES - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale [Line Items]
Fair Value	$ 1,812,476,000	$ 2,113,410,000
Book value of securities transferred from available for sale to held-to-maturity	277,300,000
Securities available for sale transferred to held-to-maturity	260,112,000	0	$ 0
Unrealized losses from available for sale securities transferred held-to-maturity converted to discount	17,200,000
Fair value of temporarily impaired securities	1,773,594,000	1,041,016,000
Available for sale securities, temporarily impaired, unrealized loss	131,925,000	7,393,000
Recovery of other-than-temporary impairment	$ (15,900)		(900)
Other than temporary impairment loss		$ 4,800
Federal Home Loan Bank of New York
Debt Securities, Available-for-sale [Line Items]
Investment owned, balance (in shares)	296,068	37,199
Investment owned, cost (in dollars per share)	$ 100	$ 100
Dividend income	$ 500,000	$ 200,000	$ 200,000
Excluding GSE, US Treasury, TRUPS
Debt Securities, Available-for-sale [Line Items]
Fair value of temporarily impaired securities	2,570,000,000
Available for sale securities, temporarily impaired, unrealized loss	205,500,000
Mortgage-related
Debt Securities, Available-for-sale [Line Items]
Fair Value	807,608,000	985,454,000
Mortgage-related | Asset Pledged as Collateral | Federal Home Loan Bank Advances
Debt Securities, Available-for-sale [Line Items]
Fair Value	1,010,000,000	907,100,000
Held to maturity securities	$ 282,800,000	$ 126,600,000

INVESTMENT SECURITIES - AFS and

INVESTMENT SECURITIES - AFS and HTM Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Amortized Cost
Amortized Cost	$ 1,944,343	$ 2,103,049
Fair Value
Fair Value	1,812,476	2,113,410
Fair Value
Fair Value	1,414,871	849,704
Other debt:
Amortized Cost
Due within one year	0
Due after one year through five years	67,979
Due after five years through ten years	425,938
Due after ten years	568,852
Amortized Cost	1,062,769	1,125,905
Fair Value
Due within one year	0
Due after one year through five years	60,511
Due after five years through ten years	409,079
Due after ten years	535,278
Fair Value	1,004,868	1,127,956
Amortized Cost
Due within one year	2,000
Due after one year through five years	9,419
Due after five years through ten years	10,561
Due after ten years	1,276,064
Amortized Cost	1,298,044
Fair Value
Due within one year	2,000
Due after one year through five years	8,919
Due after five years through ten years	9,590
Due after ten years	1,174,746
Fair Value	$ 1,195,255	$ 798,131

INVESTMENT SECURITIES - Proceed

INVESTMENT SECURITIES - Proceeds Received and Gains (Losses) Realized on Sale of Available for Sale Securities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Proceeds	$ 249,936	$ 111,274	$ 94,698
Realized gains	168	1,057	2,111
Realized losses	(3,805)	(408)	(506)
Net realized gains (losses)	$ (3,637)	$ 649	$ 1,605

INVESTMENT SECURITIES - Schedul

INVESTMENT SECURITIES - Schedule of Unrealized Losses on Available for Sale and Held to Maturity Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	$ 1,139,172	$ 772,318
Available for sale, less than 12 months, unrealized losses	61,546	5,725
Available for sale, 12 months or longer, fair value	634,422	268,698
Available for sale, 12 months or longer, unrealized losses	70,379	1,668
Available for sale, total fair value	1,773,594	1,041,016
Available for sale, total unrealized losses	131,925	7,393
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	1,267,169	105,529
Held to maturity, less than 12 months, unrealized loss	100,311	1,679
Held to maturity, 12 months or longer, fair value	145,681	3,876
Held to maturity, 12 months or longer, unrealized loss	26,128	204
Held to maturity, total fair value	1,412,850	109,405
Held to maturity, total unrealized losses	126,439	1,883
GSE residential CMOs
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	231,562	222,825
Available for sale, less than 12 months, unrealized losses	13,937	2,385
Available for sale, 12 months or longer, fair value	151,285	0
Available for sale, 12 months or longer, unrealized losses	24,356	0
Available for sale, total fair value	382,847	222,825
Available for sale, total unrealized losses	38,293	2,385
GSE commercial certificates & CMO
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	153,325	28,695
Available for sale, less than 12 months, unrealized losses	6,729	271
Available for sale, 12 months or longer, fair value	60,461	159,681
Available for sale, 12 months or longer, unrealized losses	2,105	494
Available for sale, total fair value	213,786	188,376
Available for sale, total unrealized losses	8,834	765
Non-GSE residential certificates
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	72,527	55,284
Available for sale, less than 12 months, unrealized losses	8,969	646
Available for sale, 12 months or longer, fair value	34,553	0
Available for sale, 12 months or longer, unrealized losses	7,090	0
Available for sale, total fair value	107,080	55,284
Available for sale, total unrealized losses	16,059	646
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	39,426
Held to maturity, less than 12 months, unrealized loss	4,784
Held to maturity, 12 months or longer, fair value	5,797
Held to maturity, 12 months or longer, unrealized loss	461
Held to maturity, total fair value	45,223
Held to maturity, total unrealized losses	5,245
Non-GSE commercial certificates
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	62,243	42,530
Available for sale, less than 12 months, unrealized losses	4,842	247
Available for sale, 12 months or longer, fair value	35,239	23,124
Available for sale, 12 months or longer, unrealized losses	5,962	369
Available for sale, total fair value	97,482	65,654
Available for sale, total unrealized losses	10,804	616
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	11,192	9,857
Held to maturity, less than 12 months, unrealized loss	656	288
Held to maturity, 12 months or longer, fair value	18,283	0
Held to maturity, 12 months or longer, unrealized loss	2,492	0
Held to maturity, total fair value	29,475	9,857
Held to maturity, total unrealized losses	3,148	288
GSE residential CMOs
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	54,475
Held to maturity, less than 12 months, unrealized loss	2,891
Held to maturity, 12 months or longer, fair value	10,862
Held to maturity, 12 months or longer, unrealized loss	1,163
Held to maturity, total fair value	65,337
Held to maturity, total unrealized losses	4,054
GSE commercial certificates
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	48,934	30,253
Held to maturity, less than 12 months, unrealized loss	3,404	489
Held to maturity, 12 months or longer, fair value	30,215	0
Held to maturity, 12 months or longer, unrealized loss	7,782	0
Held to maturity, total fair value	79,149	30,253
Held to maturity, total unrealized losses	11,186	489
GSE residential certificates
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	411
Held to maturity, less than 12 months, unrealized loss	17
Held to maturity, 12 months or longer, fair value	0
Held to maturity, 12 months or longer, unrealized loss	0
Held to maturity, total fair value	411
Held to maturity, total unrealized losses	17
U.S. Treasury
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	192
Available for sale, less than 12 months, unrealized losses	7
Available for sale, 12 months or longer, fair value	0
Available for sale, 12 months or longer, unrealized losses	0
Available for sale, total fair value	192
Available for sale, total unrealized losses	7
ABS
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	530,269	374,241
Available for sale, less than 12 months, unrealized losses	17,290	1,903
Available for sale, 12 months or longer, fair value	299,425	71,746
Available for sale, 12 months or longer, unrealized losses	22,327	321
Available for sale, total fair value	829,694	445,987
Available for sale, total unrealized losses	39,617	2,224
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	224,279	26,951
Held to maturity, less than 12 months, unrealized loss	11,078	50
Held to maturity, 12 months or longer, fair value	49,228	0
Held to maturity, 12 months or longer, unrealized loss	4,097	0
Held to maturity, total fair value	273,507	26,951
Held to maturity, total unrealized losses	15,175	50
Trust preferred
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	0	0
Available for sale, less than 12 months, unrealized losses	0	0
Available for sale, 12 months or longer, fair value	10,143	14,147
Available for sale, 12 months or longer, unrealized losses	845	484
Available for sale, total fair value	10,143	14,147
Available for sale, total unrealized losses	845	484
Corporate
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]
Available for sale, less than 12 months, fair value	89,054	48,743
Available for sale, less than 12 months, unrealized losses	9,772	273
Available for sale, 12 months or longer, fair value	43,316	0
Available for sale, 12 months or longer, unrealized losses	7,694	0
Available for sale, total fair value	132,370	48,743
Available for sale, total unrealized losses	17,466	273
Commercial PACE
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	228,642
Held to maturity, less than 12 months, unrealized loss	26,782
Held to maturity, 12 months or longer, fair value	0
Held to maturity, 12 months or longer, unrealized loss	0
Held to maturity, total fair value	228,642
Held to maturity, total unrealized losses	26,782
Residential PACE
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	611,620
Held to maturity, less than 12 months, unrealized loss	44,833
Held to maturity, 12 months or longer, fair value	0
Held to maturity, 12 months or longer, unrealized loss	0
Held to maturity, total fair value	611,620
Held to maturity, total unrealized losses	44,833
Municipal
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position [Abstract]
Held to maturity, less than 12 months, fair value	48,190	38,468
Held to maturity, less than 12 months, unrealized loss	5,866	852
Held to maturity, 12 months or longer, fair value	31,296	3,876
Held to maturity, 12 months or longer, unrealized loss	10,133	204
Held to maturity, total fair value	79,486	42,344
Held to maturity, total unrealized losses	$ 15,999	$ 1,056

LOANS RECEIVABLE, NET - Schedul

LOANS RECEIVABLE, NET - Schedule of Loans Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	$ 4,101,769	$ 3,307,654
Net deferred loan origination costs	4,233	4,570
Total loans receivable, net of deferred loan origination costs (fees)	4,106,002	3,312,224
Allowance for loan losses	(45,031)	(35,866)	$ (41,589)	$ (33,847)
Total loans receivable, net	4,060,971	3,276,358
Asset Pledged as Collateral with Right | Federal Home Loan Bank Advances
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable, net	800,000	1,100,000
Commercial portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	2,265,991	1,952,154
Commercial portfolio | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	925,641	729,385
Allowance for loan losses	(12,916)	(10,652)	(9,065)	(11,126)
Commercial portfolio | Multifamily
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	967,521	821,801
Allowance for loan losses	(7,104)	(4,760)	(10,324)	(5,210)
Commercial portfolio | Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	335,133	369,429
Allowance for loan losses	(3,627)	(7,273)	(6,213)	(2,492)
Commercial portfolio | Construction and land development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	37,696	31,539
Allowance for loan losses	(825)	(405)	(2,077)	(808)
Retail portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	1,835,778	1,355,500
Retail portfolio | Residential real estate lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	1,371,779	1,063,682
Allowance for loan losses	(11,338)	(9,008)	(12,330)	(14,149)
Retail portfolio | Consumer and other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans receivable	463,999	291,818
Allowance for loan losses	$ (9,221)	$ (3,768)	$ (1,580)	$ (62)

LOANS RECEIVABLE, NET - Sched_2

LOANS RECEIVABLE, NET - Schedule of Quality of Bank's Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	$ 4,101,769	$ 3,307,654
Non- Accrual	21,699	28,219
90 Days or More Delinquent and Still Accruing Interest	0	0
30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	32,901	68,019
Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	54,600	96,238
Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	4,047,169	3,307,654
Non- Accrual		3,211,416
Commercial portfolio
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	2,265,991	1,952,154
Non- Accrual	18,308	15,274
90 Days or More Delinquent and Still Accruing Interest	0	0
Commercial portfolio | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	28,171	61,618
Commercial portfolio | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	46,479	76,892
Commercial portfolio | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	2,219,512	1,952,154
Non- Accrual		1,875,262
Commercial portfolio | Commercial and industrial
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	925,641	729,385
Non- Accrual	9,629	8,313
90 Days or More Delinquent and Still Accruing Interest	0	0
Commercial portfolio | Commercial and industrial | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	27	0
Commercial portfolio | Commercial and industrial | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	9,656	8,313
Commercial portfolio | Commercial and industrial | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	915,985	729,385
Non- Accrual		721,072
Commercial portfolio | Multifamily
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	967,521	821,801
Non- Accrual	3,828	2,907
90 Days or More Delinquent and Still Accruing Interest	0	0
Commercial portfolio | Multifamily | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	0	13,537
Commercial portfolio | Multifamily | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	3,828	16,444
Commercial portfolio | Multifamily | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	963,693	821,801
Non- Accrual		805,357
Commercial portfolio | Commercial real estate
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	335,133	369,429
Non- Accrual	4,851	4,054
90 Days or More Delinquent and Still Accruing Interest	0	0
Commercial portfolio | Commercial real estate | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	11,718	21,599
Commercial portfolio | Commercial real estate | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	16,569	25,653
Commercial portfolio | Commercial real estate | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	318,564	369,429
Non- Accrual		343,776
Commercial portfolio | Construction and land development
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	37,696	31,539
Non- Accrual	0	0
90 Days or More Delinquent and Still Accruing Interest	0	0
Commercial portfolio | Construction and land development | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	16,426	26,482
Commercial portfolio | Construction and land development | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	16,426	26,482
Commercial portfolio | Construction and land development | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	21,270	31,539
Non- Accrual		5,057
Retail portfolio
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	1,835,778	1,355,500
Non- Accrual	3,391	12,945
90 Days or More Delinquent and Still Accruing Interest	0	0
Retail portfolio | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	4,730	6,401
Retail portfolio | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	8,121	19,346
Retail portfolio | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	1,827,657	1,355,500
Non- Accrual		1,336,154
Retail portfolio | Residential real estate lending
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	1,371,779	1,063,682
Non- Accrual	1,807	12,525
90 Days or More Delinquent and Still Accruing Interest	0	0
Retail portfolio | Residential real estate lending | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	1,185	4,811
Retail portfolio | Residential real estate lending | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	2,992	17,336
Retail portfolio | Residential real estate lending | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	1,368,787	1,063,682
Non- Accrual		1,046,346
Retail portfolio | Consumer and other
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	463,999	291,818
Non- Accrual	1,584	420
90 Days or More Delinquent and Still Accruing Interest	0	0
Retail portfolio | Consumer and other | 30-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	3,545	1,590
Retail portfolio | Consumer and other | Total Past Due
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	5,129	2,010
Retail portfolio | Consumer and other | Current
Financing Receivable, Past Due [Line Items]
Total Loans Receivable	$ 458,870	291,818
Non- Accrual		$ 289,808

LOANS RECEIVABLE, NET - Narrati

LOANS RECEIVABLE, NET - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans receivable, net of deferred loan origination costs	$ 4,060,971	$ 3,276,358
Related party loans outstanding	1,600	500
Nonperforming Financial Instruments
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans receivable, net of deferred loan origination costs	6,900	1,000
Asset Pledged as Collateral with Right | Federal Home Loan Bank Advances
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans receivable, net of deferred loan origination costs	$ 800,000	$ 1,100,000

LOANS RECEIVABLE, NET - Sched_3

LOANS RECEIVABLE, NET - Schedule of Troubled Debt Restructurings (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Accruing	$ 6,102	$ 24,997
Nonaccrual	13,502	13,497
Total	19,604	38,494
Commercial portfolio | Commercial and industrial
Financing Receivable, Allowance for Credit Loss [Line Items]
Accruing	3,503	4,052
Nonaccrual	9,629	8,313
Total	13,132	12,365
Commercial portfolio | Commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Accruing	0	0
Nonaccrual	2,900	3,166
Total	2,900	3,166
Commercial portfolio | Construction and land development
Financing Receivable, Allowance for Credit Loss [Line Items]
Accruing	2,424	7,476
Nonaccrual	0	0
Total	2,424	7,476
Retail portfolio | Residential real estate lending
Financing Receivable, Allowance for Credit Loss [Line Items]
Accruing	175	13,469
Nonaccrual	973	2,018
Total	$ 1,148	$ 15,487

LOANS RECEIVABLE, NET - Sched_4

LOANS RECEIVABLE, NET - Schedule of Troubled Debt Restructurings Granted (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) loan	Dec. 31, 2021 USD ($) loan
Financing Receivable, Allowance for Credit Loss [Line Items]
Number of Loans | loan	6	3
Recorded Investment | $	$ 18,818	$ 10,013
Pre-modification, weighted average interest rate	5.13%	4.86%
Post-modification, weighted average interest rate	5.13%	4.22%
Commercial portfolio | Commercial and industrial
Financing Receivable, Allowance for Credit Loss [Line Items]
Number of Loans | loan	2	1
Recorded Investment | $	$ 8,171	$ 2,536
Pre-modification, weighted average interest rate	6.79%	6.50%
Post-modification, weighted average interest rate	6.79%	4%
Commercial portfolio | Commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Number of Loans | loan	4
Recorded Investment | $	$ 10,647
Pre-modification, weighted average interest rate	3.85%
Post-modification, weighted average interest rate	3.85%
Commercial portfolio | Construction and land development
Financing Receivable, Allowance for Credit Loss [Line Items]
Number of Loans | loan		2
Recorded Investment | $		$ 7,477
Pre-modification, weighted average interest rate		4.30%
Post-modification, weighted average interest rate		4.30%

LOANS RECEIVABLE, NET - Sched_5

LOANS RECEIVABLE, NET - Schedule of Loan Portfolio by Credit Quality Indicator (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	$ 4,101,769	$ 3,307,654
Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	3,994,908	3,076,768
Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	59,360	73,208
Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	45,755	157,678
Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,746	0
Commercial portfolio
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	2,265,991	1,952,154
Commercial portfolio | Commercial and industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	925,641	729,385
Commercial portfolio | Commercial and industrial | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	893,637	693,312
Commercial portfolio | Commercial and industrial | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	6,983	10,165
Commercial portfolio | Commercial and industrial | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	23,275	25,908
Commercial portfolio | Commercial and industrial | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,746	0
Commercial portfolio | Multifamily
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	967,521	821,801
Commercial portfolio | Multifamily | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	947,661	721,869
Commercial portfolio | Multifamily | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	13,696	48,804
Commercial portfolio | Multifamily | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	6,164	51,128
Commercial portfolio | Multifamily | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	0	0
Commercial portfolio | Commercial real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	335,133	369,429
Commercial portfolio | Commercial real estate | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	299,953	295,261
Commercial portfolio | Commercial real estate | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	24,679	13,947
Commercial portfolio | Commercial real estate | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	10,501	60,221
Commercial portfolio | Commercial real estate | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	0	0
Commercial portfolio | Construction and land development
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	37,696	31,539
Commercial portfolio | Construction and land development | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	21,270	24,063
Commercial portfolio | Construction and land development | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	14,002	0
Commercial portfolio | Construction and land development | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	2,424	7,476
Commercial portfolio | Construction and land development | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	0	0
Retail portfolio
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,835,778	1,355,500
Retail portfolio | Residential real estate lending
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,371,779	1,063,682
Retail portfolio | Residential real estate lending | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,369,972	1,050,865
Retail portfolio | Residential real estate lending | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	0	292
Retail portfolio | Residential real estate lending | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,807	12,525
Retail portfolio | Residential real estate lending | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	0	0
Retail portfolio | Consumer and other
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	463,999	291,818
Retail portfolio | Consumer and other | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	462,415	291,398
Retail portfolio | Consumer and other | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	0	0
Retail portfolio | Consumer and other | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	1,584	420
Retail portfolio | Consumer and other | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Total loans receivable	$ 0	$ 0

LOANS RECEIVABLE, NET - Method

LOANS RECEIVABLE, NET - Method of Evaluating Impairment of Loans and Allowance (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	$ 27,801	$ 53,216
Loans - collectively evaluated for impairment	4,073,968	3,254,438
Total Loans Receivable	4,101,769	3,307,654
Allowance for loan losses - individually evaluated for impairment	5,668	5,105
Allowance for loan losses - collectively evaluated for impairment	39,363	30,761
Total allowance for loan losses	45,031	35,866	$ 41,589	$ 33,847
Commercial portfolio
Financing Receivable, Allowance for Credit Loss [Line Items]
Total Loans Receivable	2,265,991	1,952,154
Commercial portfolio | Commercial and industrial
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	14,716	12,785
Loans - collectively evaluated for impairment	910,925	716,600
Total Loans Receivable	925,641	729,385
Allowance for loan losses - individually evaluated for impairment	5,433	4,350
Allowance for loan losses - collectively evaluated for impairment	7,483	6,302
Total allowance for loan losses	12,916	10,652	9,065	11,126
Commercial portfolio | Multifamily
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	3,828	2,907
Loans - collectively evaluated for impairment	963,693	818,894
Total Loans Receivable	967,521	821,801
Allowance for loan losses - individually evaluated for impairment	180	0
Allowance for loan losses - collectively evaluated for impairment	6,924	4,760
Total allowance for loan losses	7,104	4,760	10,324	5,210
Commercial portfolio | Commercial real estate
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	4,851	4,054
Loans - collectively evaluated for impairment	330,282	365,375
Total Loans Receivable	335,133	369,429
Allowance for loan losses - individually evaluated for impairment	0	0
Allowance for loan losses - collectively evaluated for impairment	3,627	7,273
Total allowance for loan losses	3,627	7,273	6,213	2,492
Commercial portfolio | Construction and land development
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	2,424	7,476
Loans - collectively evaluated for impairment	35,272	24,063
Total Loans Receivable	37,696	31,539
Allowance for loan losses - individually evaluated for impairment	0	0
Allowance for loan losses - collectively evaluated for impairment	825	405
Total allowance for loan losses	825	405	2,077	808
Retail portfolio
Financing Receivable, Allowance for Credit Loss [Line Items]
Total Loans Receivable	1,835,778	1,355,500
Retail portfolio | Residential real estate lending
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	1,982	25,994
Loans - collectively evaluated for impairment	1,369,797	1,037,688
Total Loans Receivable	1,371,779	1,063,682
Allowance for loan losses - individually evaluated for impairment	55	755
Allowance for loan losses - collectively evaluated for impairment	11,283	8,253
Total allowance for loan losses	11,338	9,008	12,330	14,149
Retail portfolio | Consumer and other
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans - individually evaluated for impairment	0	0
Loans - collectively evaluated for impairment	463,999	291,818
Total Loans Receivable	463,999	291,818
Allowance for loan losses - individually evaluated for impairment	0	0
Allowance for loan losses - collectively evaluated for impairment	9,221	3,768
Total allowance for loan losses	$ 9,221	$ 3,768	$ 1,580	$ 62

LOANS RECEIVABLE, NET - Sched_6

LOANS RECEIVABLE, NET - Schedule of Activity in Allowance by Portfolio (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 35,866	$ 41,589	$ 33,847
Provision for (recovery of) loan losses	15,002	(287)	24,791
Charge-offs	(8,396)	(8,988)	(18,233)
Recoveries	2,559	3,552	1,184
Ending Balance	45,031	35,866	41,589
Commercial portfolio | Commercial and industrial
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	10,652	9,065	11,126
Provision for (recovery of) loan losses	1,990	2,179	9,175
Charge-offs	0	(813)	(11,293)
Recoveries	274	221	57
Ending Balance	12,916	10,652	9,065
Commercial portfolio | Multifamily
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	4,760	10,324	5,210
Provision for (recovery of) loan losses	2,760	(1,483)	5,114
Charge-offs	(416)	(4,081)	0
Recoveries	0	0	0
Ending Balance	7,104	4,760	10,324
Commercial portfolio | Commercial real estate
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	7,273	6,213	2,492
Provision for (recovery of) loan losses	(3,646)	1,374	7,508
Charge-offs	0	(314)	(3,787)
Recoveries	0	0	0
Ending Balance	3,627	7,273	6,213
Commercial portfolio | Construction and land development
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	405	2,077	808
Provision for (recovery of) loan losses	807	(1,675)	2,238
Charge-offs	(389)	0	(970)
Recoveries	2	3	1
Ending Balance	825	405	2,077
Retail portfolio | Residential real estate lending
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	9,008	12,330	14,149
Provision for (recovery of) loan losses	2,978	(5,409)	(2,302)
Charge-offs	(2,448)	(1,081)	(492)
Recoveries	1,800	3,168	975
Ending Balance	11,338	9,008	12,330
Retail portfolio | Consumer and other
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	3,768	1,580	62
Provision for (recovery of) loan losses	10,113	4,727	3,058
Charge-offs	(5,143)	(2,699)	(1,691)
Recoveries	483	160	151
Ending Balance	$ 9,221	$ 3,768	$ 1,580

LOANS RECEIVABLE, NET - Sched_7

LOANS RECEIVABLE, NET - Schedule of Individually Impaired Loans and Allowances (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Impaired [Line Items]
Loans without a related allowance - recorded investment	$ 12,164	$ 22,037
Loans without a related allowance - average recorded investment	17,102	28,740
Loans without a related allowance - unpaid principal balance	18,475	24,325
Loans with a related allowance - recorded investment	15,637	31,179
Loans with a related allowance - average recorded investment	23,408	38,107
Loans with a related allowance - unpaid principal balance	16,747	40,537
Total individually impaired loans - recorded investment	27,801	53,216
Total individually impaired loans - average recorded investment	40,510	66,847
Total individually impaired loans - unpaid principal balance	35,222	64,862
Individually impaired loans - related allowance	5,668	5,105
Retail portfolio | Residential real estate lending
Financing Receivable, Impaired [Line Items]
Loans without a related allowance - recorded investment	764	10,507
Loans without a related allowance - average recorded investment	5,636	15,666
Loans without a related allowance - unpaid principal balance	1,761	11,896
Loans with a related allowance - recorded investment	1,218	15,487
Loans with a related allowance - average recorded investment	8,352	18,120
Loans with a related allowance - unpaid principal balance	1,278	19,306
Total individually impaired loans - recorded investment	1,982	25,994
Total individually impaired loans - average recorded investment	13,988	33,786
Total individually impaired loans - unpaid principal balance	3,039	31,202
Individually impaired loans - related allowance	55	755
Commercial portfolio | Multifamily
Financing Receivable, Impaired [Line Items]
Loans without a related allowance - recorded investment	334
Loans without a related allowance - average recorded investment	167
Loans without a related allowance - unpaid principal balance	334
Loans with a related allowance - recorded investment	3,494	2,907
Loans with a related allowance - average recorded investment	3,201	6,241
Loans with a related allowance - unpaid principal balance	3,494	8,024
Total individually impaired loans - recorded investment	3,828	2,907
Total individually impaired loans - average recorded investment	3,368	6,241
Total individually impaired loans - unpaid principal balance	3,828	8,024
Individually impaired loans - related allowance	180	0
Commercial portfolio | Construction and land development
Financing Receivable, Impaired [Line Items]
Loans without a related allowance - recorded investment	2,424	7,476
Loans without a related allowance - average recorded investment	4,950	9,330
Loans without a related allowance - unpaid principal balance	7,476	7,476
Total individually impaired loans - recorded investment	2,424	7,476
Total individually impaired loans - average recorded investment	4,950	9,330
Total individually impaired loans - unpaid principal balance	7,476	7,476
Individually impaired loans - related allowance	0	0
Commercial portfolio | Commercial real estate
Financing Receivable, Impaired [Line Items]
Loans without a related allowance - recorded investment	4,851	4,054
Loans without a related allowance - average recorded investment	4,453	3,744
Loans without a related allowance - unpaid principal balance	5,023	4,953
Total individually impaired loans - recorded investment	4,851	4,054
Total individually impaired loans - average recorded investment	4,453	3,744
Total individually impaired loans - unpaid principal balance	5,023	4,953
Individually impaired loans - related allowance	0	0
Commercial portfolio | Commercial and industrial
Financing Receivable, Impaired [Line Items]
Loans without a related allowance - recorded investment	3,791
Loans without a related allowance - average recorded investment	1,896
Loans without a related allowance - unpaid principal balance	3,881
Loans with a related allowance - recorded investment	10,925	12,785
Loans with a related allowance - average recorded investment	11,855	13,746
Loans with a related allowance - unpaid principal balance	11,975	13,207
Total individually impaired loans - recorded investment	14,716	12,785
Total individually impaired loans - average recorded investment	13,751	13,746
Total individually impaired loans - unpaid principal balance	15,856	13,207
Individually impaired loans - related allowance	$ 5,433	$ 4,350

PREMISES AND EQUIPMENT - Schedu

PREMISES AND EQUIPMENT - Schedule of Premises and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	$ 35,498	$ 36,955
Accumulated depreciation and amortization	(25,642)	(25,220)
Premises and equipment, net	9,856	11,735
Buildings, premises and improvements
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	28,150	29,935
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	6,787	7,020
Projects in process
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	$ 561	$ 0

PREMISES AND EQUIPMENT - Narrat

PREMISES AND EQUIPMENT - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($) branchOffice	Dec. 31, 2020 USD ($)
Property, Plant and Equipment [Abstract]
Depreciation and amortization	$ 3.5	$ 3.6	$ 6.2
Number of branch office closures | branchOffice		8
Accelerated depreciation		$ 2.3

DEPOSITS - Schedule of Deposits

DEPOSITS - Schedule of Deposits (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Amount
Non-interest-bearing demand deposit accounts	$ 3,331,067	$ 3,335,005
NOW accounts	206,434	210,844
Money market deposit accounts	2,445,396	2,227,953
Savings accounts	386,190	375,301
Time deposits	151,699	207,152
Brokered CD	74,251	0
Total deposits	$ 6,595,037	$ 6,356,255
Weighted Average Rate
NOW accounts	0.73%	0.08%
Money market deposit accounts	0.94%	0.12%
Savings accounts	0.75%	0.11%
Time deposits	2.57%	0.32%
Brokered CD	3.84%	0%
Deposits	0.52%	0.06%

DEPOSITS - Schedule of Maturiti

DEPOSITS - Schedule of Maturities of Time Deposits (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Time Deposits, Fiscal Year Maturity [Abstract]
2023	$ 208,231
2024	10,866
2025	4,482
2026	1,776
2027	595
Thereafter	0
Time deposit and brokered CD	$ 225,950

DEPOSITS - Narrative (Details)

DEPOSITS - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statistical Disclosure for Banks [Abstract]
Time deposits at or above FDIC limit	$ 110.4	$ 43.7
CDARS deposits	28.3	56
Deposits from Workers United and other related entities	52.2	99.9
State and municipal deposits	$ 88.3	$ 65.5

FHLBNY ADVANCES (Details)

FHLBNY ADVANCES (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
FHLBNY advances	$ 580,000,000	$ 0
Federal Home Loan Bank of New York
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
FHLBNY advances	$ 580,000,000	$ 0
Weighted average interest rate	4.58%
Other eligible assets pledged as collateral	$ 1,400,000,000
Required percentage of pledged assets to FHLBNY of outstanding advances	110%
Compromised Securities | Federal Home Loan Bank of New York
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Other eligible assets pledged as collateral	$ 760,300,000
Mortgage-related | Federal Home Loan Bank of New York
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Other eligible assets pledged as collateral	$ 616,900,000

SUBORDINATED DEBT (Details)

SUBORDINATED DEBT (Details) - USD ($) $ in Thousands		12 Months Ended
	Nov. 08, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financial Instruments Owned and Pledged as Collateral [Line Items]
Aggregate principal amount		$ 77,708	$ 83,831
Net increase (decrease) in subordinated debt		(5,633)	$ 83,831	$ 0
Fixed-to-Floating Rate Notes | Subordinated Debt
Financial Instruments Owned and Pledged as Collateral [Line Items]
Aggregate principal amount	$ 85,000
Interest rate	3.25%
Redemption price percentage	100%
Net increase (decrease) in subordinated debt		(5,600)
Gain on repayment of debt		$ 600
Fixed-to-Floating Rate Notes | Subordinated Debt | Secured Overnight Financing Rate
Financial Instruments Owned and Pledged as Collateral [Line Items]
Variable rate	2.30%

REGULATORY CAPITAL (Details)

REGULATORY CAPITAL (Details) $ in Thousands	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Actual
Total capital to risk weighted assets, amount, actual	$ 715,458	$ 613,030
Tier 1 capital to risk weighted assets, amount, actual	668,864	575,692
Tier 1 capital to average assets, amount, actual	668,864	575,692
Common equity tier 1 to risk weighted assets, amount, actual	$ 668,864	$ 575,692
Total capital to risk weighted assets, ratio, actual	0.1475	0.1489
Tier 1 capital to risk weighted assets, ratio, actual	0.1379	0.1398
Tier 1 capital to average assets, ratio, actual	0.0844	0.0821
Common equity tier 1 to risk weighted assets, ratio, actual	0.1379	0.1398
For Capital Adequacy Purposes
Total capital to risk weighted assets, amount, capital adequacy	$ 388,107	$ 329,376
Tier 1 capital to risk weighted assets, amount, capital adequacy	291,080	247,032
Tier 1 capital to average assets, amount, capital adequacy	317,111	280,433
Common equity tier 1 to risk weighted assets, amount, capital adequacy	$ 218,310	$ 185,274
Total capital to risk weighted assets, ratio, capital adequacy	0.0800	0.0800
Tier 1 capital to risk weighted assets, ratio, capital adequacy	0.0600	0.0600
Tier 1 capital to average assets, ratio, capital adequacy	0.0400	0.0400
Common equity tier 1 to risk weighted assets, ratio, capital adequacy	0.0450	0.0450
To Be Considered Well Capitalized
Total capital to risk weighted assets, amount, well capitalized	$ 485,134	$ 411,720
Tier 1 capital to risk weighted assets, amount, well capitalized	388,107	329,376
Tier 1 capital to average assets, amount, well capitalized	396,389	205,860
Common equity tier 1 to risk weighted assets, amount, well capitalized	$ 315,337	$ 267,618
Total capital to risk weighted assets, ratio, well capitalized	0.1000	0.1000
Tier 1 capital to risk weighted assets, ratio, well capitalized	0.0800	0.0800
Tier 1 capital to average assets, ratio, well capitalized	0.0500	0.0500
Common equity tier 1 to risk weighted assets, ratio, well capitalized	0.0650	0.0650
Consolidated
Actual
Total capital to risk weighted assets, amount, actual	$ 721,324	$ 656,719
Tier 1 capital to risk weighted assets, amount, actual	597,022	534,381
Tier 1 capital to average assets, amount, actual	597,022	534,381
Common equity tier 1 to risk weighted assets, amount, actual	$ 597,022	$ 534,381
Total capital to risk weighted assets, ratio, actual	0.1487	0.1595
Tier 1 capital to risk weighted assets, ratio, actual	0.1231	0.1298
Tier 1 capital to average assets, ratio, actual	0.0752	0.0762
Common equity tier 1 to risk weighted assets, ratio, actual	0.1231	0.1298
For Capital Adequacy Purposes
Total capital to risk weighted assets, amount, capital adequacy	$ 387,957	$ 329,471
Tier 1 capital to risk weighted assets, amount, capital adequacy	290,967	247,103
Tier 1 capital to average assets, amount, capital adequacy	317,738	280,454
Common equity tier 1 to risk weighted assets, amount, capital adequacy	$ 218,226	$ 185,327
Total capital to risk weighted assets, ratio, capital adequacy	0.0800	0.0800
Tier 1 capital to risk weighted assets, ratio, capital adequacy	0.0600	0.0600
Tier 1 capital to average assets, ratio, capital adequacy	0.0400	0.0400
Common equity tier 1 to risk weighted assets, ratio, capital adequacy	0.0450	0.0450

INCOME TAXES - Schedule of Comp

INCOME TAXES - Schedule of Components of Provision (Benefit) for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current:
Federal	$ 9,201	$ 9,349	$ 15,010
State and local	3,111	1,389	1,152
Total current	12,312	10,738	16,162
Deferred:
Federal	10,709	4,409	(3,497)
State and local	3,666	2,641	3,090
Total deferred	14,375	7,050	(407)
Total income tax provision	$ 26,687	$ 17,788	$ 15,755

INCOME TAXES - Reconciliation o

INCOME TAXES - Reconciliation of Expected Income Tax Expense and Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Amount
Tax expense at federal income tax rate	$ 22,714	$ 14,852	$ 13,008
Increase (decrease) resulting from:
Tax exempt income	(497)	(317)	(862)
Change in DTA rate	84	(199)	333
State tax, net of federal benefit	5,354	3,184	3,551
Stock options windfall	(363)	(94)	(3)
Other	(605)	362	(272)
Total income tax provision	$ 26,687	$ 17,788	$ 15,755
Percentage
Tax expense at federal income tax rate	21%	21%	21%
Increase (decrease) resulting from:
Tax exempt income	(0.46%)	(0.45%)	(1.39%)
Change in DTA rate	0.08%	(0.28%)	0.54%
State tax, net of federal benefit	4.95%	4.50%	5.73%
Stock options windfall	(0.34%)	(0.13%)	(0.01%)
Other	(0.56%)	0.51%	(0.44%)
Total	24.67%	25.15%	25.43%

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Income tax receivable	$ 12.1	$ 20.8
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1.3
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	42.8
Local
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 18.7

INCOME TAXES - Schedule of Co_2

INCOME TAXES - Schedule of Components of Net Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Excess tax basis over carrying value of assets:
Allowance for loan losses	$ 13,237	$ 16,300
Nonaccrual interest income	106	389
Postretirement and other employee benefits	1,563	242
Available for sale securities carried at fair value for financial statement purposes	36,330	0
Depreciation and amortization	1,418	1,123
Operating leases	10,976	13,250
Federal, state and local net operating loss carryforward	4,468	7,285
Transfer of available for sale securities to held-to-maturity	4,379	0
Other, net	600	3,258
Gross deferred tax asset	73,077	41,847
Deferred tax liabilities:
Available for sale securities carried at fair value for financial statement purposes	0	(2,850)
Unrealized loss on investment	(150)	0
Purchase accounting adjustments, net	(676)	(874)
Operating leases	(8,575)	(10,142)
Net deferred loan fees	(1,169)	(1,262)
Gross deferred tax liabilities	(10,570)	(15,128)
Deferred tax asset, net	$ 62,507	$ 26,719

EARNINGS PER SHARE - Schedule o

EARNINGS PER SHARE - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Net income attributable to Amalgamated Financial Corp.	$ 81,477	$ 52,937	$ 46,188
Dividends paid on preferred stock	(22)	(22)	(22)
Income attributable to common stock	$ 81,455	$ 52,915	$ 46,166
Weighted average common shares outstanding, basic (in shares)	30,818	31,104	31,133
Basic earnings per common share (in dollars per share)	$ 2.64	$ 1.70	$ 1.48
Incremental shares for assumed conversion of options and RSUs (in shares)	375	408	96
Weighted average common shares outstanding, diluted (in shares)	31,193	31,512	31,229
Diluted earnings per common share (in dollars per share)	$ 2.61	$ 1.68	$ 1.48

EARNINGS PER SHARE - Narrative

EARNINGS PER SHARE - Narrative (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Number of antidilutive shares (in shares)	376	368

EMPLOYEE BENEFIT PLANS - Narrat

EMPLOYEE BENEFIT PLANS - Narrative (Details)		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2022 USD ($) hour $ / shares shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Multi-employer plan, minimum age		21 years
Multi-employer plan, number of hours of service during twelve consecutive month period | hour		1,000
Multi-employer plan, vesting percentage		100%
Multi-employer plan, vesting period		5 years
Plan number		001
Net actuarial loss and prior service credit expected to be amortized in next fiscal year | $		$ 200,000
Future estimated benefit payments expected next fiscal year | $		300,000
Future estimated benefit payments expected in year two | $		300,000
Future estimated benefit payments expected in year three | $		300,000
Future estimated benefit payments expected in year four | $		300,000
Future estimated benefit payments expected in year five | $		300,000
Future estimated benefit payments expected after year five | $		$ 300,000
Employee contributions, maximum percentage of salary		15%
Exercise price of stock options, minimum (in dollars per share) | $ / shares		$ 11
Exercise price of stock options, maximum (in dollars per share) | $ / shares		$ 14.65
Fair value of options outstanding | $		$ 4,200,000	$ 2,900,000
Proceeds from stock options exercised | $		$ 0	$ 0
Stock repurchased during period (in shares)		310,176	920,948
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	10 years
Stock Options | Employees and Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost | $		$ 0	$ 0	$ 700,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost | $		$ 2,200,000	$ 1,800,000	1,200,000
Stock repurchased during period (in shares)		54,191	21,624
Number of shares authorized for stock-based awards (in shares)		1,250,000
Number of shares available for issuance (in shares)		434,907
Unvested shares (in shares)		427,993
Restricted Stock Units | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost | $		$ 500,000	$ 300,000	$ 500,000
Restricted Stock Units | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost | $		$ 4,200,000
Unrecognized compensation cost, period for recognition		2 years 1 month 6 days
Restricted Stock Units | Employee | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of achievable awards (in shares)		331,023
Restricted Stock Units | Employee | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of achievable awards (in shares)		476,478
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in shares)		62,794
Awarded (in dollars per share) | $ / shares		$ 17.69
Unvested shares (in shares)		96,970	103,774
Performance Shares | Grant Date Fair Value, One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in dollars per share) | $ / shares		$ 17.34
Performance Shares | Grant Date Fair Value, Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in dollars per share) | $ / shares		17.39
Performance Shares | Grant Date Fair Value, Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in dollars per share) | $ / shares		$ 21.64
Performance Shares | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		3 years
Number of shares reserved for issuance (in shares)		145,455
Performance Shares | Employee | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of achievable awards (in shares)		0
Performance Shares | Employee | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of achievable awards (in shares)		47,667
Performance Shares | Employee | Grant Date Fair Value, One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in shares)		16,536
Performance Shares | Employee | Grant Date Fair Value, Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in shares)		14,376
Performance Shares | Employee | Grant Date Fair Value, Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in shares)		866
Market-Based Restricted Stock Units | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awarded (in shares)		31,016
Awarded (in dollars per share) | $ / shares		$ 17.91
Vesting period		3 years
Market-Based Restricted Stock Units | Employee | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of achievable awards (in shares)		0
Market-Based Restricted Stock Units | Employee | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of achievable awards (in shares)		46,524

EMPLOYEE BENEFIT PLANS - Schedu

EMPLOYEE BENEFIT PLANS - Schedule of Employer Contributions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Contributions	$ 6,321	$ 6,193	$ 6,278

EMPLOYEE BENEFIT PLANS - Sche_2

EMPLOYEE BENEFIT PLANS - Schedule of Changes in Benefit Obligations and Plan Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Change in benefit obligation:
Benefit obligation at beginning of year	$ 3,658	$ 4,094
Service cost	0	0	$ 0
Interest cost	71	58	118
Amendments	0	0
Actuarial loss (gain)	(397)	(16)
Benefits paid	(477)	(478)
Benefit obligation at end of year	2,855	3,658	$ 4,094
Change in plan assets:
Employer contributions	477	478
Benefits paid	(477)	(478)
Plan assets at end of year	0	0
Benefit obligation, included in other liabilities	$ 2,855	$ 3,658

EMPLOYEE BENEFIT PLANS - Amount

EMPLOYEE BENEFIT PLANS - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Amounts recognized in accumulated other comprehensive income (loss)
Net actuarial loss	$ 2,572	$ 3,235	$ 3,200
Prior service credit	(292)	(320)	(349)
Total amount recognized	$ 2,280	$ 2,915	$ 2,851

EMPLOYEE BENEFIT PLANS - Sche_3

EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Components of net periodic benefit cost:
Service cost	$ 0	$ 0	$ 0
Interest cost	71	58	118
Prior service credit amortization	(29)	(29)	(29)
Prior service credit due to curtailments	0	0	0
Recognized actuarial (gain) loss	267	400	320
Net periodic benefit	309	429	409
Components of other amounts:
Net regular actuarial (gain) loss	(397)	(16)	379
Recognized actuarial gain (loss)	(267)	(400)	(320)
Prior service credit amortization	29	29	29
Prior service credit due to curtailments	0	450	(450)
Prior service credit due to amendment	0	0	0
Total recognized in other comprehensive income	(635)	63	(362)
Total recognized in comprehensive income	$ (326)	$ 492	$ 47
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Total recognized in other comprehensive income

EMPLOYEE BENEFIT PLANS - Sche_4

EMPLOYEE BENEFIT PLANS - Schedule of Assumptions Used to Measure Plans' Benefit Obligation and Net Period Benefit Expense (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted average assumptions used to determine benefit obligations:
Discount rate	4.75%	2.07%	1.50%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	2.14%	1.66%	3.13%

EMPLOYEE BENEFIT PLANS - Stock

EMPLOYEE BENEFIT PLANS - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Number of Options
Outstanding, balance at the beginning of the period (in shares)	847,560
Granted (in shares)	0
Forfeited/expired (in shares)	(18,260)
Exercised (in shares)	(402,420)
Outstanding, balance at the end of the period (in shares)	426,880	847,560
Vested and exercisable (in shares)	426,880
Weighted Average Exercise Price
Outstanding, balance at the beginning of the period (in dollars per share)	$ 13.19
Granted (in dollars per share)	0
Forfeited/expired (in dollars per share)	12.69
Exercised (in dollars per share)	13.31
Outstanding, balance at the end of the period (in dollars per share)	13.09	$ 13.19
Vested and exercisable (in dollars per share)	$ 13.09
Weighted Average Remaining Contractual Term
Options outstanding	3 years 3 months 18 days	4 years 3 months 18 days
Options vested and exercisable	3 years 3 months 18 days
Intrinsic Value (in thousands)
Options outstanding	$ 4,246
Options exercisable	$ 4,246

EMPLOYEE BENEFIT PLANS - Restri

EMPLOYEE BENEFIT PLANS - Restricted Stock Units Activity (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Restricted Stock Units
Shares
Unvested at the end of the period (in shares) | shares	427,993
Time-Based Restricted Stock Units
Shares
Unvested at the beginning of the period (in shares) | shares	326,521
Awarded (in shares) | shares	193,339
Forfeited (in shares) | shares	(42,885)
Vested (in shares) | shares	(145,952)
Grant Date Fair Value
Unvested at the beginning of the period (in dollars per share) | $ / shares	$ 15.66
Awarded (in dollars per share) | $ / shares	19.31
Forfeited (in dollars per share) | $ / shares	15.69
Vested (in dollars per share) | $ / shares	15.83
Unvested at the end of the period (in dollars per share) | $ / shares	$ 17.72
Performance Shares
Shares
Unvested at the beginning of the period (in shares) | shares	103,774
Awarded (in shares) | shares	62,794
Forfeited (in shares) | shares	(46,137)
Vested (in shares) | shares	(23,461)
Unvested at the end of the period (in shares) | shares	96,970
Grant Date Fair Value
Unvested at the beginning of the period (in dollars per share) | $ / shares	$ 15.84
Awarded (in dollars per share) | $ / shares	17.69
Forfeited (in dollars per share) | $ / shares	16.18
Vested (in dollars per share) | $ / shares	17.91
Unvested at the end of the period (in dollars per share) | $ / shares	$ 16.37

FAIR VALUE OF FINANCIAL INSTR_3

FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value of Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	$ 1,812,476	$ 2,113,410
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	1,812,476	2,113,410
Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	192	200
Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	1,812,284	2,113,210
Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Mortgage-related
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	807,608	985,454
GSE residential CMOs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	389,260	463,883
GSE residential CMOs | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	389,260	463,883
GSE residential CMOs | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
GSE residential CMOs | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	389,260	463,883
GSE residential CMOs | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
GSE commercial certificates & CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	213,786	370,364
GSE commercial certificates & CMO | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	213,786	370,364
GSE commercial certificates & CMO | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
GSE commercial certificates & CMO | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	213,786	370,364
GSE commercial certificates & CMO | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Non-GSE residential certificates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	107,080	66,139
Non-GSE residential certificates | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	107,080	66,139
Non-GSE residential certificates | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Non-GSE residential certificates | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	107,080	66,139
Non-GSE residential certificates | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Non-GSE commercial certificates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	97,482	81,101
Non-GSE commercial certificates | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	97,482	81,101
Non-GSE commercial certificates | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Non-GSE commercial certificates | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	97,482	81,101
Non-GSE commercial certificates | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
GSE residential certificates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities		3,967
GSE residential certificates | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities		3,967
GSE residential certificates | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities		0
GSE residential certificates | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities		3,967
GSE residential certificates | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities		0
Other debt:
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	1,004,868	1,127,956
U.S. Treasury
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	192	200
U.S. Treasury | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	192	200
U.S. Treasury | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	192	200
U.S. Treasury | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
U.S. Treasury | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
ABS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	862,163	989,188
ABS | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	862,163	989,188
ABS | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
ABS | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	862,163	989,188
ABS | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Trust preferred
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	10,143	14,147
Trust preferred | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	10,143	14,147
Trust preferred | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Trust preferred | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	10,143	14,147
Trust preferred | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	132,370	124,421
Corporate | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	132,370	124,421
Corporate | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	0	0
Corporate | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	132,370	124,421
Corporate | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities	$ 0	$ 0

FAIR VALUE OF FINANCIAL INSTR_4

FAIR VALUE OF FINANCIAL INSTRUMENTS - Securities Measured on Non-Recurring Basis (Details) - Fair Value, Nonrecurring - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 3,315	$ 48,111
Other real estate owned		307
Total value of assets measured on non-recurring basis	3,315	48,418
Estimated Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	3,315	48,111
Other real estate owned		335
Total value of assets measured on non-recurring basis	3,315	48,446
Estimated Fair Value | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Other real estate owned		0
Total value of assets measured on non-recurring basis	0	0
Estimated Fair Value | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Other real estate owned		0
Total value of assets measured on non-recurring basis	0	0
Estimated Fair Value | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	3,315	48,111
Other real estate owned		335
Total value of assets measured on non-recurring basis	$ 3,315	$ 48,446

FAIR VALUE OF FINANCIAL INSTR_5

FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Basis and Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financial assets:
Held-to-maturity securities	$ 1,414,871	$ 849,704
Financial liabilities:
FHLBNY advances	580,000	0
Carrying Value
Financial assets:
Cash and cash equivalents	63,540	330,485
Held-to-maturity securities	1,541,301	843,569
Loans held for sale	7,943	3,279
Loans receivable, net	4,060,971	3,276,358
Resell agreements	25,754	229,018
Accrued interest and dividends receivable	41,441	28,820
Financial liabilities:
Subordinated debt	77,708	83,831
Accrued interest payable	1,218	569
Carrying Value | Deposits payable on demand
Financial liabilities:
Deposits	6,369,087	6,149,103
Carrying Value | Time deposits
Financial liabilities:
Deposits	225,950	207,152
FHLBNY advances	580,000
Estimated Fair Value
Financial assets:
Cash and cash equivalents	63,540	330,485
Held-to-maturity securities	1,414,871	849,704
Loans held for sale	7,943	3,279
Loans receivable, net	3,718,308	3,291,377
Resell agreements	25,754	229,018
Accrued interest and dividends receivable	41,441	28,820
Financial liabilities:
Subordinated debt	68,966	85,000
Accrued interest payable	1,218	569
Estimated Fair Value | Deposits payable on demand
Financial liabilities:
Deposits	6,369,087	6,149,103
Estimated Fair Value | Time deposits
Financial liabilities:
Deposits	225,805	207,369
FHLBNY advances	580,000
Estimated Fair Value | Level 1
Financial assets:
Cash and cash equivalents	63,540	330,485
Held-to-maturity securities	0	0
Loans held for sale	0	0
Loans receivable, net	0	0
Resell agreements	0	0
Accrued interest and dividends receivable	17	0
Financial liabilities:
Subordinated debt	0	0
Accrued interest payable	0	0
Estimated Fair Value | Level 1 | Deposits payable on demand
Financial liabilities:
Deposits	0	0
Estimated Fair Value | Level 1 | Time deposits
Financial liabilities:
Deposits	0	0
FHLBNY advances	0
Estimated Fair Value | Level 2
Financial assets:
Cash and cash equivalents	0	0
Held-to-maturity securities	574,609	216,377
Loans held for sale		0
Loans receivable, net	0	0
Resell agreements	0	0
Accrued interest and dividends receivable	12,197	28,820
Financial liabilities:
Subordinated debt	68,966	85,000
Accrued interest payable	1,218	569
Estimated Fair Value | Level 2 | Deposits payable on demand
Financial liabilities:
Deposits	6,369,087	6,149,103
Estimated Fair Value | Level 2 | Time deposits
Financial liabilities:
Deposits	225,805	207,369
FHLBNY advances	580,000
Estimated Fair Value | Level 3
Financial assets:
Cash and cash equivalents	0	0
Held-to-maturity securities	840,262	633,327
Loans held for sale	7,943	3,279
Loans receivable, net	3,718,308	3,291,377
Resell agreements	25,754	229,018
Accrued interest and dividends receivable	29,227	0
Financial liabilities:
Subordinated debt	0	0
Accrued interest payable	0	0
Estimated Fair Value | Level 3 | Deposits payable on demand
Financial liabilities:
Deposits	0	0
Estimated Fair Value | Level 3 | Time deposits
Financial liabilities:
Deposits	0	$ 0
FHLBNY advances	$ 0

COMMITMENTS, CONTINGENCIES AN_3

COMMITMENTS, CONTINGENCIES AND OFF BALANCE SHEET RISK - Schedule of Financial Instruments Outstanding Representing Credit Risk (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total	$ 753,470	$ 946,180
Commitments to extend credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total	723,902	927,428
Standby letters of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total	$ 29,568	$ 18,752

COMMITMENTS, CONTINGENCIES AN_4

COMMITMENTS, CONTINGENCIES AND OFF BALANCE SHEET RISK - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Reserve for credit risk inherent in off balance sheet credit commitments	$ 1.6	$ 1.5
Property Assessed Clean Energy Commitments
Purchase Commitment, Excluding Long-term Commitment [Line Items]
Investment obligations, amount purchased	451.7
Remaining commitment under investment obligations	150
Petros PACE Finance
Purchase Commitment, Excluding Long-term Commitment [Line Items]
Investment obligations, amount purchased	53.5
Remaining commitment under investment obligations	$ 14.3

LEASES - Lease Cost and Other I

LEASES - Lease Cost and Other Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease cost	$ 7,216	$ 8,219
Cash paid for amounts included in the measurement of Operating leases liability	$ 10,745	$ 10,193
Weighted average remaining lease term on operating leases (in years)	3 years 10 months 24 days	4 years 8 months 12 days
Weighted average discount rate used for operating leases liability	3.25%	3.25%

LEASES - Remaining Commitments

LEASES - Remaining Commitments of Operating Lease Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2023	$ 11,285
2024	11,310
2025	10,574
2026	9,176
2027	955
Thereafter	0
Total undiscounted operating lease payments	43,300
Less: present value adjustment	2,521
Total Operating leases liability	$ 40,779	$ 48,160

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 12,936	$ 12,936
Accumulated amortization of intangible assets	5,900
Amortization of intangible assets	$ 1,046	$ 1,207	$ 1,370

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2023	$ 888
2024	730
2025	574
2026	419
2027	265
Thereafter	229
Total	$ 3,105

VARIABLE INTEREST ENTITIES (Det

VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Maximum exposure to credit loss	$ 64,200
Unconsolidated Variable Interest Entities
Variable Interest Entity [Line Items]
Tax credit investments included in equity investments	3,299	$ 1,681
Loans and letters of credit commitments	60,857	52,813
Funded portion of loans and letters of credit commitments	47,683	15,512
Tax credits and other tax benefits recognized	$ 2,672	$ 11,571

PARENT COMPANY ONLY CONDENSED_3

PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION - Condensed Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 63,540	$ 330,485
Other assets	29,522	46,439
Total assets	7,843,124	7,077,876
LIABILITIES AND EQUITY
Subordinated debt, net	77,708	83,831
Stockholders' equity	508,955	563,875	$ 535,821	$ 490,544
Total liabilities and stockholders’ equity	7,843,124	7,077,876
Parent Company
ASSETS
Cash and cash equivalents	10,884	42,886
Investment in banking subsidiary	580,664	605,074
Other assets	113	12
Total assets	591,661	647,972
LIABILITIES AND EQUITY
Subordinated debt, net	77,708	83,831
Accrued expense and other liabilities	5,131	399
Stockholders' equity	508,822	563,742
Total liabilities and stockholders’ equity	$ 591,661	$ 647,972

PARENT COMPANY ONLY CONDENSED_4

PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION - Condensed Statements of Income and Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Condensed Income Statements, Captions [Line Items]
Interest expense	$ 18,649	$ 6,222	$ 10,479
Other expense	12,960	9,360	7,542
Net income	81,477	52,937	46,188
Total comprehensive income (loss), net of taxes	(32,639)	41,170	$ 60,139
Parent Company
Condensed Income Statements, Captions [Line Items]
Other income	617	11,800
Equity in undistributed subsidiary income	84,321	41,684
Interest expense	2,693	399
Other expense	768	148
Net income	81,477	52,937
Total comprehensive income (loss), net of taxes	$ (32,639)	$ 41,170

PARENT COMPANY ONLY CONDENSED_5

PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION - Condensed Statement of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net income	$ 81,477	$ 52,937	$ 46,188
Adjustments:
Net gain on repurchase of subordinated debt	(617)	0	0
Change in other assets	19,114	7,445	11,041
Change in other liabilities	(5,767)	(11,071)	(4,131)
Net cash provided by operating activities	147,322	70,538	65,771
Cash flows from investing activities
Net cash used in investing activities	(1,202,491)	(865,410)	(755,137)
Cash flows from financing activities
Dividends paid	(11,211)	(9,978)	(9,987)
Repurchase of shares	(12,478)	(2,920)	(7,001)
Net increase (decrease) in subordinated debt	(5,633)	83,831	0
Proceeds from common stock issued under Employee Stock Purchase Plan	665	0	0
Net cash provided (used) by financing activities	788,224	1,086,588	605,597
Net change in cash and cash equivalents	(266,945)	291,716	(83,769)
Cash, cash equivalents, and restricted cash at beginning of year	330,485	38,769	122,538
Cash, cash equivalents, and restricted cash at end of year	63,540	330,485	38,769
Parent Company
Cash flows from operating activities
Net income	81,477	52,937
Adjustments:
Equity in undistributed subsidiary income	(84,321)	(41,684)
Net gain on repurchase of subordinated debt	(617)	0
Change in other assets	726	(12)
Change in other liabilities	(610)	399
Net cash provided by operating activities	(3,345)	11,640
Cash flows from investing activities
Payments for investments in subsidiaries	0	(42,490)
Net cash used in investing activities	0	(42,490)
Cash flows from financing activities
Dividends paid	(11,211)	(7,597)
Repurchase of shares	(12,478)	(2,498)
Net increase (decrease) in subordinated debt	(5,633)	83,831
Proceeds from common stock issued under Employee Stock Purchase Plan	665	0
Net cash provided (used) by financing activities	(28,657)	73,736
Net change in cash and cash equivalents	(32,002)	42,886
Cash, cash equivalents, and restricted cash at beginning of year	42,886	0
Cash, cash equivalents, and restricted cash at end of year	10,884	42,886	$ 0
Supplemental non-cash investing activities:
Equity exchange for the outstanding common stock of Amalgamated Bank	$ 0	$ 541,093